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Childhood asthma and preterm birth (PTB) are both major health problems in the 
United States. This dissertation addressed three knowledge gaps regarding PTB and 
development of childhood asthma, including inconsistency of their association, 
limited exploration on pathways that linking them, and sparse information on 
longitudinal patterns of childhood asthma. 
This dissertation used data from a large, well-established, prospective birth 
cohort, the Boston Birth Cohort, which is urban, predominantly poor, and multiethnic 
(about 60% is African Americans). 2,540 children followed up to 9 (mean=5±2.8) 
years old were included for analysis. PTB was defined as <37 completed weeks of 
gestation from medical records. Asthma was defined by relevant diagnoses and 
medications from electronic medical records up to age 9 years. An array of pre- and 
peri-natal risk factors were coded from maternal surveys and medical records. The 
analysis was guided by a life course framework linking pre-, peri- and post-natal 
factors together. 
Results of analysis firstly showed that the estimates of PTB-asthma association 
were robust over 11 different measures of asthma at both ages 0-5 and 6-9 years, as 
well as the dose-response association between degree of prematurity and asthma. 
Second, PTB was not only ranked one of the strongest independent risk factors for 
asthma (defined by ≥2 diagnoses) among the pre- and peri-natal risk factors 
examined, but also mediated the effects of preeclampsia and chorioamnionitis and 
moderated (enhanced) the effects of maternal smoking during pregnancy, maternal 
iii 
history of allergies, and cesarean delivery on asthma. Third, from birth to age 6 
years, PTB increased the risk of persistent asthma defined by both the Tucson 
Children’s Repository Study and Longitudinal Latent Class Analysis approaches, but 
not the risk of late-onset asthma defined by either approaches. 
Findings of this dissertation suggest that PTB has become one of the major 
determinants for childhood asthma, particularly in the urban, low-income 
populations (population attributable fraction of PTB is 12~18%); and imply that 
primary prevention of PTB is not only important in itself but may simultaneously 
reduce the burden of childhood asthma, which may be a cost-efficient strategy to 
improve health disparities and population health across the lifespan. 
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Asthma is among the most common chronic childhood illnesses in the United 
States, affecting about 9.3% (6.8 million) of American children under 18 years old in 
2012.1 The disproportionately high rate of childhood asthma among 
socioeconomically disadvantaged minorities, particularly African Americans, is 
among the major health disparities in the United States.1-4 Asthma is a complex 
disorder characterized by variable and recurring symptoms, airflow obstruction, 
bronchial hyperresponsiveness, and underlying inflammation.5 
Previous studies suggest that the airway inflammation develops through an 
interactive process between host and environment beginning early in life,5 at the 
same time as the development of the immune system,6 the airway matrix,7 and the 
stress response system (Hypothalamic–Pituitary–Adrenal axis).8 Indeed, the majority 
of children with persistent asthma experienced the onset of symptoms (e.g. 
wheezing and cough) in the first six years of life.9 These findings suggest that a 
systematic and in-depth investigation of early-life risk factors and developmental 
patterns is as a promising approach to understanding the root causes of asthma. 
Preterm birth is also a major health problem in the United States, affecting one 
in nine live births.10,11 Like asthma, it is more common in the African American 
population, affecting one in five live births. Preterm birth can have profound adverse 
impacts on lung growth and development,12 lung function,13 and innate and adaptive 
immune responses.6,14 Growing evidence pinpoints preterm birth as an important 
risk factor for asthma among children under 10 years old.15-17 Preterm birth may be 
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of particular importance in understanding the “fetal origins of asthma”7,18,19 and 
“infant origins of asthma”20 hypotheses. Investigating the linkage among the 
disadvantaged African American population is especially important, given that this 
population is disproportionally affected by both preterm birth and asthma. 
This dissertation research aims to address three major knowledge gaps 
regarding the link between preterm birth and development of childhood asthma. 
First, uncertainties remain about the relationship between preterm birth and 
childhood asthma. Although recent epidemiological studies have found that preterm 
birth was associated with an increased risk of childhood asthma, the effect size and 
the strength of the association varied considerably among studies.17 The differences 
may be due to heterogeneities in the measurement of childhood asthma,21 degree of 
prematurity,22 and age ranges of the included children.1 To date, no cohort study has 
simultaneously examined the extent to which these heterogeneities affect estimates 
of the association between preterm birth and childhood asthma. 
Second, although previous studies have shown that some pre- and peri-natal 
variables are associated with both preterm birth and childhood asthma,5 how pre- 
and peri-natal variables, preterm birth, and childhood asthma are interrelated 
remains unclear. More longitudinal research is needed to elucidate the role of 
preterm birth -- as a mediator and/or moderator -- in the pathways between early 
life factors and childhood asthma. 
Third, the age of onset and longitudinal pattern of key symptoms (e.g., 
wheezing) vary among asthmatic children during the first 7 years of life,23 and a 
4 
better understanding of this variation will provide insight about the etiology of 
childhood asthma and the prognosis for diagnosed children. Longitudinal patterns of 
wheezing were characterized twenty years ago by the Tucson Children’s Respiratory 
Study (TCRS)9 based on two rounds of follow-up data (the TCRS classification 
approach). More recent studies have attempted to characterize longitudinal patterns 
of wheezing using advanced statistical modeling based on multiple rounds of follow-
up data24 (the statistical modelling approach). To my knowledge, this stream of 
research25,26 has focused on wheezing symptoms only, and has not been extended to 
include physician-diagnosed asthma or its relationships with preterm birth. 
This dissertation uses data from a large, well-established, prospective birth 
cohort, the Boston Birth Cohort (BBC), which is urban, predominantly poor, and 
multiethnic (about 60% is African American). The BBC recruits mother-child dyads at 
birth to examine the determinants of preterm birth,27 and follows them to study 
child development and disease, including asthma. At both the baseline and follow-
up, the BBC has collected comprehensive maternal, child, and family information 
from face-to-face maternal questionnaire interviews and medical records.28 A unique 
feature of this cohort is its ability to link pre-, peri- and post-natal variables in a life 
course framework to better understand the role of early-life factors and preterm 
birth in the development of childhood asthma. 
1.2 Specific Aims 
Specific Aim 1 is to examine the consistency of various childhood asthma 
measures, and to determine whether the association between preterm birth and 
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childhood asthma varies by measurement of asthma, degree of prematurity, and age 
at asthma assessment. 
Specific Aim 1 has five objectives:  
1a. To examine the agreement among eleven childhood asthma measures 
defined by type of EMR data (physician diagnosis vs. prescribed 
medication), clinical phenotype (wheezing vs. asthma vs. asthma 
exacerbation), and number of episodes (single vs. multiple) at ages 0-5 
years;  
1b. To examine the agreement among eight asthma measures defined by type 
of EMR data (physician diagnosis vs. prescribed medication), clinical 
phenotype (wheezing vs. asthma vs. asthma exacerbation), and number of 
episodes (single vs. multiple) at ages 6-9 years;  
1c. To examine the agreement between eleven childhood asthma measures 
assessed at ages 0-5 years and two asthma measures assessed at ages 6-9 
years;  
1d. To assess the association between preterm birth and eleven measures of 
childhood asthma assessed when children were ages 0-5 years;  
1e. To assess the association between preterm birth and eight measures of 
childhood asthma assessed when children were ages 6-9 years. 
Specific Aim 2 is to systematically examine the role of preterm birth and other 
pre- and peri-natal risk factors in the development of childhood asthma. 
Specific Aim 2 has three objectives: 
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2a. To compare the relative importance of preterm birth and other pre- and 
peri-natal risk variables in the development of childhood asthma;  
2b. To investigate the degree to which the effects of pre- and peri-natal risk 
factors on the risk of childhood asthma are explained (mediated) by preterm 
birth; 
2c. To investigate whether the effects of pre- and peri-natal risk factors on the 
risk of childhood asthma differ (are moderated) by preterm birth. 
Specific Aim 3 is to characterize longitudinal patterns of childhood asthma using 
both the TCRS classification and statistical modeling, and to determine whether 
these longitudinal patterns vary between children born preterm and children born 
term. 
Specific Aim 3 has four objectives: 
3a. To identify longitudinal patterns of childhood asthma using the original and 
modified TCRS classification rules; 
3b. To identify longitudinal patterns of childhood asthma using Longitudinal 
Latent Class Analysis (LLCA); 
3c. To assess the relationship between preterm birth and longitudinal patterns 
of childhood asthma defined by the TCRS rules; 
3d. To assess the relationship between preterm birth and longitudinal patterns 
of childhood asthma defined by LLCA. 
1.3 Conceptual Framework: A Life Course Model 
 Figure 1-1 presents the life course, multilevel conceptual framework that 
7 
guided my dissertation research. It illustrates that the preterm birth-asthma link is 
part of the life course pathways that unfold from the pre- and peri-natal periods 
through childhood and how these pathways are influenced by multiple ecological 
layers of the environment. This framework is motivated by the growing literature that 
is reviewed in Chapter 2, in particular, the causal pathways linking preterm birth and 
asthma proposed by Jaakkola et al,17 the life course/developmental framework29 
(particularly the “fetal origins”7 and the “fetal and infant origins”20 hypotheses of 
asthma), and the social ecological framework.30,31 
At the center of the framework is the association between preterm birth and 
childhood asthma. The horizontal axis identifies three life stages: prenatal, perinatal, 
and infancy and childhood. The vertical axis identifies different ecological layers from 
the molecular and physiological through individual, microsystem (family), and 
exsosystem (neighborhood). The diagram illustrates the potential causal pathways 
linking preterm birth and asthma and the ways these pathways are influenced by 
factors at multiple levels. In particular, this framework can be divided into two parts 
by life stage – the fetal origins perspective and the infant origins perspective on the 
role of preterm birth in the development of childhood asthma. The diagram shows 1) 
the fetal origins perspective (mainly the left half of Figure 1-1, the red + purple lines 
and boxes), and 2) the infant origins perspective (mainly the right half of Figure 1-1, 
blue + purple lines and boxes).  
This dissertation focused on three parts of the framework, as highlighted by 
boxes and solid lines. The first part is the association between preterm birth and 
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childhood asthma. As noted above and detailed in Chapter 2, there is inconsistency 
in the estimation of the preterm birth-asthma association. Therefore, this 
dissertation begins with the boxes at center of the diagram, testing the relationship 
between preterm birth and asthma allowing for different measures of childhood 
asthma, various degrees of prematurity, and different ages at assessment of asthma 
(Specific Aim 1). 
The second part is to understand the preterm-asthma link from a fetal origins 
perspective, shown in the diagram by the red and purple solid lines and boxes. The 
fetal origins perspective states that childhood asthma is the result of the joint effects 
of pre- and peri-natal variables and preterm birth. I hypothesize that 1) preterm birth 
partially mediates the effect of pre- and peri-natal factors on childhood asthma; 2) 
preterm birth also moderates the links between prenatal variables and childhood 
asthma (Specific Aim 2). The fetal origins perspective is prioritized in this dissertation 
as it will potentially have more implications for the primary prevention of both 
preterm birth and asthma than the infant origins perspective. 
The third part is to further delineate the association between preterm birth and 
asthma by focusing on longitudinal patterns of childhood asthma. This is a largely 
unexplored area, and this dissertation aims to apply both existing and evolving 
analytic methods to advance our understanding of the relationship between preterm 
birth and longitudinal patterns of childhood asthma (Specific Aim 3). 
The remaining parts of the framework, the infant origins and ecological 
approaches shown by dotted lines, are included to provide a comprehensive picture 
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of the life course framework, but they are beyond the scope of this dissertation, and 
something I plan to tackle in my postdoctoral work. 
1.4 Overview of this Dissertation 
The three specific aims of this dissertation are addressed in three separate 
chapters, and written as three stand-alone manuscripts, each containing an abstract 
and introduction, methods, results, and discussion sections. Chapter 1 serves as an 
overall introduction to the entire project. Chapter 2 reviews the literature and 
summarizes knowledge and gaps in knowledge about the association between 
preterm birth and asthma. Chapter 3 describes the Boston Birth Cohort, the 
measures used, and the methods used to address each specific aims. Chapters 2 and 
3 contain more detail than the introductory and methods sections of each paper 
(Chapters 4-6). 
Chapter 4 addresses Specific Aim 1 with a manuscript titled “Preterm Birth and 
Childhood Asthma: The Role of Asthma Measures, Degree of Prematurity, and Age at 
Asthma Assessment”. Chapter 5 addresses Specific Aim 2, with a manuscript titled 
“The Multiple Roles of Preterm Birth in the Development of Childhood Asthma”. 
Chapter 6 addresses Specific Aim 3, with a manuscript titled “Preterm Birth and 
Longitudinal Patterns of Childhood Asthma in the Boston Birth Cohort”. 
Chapter 7 summarizes the key findings and the contributions of the dissertation 
to the literature, and discusses the strengths and limitations of this dissertation. 
Finally, it offers perspectives on the implications of my research findings, both for 
future research and for clinical and public health practice.  
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Figure 1-1. A Life Course Multilevel Framework for Preterm Birth and Childhood Asthma 
Notes: Only the parts with solid lines (fetal origins) are the foci of this dissertation. The red + purple part is the fetal origins perspective. The blue + purple 
part is the infant origins perspective.  
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2.1 Clinical and Public Health Significance of Childhood Asthma in the United 
States 
Childhood asthma is a chronic condition with high prevalence, heavy disease 
burden, pronounced disparities among social groups, and multifaceted and 
potentially long-term effects on child development and family wellbeing. 
Prevalence: Asthma is one of the most prevalent chronic health conditions 
among American children under age 18 years.1 According to the 2012 National 
Health Interview Survey, the age-adjusted prevalence of current asthma among 
American children was 9.3%,2 and the age-adjusted lifetime prevalence of asthma 
was 14.0%.2 In 2010, the asthma attack rate was 5.6% for all American children.3 
Cost and Burden: Childhood asthma generates heavy medical4 and economic 
burdens5-9 in the Unites States. The annual direct medical spending on asthma 
treatment for children was about $4.4 billion U.S. dollars in 2005.5 Children with 
asthma have more clinical visits10 and hospitalizations,11 and more comorbidities of 
atopic diseases12 relative to children without asthma. 
Health Disparities: Poor, minority children are at the highest risk of asthma in 
the Unites States. In recent years, asthma prevalence for children living in poverty 
has been at least 1.4 times higher than that for their non-poor counterparts.2,13 The 
prevalence of asthma among children covered by Medicaid or other public insurance 
is about 1.3 times than children covered by other types of insurance.2 Asthma 
prevalence among African American children aged under 18 years is at least 1.5 
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times higher than that for all American children.2,13,14 Not growing up in a farm 
environment15 and male sex13 are both associated with a slightly increased likelihood 
of childhood asthma. 
Child Health and Development: Childhood asthma has adverse effects on many 
aspects of child health and development. Even mild to moderate asthma interferes 
with a child’s lung growth and function,16 and even leads to airway remodeling in 
severe cases, which cannot be reversed by existing treatments.17 Moreover, the 
psychosocial development of some asthmatic children may be compromised due to 
poorer school attendance,18 and lower participation in sports and other daily life 
activities.19 
Long Term Effect: Childhood asthma also has long-term effects on health over 
the life course. Asthma will persist into adulthood for over half of children with 
asthma,20 adding disease burden to the adult period since asthma cannot be cured 
by current treatments.21 Even among children who grow out of asthma symptoms, 
childhood asthma affects general health, body mass index, and missed days of work 
and school in young adulthood.22 In addition, childhood-onset asthma, especially 
severe asthma, may lead to lower labor market participation in adulthood.18 
Quality of Life and Family Impact. A child’s asthma not only reduces his or her 
quality of life,23 but also reduces the quality of life of his or her caregivers24-26 and 
increases psychosocial stress among family members.27 
Prevention of Asthma. Disease prevention efforts can be classified into three 
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stages: primary (reducing incidence of disease by eliminating risk factors before 
occurrence of clinical symptoms), secondary (disease detection, management, and 
control), and tertiary (reducing disease complications and consequences).28 Current 
prevention efforts for childhood asthma in the United States are mainly secondary, as 
asthma cannot be cured by current treatments. While most childhood asthma can be 
controlled with medication,29 the adherence rate for long term control medication -- 
inhaled steroids -- is low.30 Half of previous studies reported the adherence rate to be 
less than 50% among asthmatic children31. Secondary prevention strategies such as 
educating or changing disease control behaviors among asthmatic children and their 
parents32 and removing triggers from the child’s environment33 have shown limited 
effectiveness. Primary interventions to reduce risk factors in the pre and peri-natal 
periods are rarely reported,33 but may represent a promising and cost-effective 
strategy for reducing the incidence of childhood asthma. 
2.2 Childhood Asthma: Definition, Pathogenesis, Diagnosis, Working 
Definition, and Longitudinal Patterns 
Definition: Asthma is currently accepted as a syndrome34 with no universally 
agreed upon definition due to its complex causes and variable manifestations.35 The 
National Heart, Lung, and Blood Institute (NHLBI) provides an operational definition 
of asthma, which summarizes current understanding of this disease: 
“Asthma is a chronic inflammatory disorder of the airways in which many 
cells and cellular elements play a role: in particular, mast cells, eosinophils, 
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T lymphocytes, macrophages, neutrophils, and epithelial cells. In 
susceptible individuals, this inflammation causes recurrent episodes of 
wheezing, breathlessness, chest tightness, and coughing, particularly at 
night or in the early morning. These episodes are usually associated with 
widespread but variable airflow obstruction that is often reversible either 
spontaneously or with treatment. The inflammation also causes an 
associated increase in the existing bronchial hyperresponsiveness to a 
variety of stimuli. Reversibility of airflow limitation may be incomplete in 
some patients with asthma (EPR 1991; EPR⎯2 1997).”21 
Pathogenesis. The origin of the underlying airway inflammation that leads to 
the clinical expression of asthma has no definitive explanation. The NHLBI guideline 
summarizes that such airway inflammation develops through an interactive process 
between host and environmental factors happening at a crucial time in the 
development of the immune system21. Genetics are emphasized by the NHLBI 
guideline as key host factors.21 Although asthma is reported to be highly heritable 
(heritability ranges from 53% to 92% in large twin studies),36 identified genetic 
variants explain only a small proportion of the heritability of asthma.37 Environment38 
and host-environment factors are also important.37 Given that genetics cannot 
explain the rapid increases in the incidence of asthma, especially childhood asthma,39 
observed in developed countries since the 1970s,40 the search for modifiable 
environmental factors is of great interest to asthma researchers.41 
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The complex interplay of genetic and environmental factors in the pathogenesis 
of asthma is illustrated in Figure 2-1, in which Henderson and Warner41 summarized 
two pathways (“components”) that combined to predispose children to asthma. First, 
the airway development pathway (left half of Figure 2-1) suggests that the 
inflammation originates from altered form and function of airway matrixes. Second, 
the airway inflammation pathway (right half of Figure 2-1) suggests that excessive 
and persistent airway inflammation is predisposed by genetic susceptibility in the 
immune system with exposure to certain environmental stimuli in early life. Of note, 
development of immune system and lung can be dated back to fetal period and 
influenced by those genetic and environmental factors during prenatal period. Thus, 
these two hypothesized pathways are consistent with the perspective of “fetal 
origins of asthma” that they argued with evidence from epidemiological studies and 
known physiological mechanisms. 
Henderson and Warner‘s hypothesized pathways are insightful but limited in the 
following aspects. First, from a life-course perspective, their diagram emphasizes 
prenatal factors and doesn’t differentiate the risk factors by life-stages. For example, 
the pathways proposed from the “fetal and infant origins of asthma” perceptive by 
Duijts42 also emphasize the environmental factors in both fetal period (smoking and 
diet) and infancy (e.g. breastfeeding and respiratory infectious diseases). Second, 
from an ecological perspective, they omit other physiological systems (such as neural 
and endocrine systems) that may influence the risk of asthma and other 
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environmental factors such as psychosocial stressors. Given that response to stress 
could also increase inflammatory responses, Wright argued that maternal 
psychological functioning through disrupted maternal physiological functioning 
(immune/autonomic/hypothalamus-pituitary-adrenal [HPA] axes response to stress) 
during pregnancy may influence the development of immune system of fetus and 
thus might influence the occurrence and progression asthma.43 Third, Henderson and 
Warner did not recognize the important role of preterm birth as a risk factor and 
potential mediator or moderator in the early life origins of asthma.44 The framework I 
presented in Chapter 1 (Figure 1-1) addresses these gaps. 
Diagnosis of Childhood Asthma. According to the NHLBI guidelines, a diagnosis 
of asthma is based on 3 major components: 1) clinical assessments of symptoms to 
determine the presence of “episodic symptoms of airflow obstruction”, among which 
wheezing is of special importance in early childhood; 2) physiological measurements 
of airflow obstruction and its reversibility, 3) exclusion of alternative diagnoses, such 
as allergic rhinitis.21,45 
Asthma is primarily a clinical diagnosis, which is established by a physician 
conducting a detailed medical history interview and physical examination. Children’s 
responses to a trial of asthma medications can also be used to establish diagnoses.21 
For children over age 5 years or older,35 spirometry is used to demonstrate reversible 
airflow obstruction,21 but it is not recommended for younger children due to the 
difficulty of maneuvering the devices and completing the tasks appropriately.46 In 
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practice, diagnosing asthma among preschoolers is difficult, as it is mainly based on 
clinical symptoms, such as recurrent episodes of wheeze and cough taking into 
account family history of asthma and allergies, without objective measurements of 
airflow obstruction and reversibility.21 Appendix Boxes 2-1 and 2-2 display the key 
indicators suggesting and differentiating asthma diagnoses. 
Working Definition: Due to lacking a universal definition of asthma, previous 
epidemiological studies have used different measures of childhood asthma. A recent 
review of the literature identified 60 working definitions of asthma, which produced 
a wide range of estimation of asthma prevalence (15.1% to 51.1%)47 among children. 
These definitions differ in core clinical phenotypes (recurrent wheezing48 vs. 
asthma49 vs. bronchial hyperresponsiveness47), types of medical records data 
(physician diagnosis48,50 vs. medication use51), and sources of data (parental reports52 
vs. medical records53). Measures based on distinct working definitions may also have 
different reporting errors.53,54 Very few studies have examined how different working 
definitions of asthma may influence the estimates of associations between early life 
factors and childhood asthma. 
As reviewed above and in Box 2-1, recurrent wheezing is the major symptom 
indicating a diagnosis of asthma, but differentiating the wheezing symptoms caused 
by asthma from other respiratory diseases is difficult among young children, even in 
clinical settings, due to lack of objective measurements of airflow obstruction and 
reversibility in early life. To avoid misclassification and inconsistency, a stream of 
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epidemiological studies have chosen to focus on recurrent wheezing55 or wheezing 
associated with viral respiratory illnesses56 rather than a physician diagnosis of 
asthma to study the development of childhood asthma in the first 5 or 6 years of life. 
To accommodate the complexity of classification, both physician diagnosed wheezing 
and asthma are included as major measures of childhood asthma in this dissertation, 
to discuss about the consistency of measures and developmental patterns of 
childhood asthma. 
Longitudinal Patterns of Childhood Asthma: Various longitudinal patterns of 
childhood asthma (also called “phenotypes of childhood asthma” or “phenotypes of 
wheezing” in some literature; referred to as “longitudinal patterns of asthma” in this 
dissertation) can be defined based on age of onset and duration of asthma or 
wheezing in the first decade of life.57 Different longitudinal patterns of asthma may 
have distinct prevalence and severity, be associated differently with risk factors, and 
imply potential particular etiological mechanisms.58 For example, persistent asthma 
cases (i.e., early onset and continuation through childhood) have more severe 
symptoms and worse lung function compared to cases with transient asthma (i.e., 
variable onset, but short duration).59 Distinguishing various longitudinal patterns of 
asthma can facilitate both the detection of asthma and research on asthma 
development. 
Most studies on longitudinal patterns of childhood asthma follow the 
classification rules introduced by Martinez and colleagues using parental reported 
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history of wheezing data from the Tucson Children's Respiratory Study (TCRS).56 Like 
other studies mentioned above that use wheezing to study development of asthma, 
this classification is based on the presence of lower respiratory tract illness with 
wheezing at two ages -- the first three years of life (ages 0-2 years) and age 6 year 
identifies, and found four longitudinal patterns of wheezing -- transient early, late-
onset, persistent, and none.56 Transient early wheezing refers to the pattern with 
presence of wheezing in the first three years of life but not at age 6. Late-onset 
wheezing refers to the pattern with wheezing at age 6 but not in the first three years 
of life. Persistent wheezing refers to the pattern with wheezing in both the first three 
years of life and at age 6. No wheezing refers to having no wheezing symptoms in the 
first three years of life or at age 6. 
These rules do not include symptoms between ages 3 and 5 years in the 
classification due to lack of data in the original study, which may lead to 
misclassification or under-identification of some asthma patterns. For example, if a 
child has wheezing symptoms only between ages 3 and 5, he or she will be assigned 
to the no wheezing pattern. 
Recent cohort studies have used more complex , data driven statistical 
approaches60, such as cluster analysis,61 longitudinal latent class analysis62 and latent 
class growth analysis,63 to identify longitudinal patterns of childhood asthma based 
on repeated measures of wheezing. Results from these studies have confirmed the 
four longitudinal patterns of asthma in the original TCRS classification rules, but have 
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also discovered new longitudinal patterns, such as prolonged wheezing and 
intermediate-onset wheezing.62 Studies using longitudinal wheezing patterns as 
outcome variables suggest that different longitudinal patterns are associated with 
distinct symptoms (e.g. atopic vs. non-atopic, declined vs. non-declined lung 
functions)64, and different genetic and environmental factors.64 
Research on longitudinal patterns of childhood asthma is growing, but has 
mostly relied on parental reports of wheezing instead of physician diagnosed asthma. 
This is a limitation as parental reported wheezing may be subject to report or recall 
biases and less accurate compared to physician diagnosed asthma and use of asthma 
medications documented in the medical records. These points will be reviewed in 
detail in section 2.5.1. 
2.3 Preterm Birth: Definition, Prevalence, Etiology, Risk Factors, and 
Consequences 
Definition. The World Health Organization (WHO) defines preterm birth as 
“babies born alive before 37 weeks of pregnancy are completed”.65 Recently, the 
American College of Obstetricians and Gynecologists (ACOG) have refined the 
definitions of preterm and term births,66,67 as summarized in Table 2-1. 
No uniform standard exists for categorizing gestational age to reflect degree of 
prematurity (i.e., to distinguish babies born very early, early, not very early, etc.).68 
Table 2-1 summarizes the classifications of gestational age used by the WHO,65 the 
Unites States Centers for Disease Control and Prevention (USCDC),69 and the 
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ACOG.67,70,71 These three guidelines are consistent in their cut-offs for preterm birth, 
but differ in sub-categories of preterm and term births. However, all three 
classifications reflect the notion that fetal maturation is a continuum, and that 
shorter gestational age indicates greater prematurity (less maturity) of a fetus.72 
Different degrees of prematurity may reflect distinct etiologies, clinical presentations, 
and impact on neonatal and childhood outcomes.72-74 
Prevalence. Data from the National Center for Health Statistics showed that the 
preterm birth rate was 11.4% for all live births in 2013.69 Moreover, preterm birth 
remained the highest among non-Hispanic black mothers (16.3%), followed by 
Hispanic mothers (11.3%) and non-Hispanic white mothers (10.2%).69 
In 2013, about 0.7% of all American live births occurred under 28 weeks of 
gestational age, 1.2% between 28 to 31 weeks, 1.5% between 32 to 33 weeks, 8.0% 
between 34 and 36 weeks (late preterm, also represented 70.1% of all preterm 
births), 24.8% were between 37 to 38 weeks (early term, also represented 29.8% of 
all term births), 49.8% between 39 to 40 weeks (full term), and 8.5% at the 41 weeks 
(late term), and 5.5% at 42 weeks or beyond (postterm).69 
Etiology and Risk Factors. Preterm birth is a complex syndrome.75 Current 
knowledge suggests that preterm birth results from multiple biological mechanisms, 
including activation of the maternal and/or fetal stress response system, 
inflammation or infection, ischemia/ decidual hemorrhage, and pathological uterine 
distension.21 However, many preterm births cannot be explained by the known 
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biological mechanisms.76,77 Therefore, a broad range of associated factors, from 
sociodemographic and community, psychosocial, clinical, and environmental to 
genetic aspects, are studied to explain the occurrence of preterm births.68 Many 
established risk factors for preterm birth are also associated with an increased risk of 
asthma among children, including psychosocial stress,78,79 race/ethnicity,76 
unmarried status,80 pregnancy complications (urinary tract infection, pre-eclampsia, 
intrauterine infection),75 maternal preexisting conditions (asthma, diabetes, 
hypertension, genital herpes, and previous caesarean delivery),81 and maternal 
smoking during pregnancy.82,83 Whether preterm birth is involved in the pathways 
from prenatal environment factors to childhood asthma remains unclear. 
Consequences: Preterm birth is the leading cause of neonatal and infant 
mortality and morbidity in the United States.84,85 Preterm birth accounted for about 
67% of infant deaths in 2010.86 Children born preterm have longer inpatient 
hospitalization after birth, more health care utilization in the first year of life,74 and 
higher medical costs during their first 18 years of life,87 compared with their term 
born counterparts. 
The survival rate of all live births in the United States, including preterm births, 
significantly improved in the 1970s88 due to wide availability of assisted ventilation,77 
and in the middle 1990s89(particularly for births under 28 weeks of gestational age90) 
due to several changes in neonatal intensive care.77 These improvements in survival 
increased the proportion of children born preterm in the population, and parallel 
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increases in asthma incidence, providing general support for the hypothesis that 
preterm birth has contributed to the epidemic of asthma. 
Preterm birth contributes to a range of diseases and functional problems. 
Besides well-recognized neurodevelopment and behavioral problems,91 preterm 
infants, even late and moderate preterm infants,92 are more likely to suffer from 
respiratory distress syndrome93 and bronchopulmonary dysplasia (BPD)94,95 
compared with term born infants. Of particular relevance to this dissertation, 
growing attention has been devoted to the long-term pulmonary outcomes 
associated with preterm birth,96 including chronic obstructive pulmonary disease97 
and asthma.98,99 
2.4 Overall Relationship between Preterm Birth and Childhood Asthma 
Over the past decade, preterm birth has increasingly been accepted as a 
contributor to respiratory conditions in childhood,100 in part due to the publication of 
relevant meta-analyses and the introduction of the “fetal origins”41,101,102 and “fetal 
and infant origins”42 hypotheses of asthma. However, estimates of the magnitude, 
direction, and significance of the preterm birth-asthma association in the literature 
are inconsistent. Both the robustness of the association between preterm birth and 
asthma, and the pathways that underlie their association are inadequately studied. 
2.4.1 Evidence from Meta-Analyses 
In 2006, Jaakkola and colleges103 reported a meta-analysis based on 19 original 
studies published during 1990-2005 using child and/or adult samples. The results 
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showed that preterm birth slightly increased the odds of asthma using both the 
fixed-effect model (pooled odds ratio [POR] = 1.07, 95% confidence interval [CI], 
1.07-1.08) and the random-effects model (POR = 1.37, 95%CI, 1.30-1.43). This was 
the first meta-analysis to evaluate the evidence about the preterm-asthma 
association, and supported preterm birth as determinant of asthma, including 
childhood asthma. However, this meta-analysis relied on studies using populations 
born before the mid-1990s, during which neonatal care practices and outcomes were 
somewhat different from the more recent situation as reviewed in section 2.3. 
Since 2005, additional studies have been published about the association 
between preterm birth and childhood asthma, but as a whole, these studies still 
reported inconsistent findings.48,55,104,105 In 2014, Been and colleagues99 conducted a 
systematic review and meta-analysis about the association between preterm birth 
and childhood asthma (wheezing disorders) among children (defined as under age 18 
years) based on 30 original studies published worldwide during 2003-2013. They also 
found that preterm birth was associated with an increased odds of childhood asthma 
(unadjusted POR = 1.71, 95%CI: 1.57-1.87, adjusted POR = 1.46, 95%CI: 1.29-1.65). In 
the same year, another meta-analysis aggregating individual data from 147,252 
children in 31 European birth cohorts was published,98 and reported that preterm 
birth was associated with higher odds of wheezing and asthma, adjusting for major 
confounders. These two studies provide additional support for the positive effect of 
preterm birth on the risk of childhood asthma. 
30 
Of note, while the rate of preterm birth in the United States was ranked the 
highest among all the developed countries,65 most of the studies on the preterm 
birth-asthma association were not based on American samples. The first meta-
analysis by Jaakkola and colleges103 only included 3 studies from the United States. 
The second meta-analysis by Been and colleagues99 included 8 studies from the 
United States, and only 2 of them focused on relatively older children (average age 
older than 5 years). The birth cohorts used for the last meta-analysis were all from 
Europe. Given the demographic and environmental differences between Europe and 
the United States, studies of American populations, especially high-risk populations 
such as low income African Americans,2,69 are critically needed. 
2.4.2 Possible Biological Pathways 
Preterm birth has adverse effects on the development of the lungs and other 
physiological systems, including the immune and endocrine systems, which may 
collectively contribute to the fetal origins of asthma mentioned in section 2.2. 
A major consequence of preterm birth is immature lungs.103 Lung development 
is still at the canalicular (16 to 24 or 26 weeks) or saccular stage (24 to 38 or 40 
weeks) at the time of preterm delivery,97,106,107 during which the structure of the lung 
and function of the surfactant and cortisol systems are not sophisticated enough to 
sustain autonomous respiration appropriately.107 Immature lungs coupled with lung 
tissue injuries due to mechanical ventilation and oxygen toxicity can lead to 
development of bronchopulmonary dysplasia (BPD) among preterm infants, 
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particularly among those delivered between 23 to 30 weeks of gestational age.97 All 
of these events can lead to abnormal development of airways and compromised lung 
function,107 and increased susceptibility to airway inflammation and early onset of 
asthma. 
Preterm birth may also adversely influence the development of the immune 
system and thus increase susceptibility to asthma. The innate (the first line of 
defense, targeting non-specific invasions) and adaptive (the second line of defense, 
targeting specific problems and refined with response to infections) immune 
responses are two major ways in which the human immune system protects the 
body against invasions of other organisms.108 Both the innate and adaptive functions 
are immature among preterm infants.34 In addition, trans-placental transport of 
Immunoglobulin G (IgG), cells involving in adaptive immunity response, from the 
mother to fetus occurs in the third trimester.34 Preterm birth thus disrupts both the 
normal maturation of the immune system and the trans-placental acquisition of 
antibodies. 
For the innate immune responses, according to Sharma and colleges109 the 
proinflammatory (e.g. Interleukin-1 beta [IL-1β], IL-6, IL-12, IL-23, Tumor Necrosis 
Factor-alpha [TNF-α]) and anti-viral (e.g. interferon- alpha [IFN-α]) cytokine 
responses are immature in preterm infants, increasing susceptibility to pathogens, 
and suffer functional loss “from infection itself or the inflammatory response 
generated under an oxidative stress”. In addition, two of the major pathways leading 
32 
to preterm birth are intrauterine infection and inflammation and maternal stress,75,76 
which may also disrupt development of the innate immune functions, contributing to 
the risk of asthma. One example is the effect of chorioamnionitis,110 which is 
associated with strong proinflammatory responses with increased level of 
cytokines.55 The same group of cytokines may also interfere with normal lung 
development and increase susceptibility to chronic respiratory diseases such as 
respiratory syncytial virus bronchiolitis111 and rhinovirus,112 both of which predict 
increased risks of wheezing51,113 and asthma51,114 in childhood. 
The adaptive immune response mainly comprises of antibodies (e.g. 
Immunoglobulin A, E, G) and T-helper cells (T-helper-1 [Th1] and T-helper-2 [Th2]). 
Previous research has focused on how an imbalance between Th1 and Th2 activities -
- overexpression of Th2 activity or underexpression of Th1 activity, affects the 
development of asthma and other allergic diseases.21 Preterm birth may increase the 
risk of asthma by shaping adaptive immune responses towards Th2 biased activities 
in at least two ways: non-vaginal delivery or altered postnatal environment. The 
“hygiene hypothesis”115 assumes that certain types of infections (induced by 
helminths, mycobacteria or the hepatitis A virus) are associated with 
underexpression of Th1 activity, thus reducing the allergic immune response.115 
Preterm children are likely to be delivered through cesarean section (C-section, 47% 
of all preterm births in 201369), which interrupts the colonization of gut flora and 
promotes allergic immune responses.116 Preterm infants, particularly those less than 
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32 weeks gestational age, may spend a long time in incubators at the neonatal 
intensive care unit and/or delay the timing of enrollment to daycare due to poor 
health conditions. These experiences may also lead to underexpression of Th1 
activity and more allergic responses, and thus increase the risk of asthma.117 
2.4.3 Inconsistency and Heterogeneity 
Previous studies have produced inconsistent results about the relationship 
between preterm birth and childhood asthma. For the 19 studies reviewed by 
Jaakkola and colleges,103 the estimated ORs for the preterm birth effect on asthma 
ranged from 0.7 to 2.3, and 10 of them reported a null effect instead a significant 
adverse effect.103 For the 30 studies reviewed by Been and colleagues,99 nearly a 
third reported null effects, while the others reported adjusted or unadjusted ORs 
ranging from 1.2 to 4.9.99 The majority of the studies based on the 31 European birth 
cohorts described in the third meta-analysis reported a null effect.98 
These meta-analyses explored whether study characteristics could explain the 
heterogeneity of results, but found that sample size, source of data (physician 
diagnosed vs. parental reported), geographic location (Europe vs. others), and 
publication year did not account for the differences in estimated effects.99,103 
Measure of asthma (asthma vs. wheezing, or physician diagnosed vs. others), mean 
age of the study sample, and study design (cross-sectional vs. cohort) might be 
related to the heterogeneity of estimates across studies, though their independent 
effects became attenuated or non-significant when adjusting for each other.103 
34 
However, the small sample sizes of the meta-analyses (n = 19 and n = 30) and 
differences in confounders adjusted for in the component studies limit the extent to 
which conclusions may be drawn.  
Based on my review of the literature, I identified five study characteristics that 
may account for the different estimates of the association between preterm birth 
and childhood asthma in the literature: 1) geographic location, 2) measurement of 
childhood asthma, 3) degree of prematurity, 4) age at assessment of asthma, 5) the 
confounders, such as prenatal maternal variables, adjusted in the statistical analyses. 
These aspects have not been well explored using a large prospective birth cohort in 
the United States. 
This dissertation is conducted in a single study site and thus controls geographic 
variations. It is thus focused on addressing the remaining four variations in study 
characteristics. Specific Aim 1 is to examine the consistency of various childhood 
asthma measures, and to determine whether the association between preterm birth 
and childhood asthma varies by measurement of asthma, degree of prematurity, and 
age at asthma assessment. Given that the confounding effects of other explanatory 
variables may reflect the variant etiologies and mechanisms of asthma development, 
Specific Aim 2 is to systematically examine the role of preterm birth and other pre- 
and peri-natal risk factors in the development of childhood asthma. Specific Aim 3 is 
to characterize longitudinal patterns of childhood asthma using both the TCRS 
classification and statistical modeling, and to determine whether these longitudinal 
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patterns vary between children born preterm and term. These analyses extend this 
dissertation research to a relatively new topic in the field, the phenotypic 
heterogeneity of childhood asthma118 and its relation to preterm birth. 
The analyses for all three specific aims will provide in-depth and rigorous 
knowledge about how preterm birth contributes to development of asthma. The 
following sections review the literature relevant to each of the Specific Aims. 
2.5 Specific Issues Related to Preterm Birth and Childhood Asthma 
2.5.1 Association of Preterm Birth and Childhood Asthma by Measure of Asthma, 
Degree of Prematurity, and Age at Asthma Assessment (Specific Aim 1) 
2.5.1.1 Degree of Prematurity  
Most large studies based on registration data, such as those in Sweden,119,120 
Australia,121 the United Kingdom,122 and the United States,51 support a dose-
response effect of younger gestational age on the likelihood of asthma from 
childhood to adolescence. The global meta-analysis showed that older gestational 
age was significantly protective for childhood asthma based on pooled results (POR = 
0.94, 95%CI: 0.92-0.96).99 The meta-analysis of 147,000 European children supported 
a reverse linear effect of length of gestational age on preschool wheezing under 5 
years, but not for school age asthma between ages 5 to 10, with some non-linear 
effects of early gestational age.123 
In addition, early preterm/very preterm birth is consistently reported to be 
associated with a higher risk of childhood asthma. The recent meta-analysis found 
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the pooled OR for very preterm (< 32 weeks) to be 3.0 (95%CI: 2.6-3.4), and all the 
reviewed studies reported a significant adverse effect of early preterm birth.99 
However, previous results about the effect of moderate to late preterm birth on 
asthma risk are inconsistent. On the one hand, some studies suggest that moderate 
and late preterm birth increase the risk of asthma in childhood. For example, a Dutch 
prospective cohort study found that asthma prevalence was the higher in moderate 
preterm (33-36 weeks) compared to full term (37-41 weeks).124 On the other hand, 
studies also have identified a null effect of late preterm birth on the development of 
childhood asthma. For example, a study using the Third National Health and 
Nutrition Examination Survey reported that late preterm birth was not significantly 
associated with the onset of physician diagnosed asthma.104 Another study based on 
part of the Boston Birth Cohort found that neither late preterm itself nor its 
interaction with chorioamnionitis significantly increased the risk of physician 
diagnosed asthma.55 
Early term is a relatively new classification of gestational age. Some studies have 
tested the effect of early term birth on childhood asthma and showed support for a 
slight increase in asthma compared with full term children. A large (n = 44,173) case-
control study from Finland found that the odds of prescribed asthma medication 
were higher for early term children (adjusted OR = 1.2; 95% CI: 1.1-1.4) than full term 
children.125 Another large (n = 14,273) longitudinal analyses based on the Millennium 
Cohort Study (MCS) in the United Kingdom found that early term children had higher 
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odds of wheezing or whistling in chest in the past 12 months at age 3 years (adjusted 
OR = 1.1, 95%CI: 1.0-1.2) and at age 5 years (adjusted OR = 1.2, 95%CI: 1.0-1.3), 
compared with full term children.122 Given that the very low effect sizes and the large 
samples in these studies, the association may not be detected in smaller samples. 
The observed significant association may also be due to the low standard errors in 
large samples, and not be a true effect with clinical significance. 
2.5.1.2 Measures of Asthma 
Studies of the preterm birth-asthma association in childhood have mainly relied 
on two outcome measures – recurrent wheezing and asthma. However, these two 
terms reflect different clinical manifestations, and may also reflect age patterns of 
diagnoses by physicians as discussed in section 2.5.1.3. According to the NHLBI 
guidelines, wheezing is the key indicating symptom for a diagnosis of asthma, but is 
neither sufficient nor necessary.21 Wheezing is defined as “high-pitched whistling 
sounds when breathing out”,21 and is a symptom of variable airway limitation. 
Wheezing is not specifically caused by asthma, and could be a result of other lung 
diseases that also induce variable airway limitation, such as bronchitis35. Besides 
variable airway limitation, asthma also has two additional components, airway 
hyperresponsiveness and airway inflammation.35 Due to the difficulty of excluding 
other lung diseases, recurrent wheezing is often used to measure the risk of asthma 
in childhood.126 A validation analysis found that relying on wheezing for a diagnosis 
of asthma may underestimate the risk of asthma.126 Using the same cohort and study 
38 
design, Kumar and colleagues studied the effects of preterm birth on recurrent 
wheezing (≥ 2 episodes of physician documented wheezing) and asthma (ever 
physician documented asthma) in early childhood, and found that the preterm birth 
effect was higher for recurrent wheezing than for asthma.55 
Apart from differences in clinical manifestations, measures of asthma also differ 
in the type of clinical data used. Physician diagnosis and prescribed asthma 
medication are the two main types of clinical data used in childhood asthma studies. 
Asthma measures based on diagnoses are more frequently used than those based on 
medication according to reviews of the literature on the preterm birth-asthma 
association99 and childhood asthma47. Studies in the United States are especially 
likely to use physician diagnosis measures for three reasons: 1) diagnosis data are 
more available from health care systems (e.g. Medicaid) or parental reports (e.g. 
interview questions47), and easier to recode than medication data; 2) diagnosis data 
measure the asthma syndrome more directly than medications, which may be 
treating single or some combination of respiratory symptoms; and 3) diagnoses are 
more often used in surveillance studies to define a disease, and thus may be more 
useful to public health practice. However, medication data are useful for measuring 
subtypes of asthma. For example, the Healthcare Effectiveness Data and Information 
Set (HEDIS), a tool used to measure health care quality in the United States, relied on 
long-term control medications (Long-Acting Beta-Agonists [LABAs] and/or inhaled 
corticosteroids) to detect persistent asthma.127 A study verified that medications are 
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more specific than diagnoses for measuring and tracking asthma.128 
 Finally, asthma measures differ in the source of data used. Parental reports and 
medical records are the two main sources for physician diagnoses of asthma. 
Parental reports are widely used globally, for example, in the International Study of 
Asthma and Allergies in Childhood (ISAAC).129 Given the popularity of electronic 
medical record (EMR) systems, more attention has been given to using EMR data in 
childhood asthma studies in the United States.130 EMR data are less subject to recall 
bias and to biases introduced by parents’ characteristics. However, EMR recorded 
diagnoses may be influenced by other errors (e.g. International Classification of 
Diseases [ICD] codes for diagnoses may be inaccurately documented by coders131) 
and the training and specialties of physicians.132 Studies in the United Kingdom found 
that parents were likely to under report asthma compared to than physicians,133 
particularly for children under age 3 years.134 They also found that only about 30% of 
parental reports of physician diagnosed asthma were verified by records from 
general practice physicians.134 Differences between medical records and parental 
reports may influence the estimates of preterm-asthma association. For example, 
two cohort studies with similar age ranges of children, published around the same 
time, found inconsistent results for the relationship between preterm birth and 
physician diagnosed asthma: the one that used parents’ reports found a non-
significant, small effect (OR = 1.12, p > 0.05), while the one that used EMR records 
found a significant, moderate effect (OR = 1.60, p < 0.05). 
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2.5.1.3 Age of Asthma Assessment 
Meta-analyses have reported that the effect of preterm birth on the 
development of asthma is strongest among children under age 10 years compared 
with older children or adults103. However, within samples of children (under age 18 
years) this age effect is less clear99. Age-specific physician diagnosing practices and 
the course of asthma development with age may influence the measurement of 
childhood asthma and thus estimates of the effect of preterm birth. 
As mentioned in section 2.2, diagnosing asthma with spirometry tests to 
establish variable airway limitation is difficult among children under 6 years.21 46 
Thus, wheezing is the key symptom to establish variable airway limitation for young 
children. Childhood asthma is also a chronic condition with variable origins and 
natural histories.135 About half of children with early onset of symptoms will grow 
out of asthma by school age,20 and a considerable proportion of children without 
early symptoms will develop asthma during school age.56 Thus asthma measures 
assessed in early childhood tend to include more transient and mild cases, while 
those measured in school age tend to include more persistent and severe cases. 
To emphasis the compromised diagnosing procedures and developmental of 
childhood asthma in early childhood, some clinical guidelines21,136 have cautioned 
physicians not to label a child with asthma, and recommended using the diagnosis of 
wheezing for uncertain cases. Therefore, childhood asthma is often called early 
wheezing disorder if the child is under age 5 or 6 years, and school age asthma if 
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assessed at ages 5 or 6 to 10 years.98 The European meta-analysis based on individual 
participant data found preterm birth effects of similar size on preschool wheezing at 
ages 1-4 years (1.34, 95%: 1.25-1.43) and school age asthma at ages 5-10 years (1.40, 
95%CI: 1.18-1.67).98 In the United States, two cohort studies both using EMR 
documented physician diagnosis of asthma but differing in ages of the children found 
very different effects of preterm birth on asthma: the one with a study sample under 
age 8 years found a moderate, significant effect (OR = 1.51, p < 0.05),137 while the 
one with a study sample age 1.5 years or younger found a lower, non-significant 
effect (OR = 1.26, p > 0.05).50 
In sum, different degree of preterm birth, various measures of asthma, and age 
of asthma assessment could influence the estimates of association between preterm 
birth and childhood asthma theoretically, but existing studies are very limited to 
describe the discrepancies and explore their impacts on preterm birth-asthma 
association. To address this gap, this dissertation is testing if the observed preterm 
birth-asthma association vary by asthma measure, degree of prematurity, and age of 
asthma assessment in Specific Aim 1. 
2.5.2 The Role of Preterm Birth and Pre- and Peri-natal Risk Factors in the 
Development of Childhood Asthma (Specific Aim 2) 
2.5.2.1 A Life Course Perspective on Preterm Birth and Childhood Asthma  
As mentioned in Chapter 1, three frameworks can be used to conceptualize the 
relationship between preterm birth and asthma: 1) the causal pathway framework, 
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2) the life-course developmental framework, and 3) the social ecological framework. 
Although previous literature has proposed these frameworks to explain the 
association between preterm birth and asthma, very few studies have integrated 
them or used them to guide investigations of the association between preterm birth 
and childhood asthma. I integrated these three frameworks into a life-course 
multilevel framework (Figure 1-1) to guide my work on this dissertation. The 
framework is deliberately broad, to provide a context for the questions addressed in 
this dissertation and a plan for my future work. The framework is especially useful for 
Specific Aim 2, because it allowed me to conceptualize the pathways linking preterm 
birth and childhood asthma and design analyses to understand the observed 
preterm-asthma association more deeply. 
The first motivating framework is the causal pathway framework summarized by 
Jaakkola et al103, which hypothesizes that 1) preterm birth is a mediator on the 
pathway from prenatal genetic and environmental factors to asthma, through the 
mechanism of lung development; 2) preterm birth and asthma have common genetic 
roots; 3) preterm birth and asthma reflect similar environmental hazards that are 
closely related, so the association between them reflects statistical covariation rather 
than “mechanistic changes” (i.e., the observed relationship is largely spurious). The 
general framework of causal pathways is widely used to explain associations found in 
observational studies. 
The second motivating framework is the life-course developmental framework, 
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which emphasizes the timing of exposures, adaptive processes, health trajectories, 
and cumulative risk across life stages.138 The “fetal origins of asthma”41 and the “fetal 
and infant origins of asthma”42 both hypothesize that the development of the lungs, 
the immune system, and the stress response system happen most rapidly in fetal and 
infant periods. Thus experiences during these periods will have a profound impact on 
the trajectory of asthma-related symptoms in childhood, through an adaptive 
process between the bio-behavioral regulatory systems and the contexts 
(psychosocial, environmental, and symbolic) experienced by the child.138,139 
The third framework is the social ecological framework.140-142 In this model, the 
health and development of individual is the result of the interaction between 
personal characteristics and the characteristics of multiple social systems. These 
social systems are nested within each other, and could be classified as individual (e.g. 
stress and behaviors), microsystem (school, family, community, and social network), 
mesosystem (interactions of the microsystems), exsosystem (e.g. welfare program 
and work place) and macrosystem (e.g. culture and social norms). In this framework, 
preterm birth as a complex syndrome and asthma as a development disease can be 
considered the result of the nested social ecological environments that human 
beings live in. 
I integrated these three motivating frameworks to build a three dimensional life-
course multilevel conceptual framework for the relationship between preterm birth 
and asthma (Figure 1-1). Specially, the life course perspective serves as the x-axis, 
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and the ecological layers as the y-axis, and three causal hypotheses linking variables 
from different life stages and ecological layers to preterm birth and asthma as the 
third dimension. This framework serves as tool to organize the multiple explanatory 
variables for preterm birth and childhood asthma into a set of testable hypotheses 
about pathways of influence. In this dissertation, I focus on the fetal origins portion 
of this complex conceptual framework. 
2.5.2.2 Fetal Origins Perspective on Childhood Asthma: the Role of Preterm Birth 
Multiple factors prior to and during pregnancy are associated with childhood 
asthma44,143, and also are associated with preterm birth.68 Genetic predispositions, 
indicated by family disease histories, especially maternal histories of asthma144 and 
allergic diseases145, are strongly associated with increased risks of asthma and born 
preterm68 in offsprings. Maternal social demographics, including African American 
race/ethnicity,146 unmarried status,147 and maternal acculturation,148 are all 
associated with increased the risks of childhood asthma and preterm birth68. 
Maternal pregnancy smoking, particularly continued to smoking during the 2nd and 
3rd trimesters, significantly increases the risks of childhood asthma48,147,149 and 
preterm birth68. Maternal health history, maternal pre-pregnancy obese150 may also 
increase the risks of childhood asthma and preterm birth68. Maternal pregnancy 
stress, maternal perceived stress151,152 and low social support153 during pregnancy 
are associated with increased risks of childhood asthma and preterm birth68. 
Pregnancy and obstetric complications154,155, maternal vaginitis and febrile 
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infections,145 and uterus-related pregnancy complications, including antepartum 
hemorrhage, preterm contractions, insufficient placenta and restricted growth of the 
uterus,156 chorioamnionitis,55 cesarean section delivery,157,158 and inadequate weight 
gain during pregnancy,159 are reported to be associated with different level of 
increases in the risk of childhood asthma, and strong precursors to preterm birth68. 
Family characteristics of the psychosocial aspect,160 including low socioeconomic 
status, conflicts, less support, and lack of family routine161 may be associated with 
the onset and development of childhood asthma and occurrence of preterm birth68. 
Home environment, including home dampness and low ventilation162 and 
environmental smoking163 during pregnancy are reported to be associated with 
increased risks of asthma and preterm birth68 in some studies. Neighborhood 
characteristics, such as socioeconomic variables (e.g. poverty rate, race segregation, 
crime) may increase the risks of asthma and preterm birth68 through the stress 
response pathways.164,165 
These shared social and clinical antecedents from the fetal period, along with 
potential shared biological mechanisms involving fetal physiological development 
(adverse effects of inflammation or infection, and fetal development of lung and 
immune systems, as reviewed in section 2.4.2), suggest that childhood asthma has its 
origins in the fetal period -- the “fetal origins hypothesis”. In this hypothesis, preterm 
birth could have at least two roles as shown on the conceptual framework. First, a 
mediating role, in which preterm birth is a result of genetic and prenatal antecedents 
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(e.g., maternal history of asthma and chorioamnionitis), and also a special event 
causes physiological changes in newborns, including altered gene expression,166 
abnormal airway matrix development in structure and function,41 and/or disrupted 
immunomodulation shaped towards airway inflammation,41 which all contribute to 
development of childhood asthma. Thus preterm birth explains a proportion of the 
effects of genetic and prenatal factors, but does not change the sizes or significances 
of effects of genetic and prenatal factors. Second, a moderating role, in which 
preterm birth changes the effects of pre- and peri-natal factors (e.g. maternal history 
of allergies, cesarean section delivery) on childhood asthma.41,68 In this setting, the 
pre- and peri-natal factors influences the developments of the above mentioned 
physiological systems early in the fetal period to increase susceptibility to childhood 
asthma, even before the occurrence of preterm birth. And preterm birth as a special 
event introduces extra susceptibility to development asthma, thus may augment or 
attenuated the original effects from other pre- and peri-natal factors. 
However, little effort has been dedicated to explain the association between 
preterm birth and childhood asthma, and tested the life course pathways that could 
potentially link preterm birth to development of childhood asthma. And even fewer 
prospective birth cohort studies have been done to assess the mediating and the 
moderating effects of preterm birth on childhood asthma. This may limit the 
understanding of the causal relationships between preterm and childhood asthma, 
and compromise the ability to identify the modifiable factors to develop better 
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primary and secondary prevention strategies for childhood asthma. To fill this gap, 
under the life course conceptual framework, this dissertation explores the origins of 
asthma from a fetal origins perspective in Specific Aim 2, which hypothesizes that the 
development of asthma is a long process which originates from fetal period and a 
result of multiple contributors; and this process is modified by preterm birth, or takes 
the route of preterm birth. 
2.5.3 Preterm Birth and Longitudinal Patterns of Childhood Asthma (Specific Aim 3) 
The association between preterm birth/degree of prematurity and 
longitudinal patterns of childhood asthma has not been studied extensively or 
appropriately. As mentioned before, one way to define the longitudinal patterns 
of childhood asthma is based on age of onset and duration of wheezing in young 
childhood, such as transient, late-onset, and persistent wheezing,167 using either 
the traditional classification approach from the TCRS or the statistical modeling 
of latent analysis. To my knowledge, no study has empirically tested the 
relationship between preterm birth status (defined as less than 37 weeks of 
gestation) and longitudinal patterns of childhood asthma. One study has 
examined the relationship between gestational age and longitudinal patterns of 
wheezing, and found that older gestational age significantly increased the odds 
of transient early wheezing but not the late-onset or persistent wheezing 
longitudinal patterns.168 However, this study is limited by having low prevalence 
of preterm birth. 
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Although the phenotypic heterogeneity of childhood asthma has been 
acknowledged for parental reported wheezing using both TCRS and latent statistical 
methods, the longitudinal patterns of asthma identified from the TCRS and latent 
analyses are not always the same. The original TCRS rule is limited by not including 
wheezing information during ages 3 to 5 years, but hasn’t been updated for 20 years. 
Since wheezing is still conceptually and clinically different from asthma, it is far from 
enough to explore the longitudinal patterns of childhood asthma based on only 
parental reported wheezing. Research on the preterm birth effects on childhood 
asthma longitudinal patterns has just begun, and the basic relationships are not 
tested. To fill this gap, this dissertation characterizes the longitudinal patterns of 
childhood asthma using physician diagnosed asthma by both the TCRS and the 
statistically modelling approaches, and assesses the relationships between preterm 
birth and these longitudinal patterns of childhood asthma in Specific Aim 3. 
2.6 The Significance of this Dissertation 
As described in section 2.5, this dissertation aims to address three major 
knowledge gaps in the research field of preterm birth and childhood asthma, 
including inconsistency of their association, limited exploration on pathways that 
linking them together, and sparse information on longitudinal pattern of childhood 
asthma. In addition, current evidence on the relationships of preterm birth and 
childhood asthma are mostly relying on cohorts with relatively young children 
(average age less than 5 years), on European cohorts rather than cohorts from the 
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United States, on general population rather than population at high-risk for asthma 
and preterm birth. This undiversified distribution of study characteristics limits the 
external generalizability and internal validity of pooled results in the field, and reduce 
their relevance to understand the core burden of health problems and implications 
for clinical and public health practices in the United States. This dissertation also 
addresses this gap by using a large well-established birth cohort with long-term 
follow-up that consists of population at high-risk for asthma and preterm birth, the 
Boston Birth Cohort, continuously funded by the NIH for the past 15 years. Achieving 
the goal of my dissertation will fill in critical knowledge gaps about the relationship 
between preterm birth and childhood asthma and their longitudinal patterns; the 
pathways/factors underlying the preterm birth-childhood asthma associations; and 
the role of early life factors and preterm birth in the development of childhood 
asthma. This will be the first large-scale prospective birth cohort study to test pre- 
and peri-natal pathways to childhood asthma, taking preterm birth as a risk factor, 
mediator and/or moderator, with a life course framework.  
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Figures and Tables and Boxes 
 
Figure 2-1. Fetal origins hypothesis of asthma summarized by Henderson & Warner 
The original title and caption from Henderson and Warner: “Fig. 1. Algorithm representing the 
concept of the two independent predisposing combinations of factors which are precursors to the 
ultimate development of asthma. Airway gene polymorphisms such as in Orm dl3 together with 
environmental factors such as environmental tobacco smoke (ETS) exposure lead to the altered airway 
matrix which predisposes to wheezing illnesses including chronic obstructive pulmonary disease 
(COPD) but not necessarily asthma. This latter condition requires the additional component of 
susceptibility to persistent airway inflammation. Genetic factors, such as those affecting cytokine 
production on the long arm of chromosome 5 (5q) affecting immune responsiveness, interact with 
environmental exposures, most notably to cause allergic sensitization. It is the combined effect of 
altered airway structure and persistent inflammation which leads to the full asthma phenotype.” 
Reprinted from Henderson AJ, Warner JO. Fetal origins of asthma. Semin Fetal Neonatal Med. 
2012;17(2):82-91. Copyright ©  2012 Elsevier Ltd with permission from Elsevier.  
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Table 2-1. Classifications for Degree of Prematurity based on Gestational Age 
Gestational Age 
Classification of Degree of Prematurity from Different Sources 
WHOa USCDCb ACOGc 





28-31 weeks Very preterm 
32-33 weeks Moderate or Late 
preterm 
  
34-36 weeks Late preterm Late preterm 
37-38 weeks 
Term 
Early term Early term 
39-40 weeks Full term Full term 
41 weeks Late term Late term 
42 weeks or 
more 
Postterm Postterm Postterm 
Notes: a) WHO = World Health Organization, source: March of Dimes, PMNCH, Save the Children, 
WHO. Born too soon: The global action report on preterm birth. Geneva: World Health 
Organization;2012. 
b) USCDC = United States Centers for Disease Control and Prevention, source: Martin JA, Hamilton BE, 
Osterman MJK, Curtin SC, Mathews TJ, Division of Vital Statistics. Births: Final data for 2013. Nati Vital 
Stat Rep. 2015;64(1):1-65. 
c) ACOG = the American Congress of Obstetricians and Gynecologists, sources: American College of 
Obstetricians and Gynecologists Committee on Obstetric Practice Society for Maternal-Fetal Medicine. 
Early preterm birth. 2013. https://www.acog.org/-/media/For-
Patients/faq173.pdf?dmc=1&ts=20150103T1848215815. Accessed Dec 20, 2014; American College of 
Obstetricians and Gynecologists Committee on Obstetric Practice Society for Maternal-Fetal Medicine. 
Acog committee opinion no. 560: Medically indicated late-preterm and early-term deliveries. Obstet 
Gynecol. 2013;12(4):908.; American College of Obstetricians and Gynecologists Committee on 
Obstetric Practice Society for Maternal-Fetal Medicine. Acog committee opinion no. 579: Definition of 




Box 2-1. Key Indicators for Considering a Diagnosis of Asthma 
Consider a diagnosis of asthma and performing spirometry if any of these indicators is present.* 
These indicators are not diagnostic try themselves, but the presence of multiple key indicators 
increases the probability of a diagnosis of asthma. Spirometry is needed to establish a diagnosis 
of asthma. 
 Wheezing – high-pitched whistling sounds when breathing out – especially in children. 
(Lack of wheezing and a normal chest examination do not exclude asthma.) 
 History of any of the following: 
- Cough, worse particular at night 
- Recurrent wheeze 
- Recurrent difficulty in breathing 
- Recurrent chest tightness 
 Symptoms occur or worsen in the presence of: 
- Exercise 
- Viral infection 
- Animals with fur or hair 
- House-dust mites (in mattresses, pillows, upholstered furniture, carpets) 
- Mold 
- Smoke (tobacco, wood) 
- Pollen 
- Changes in weather 
- Strong emotional expression (laughing or crying hard) 
- Airborne chemicals or dusts 
- Menstrual cycles 
 Symptoms occur or worsen at night, awakening the patient. 
* Eczema, hay fever, or a family history of asthma or atopic diseases are often associated with 
asthma, but they are not key indicators. 
Note: This box is reused from Box 3-1, page 42, National Asthma Education and Prevention 
Program. Expert panel report 3:Guidelines for the diagnosis and management of asthma (epr-




Box 2-2. Differential Diagnostic Possibilities for Asthma 
Infants and Children 
Upper airway diseases 
 Allergic rhinitis and sinusitis 
Obstructions involving large airways 
 Foreign body in trachea or bronchus 
 Vocal cord dysfunction 
 Vascular rings or laryngeal webs 
 Laryngotracheomalacia, tracheal stenosis, or bronchostenosis 
 Enlarged lymph nodes or tumor 
Obstructions involving small airways 
 Viral bronchiolitis or obliterative bronchiolitis 
 Cystic fibrosis 
 Bronchopulmonary dysplasia 
 Heart disease 
Other causes 
 Recurrent caught not due to asthma 
 Aspiration from swallowing mechanism dysfunction or gastroesophageal reflux 
Adults 
 COPD (e.g., chronic bronchitis or emphysema) 
 Congestive heart failure 
 Pulmonary embolism 
 Mechanical obstruction of the airways (benign and malignant tumors) 
 Pulmonary infiltration with eosinophilia 
 Cough secondary to drugs (e.g. angiotensin-converting enzyme (ACE) inhibitors) 
 Vocal cord dysfunction 
Note: This box is reused from Box 3-3, page 46, National Asthma Education and Prevention 
Program. Expert panel report 3:Guidelines for the diagnosis and management of asthma (epr-
















Research Design and Methods  
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3.1 Data Source: the Boston Birth Cohort Study 
This dissertation used data from the Boston Birth Cohort (BBC). The BBC is an 
ongoing, prospective birth cohort study initiated by Dr. Xiaobin Wang (the Principal 
Investigator [PI]) at Boston Medical Center (BMC) in 1998. It is one of the largest 
longitudinal, predominantly urban and minority birth cohorts in the United States for 
studying pregnancy and infant and child health outcomes, and is well-suited for 
studying preterm birth and allergic diseases, including asthma. The data collection 
process in the BBC can be divided into two phases: the baseline and the postnatal 
follow-up (see Figure 3-1). The study design, inclusion, exclusion, and data collection 
modes for each phase are described below. 
3.1.1 Data Collection for Baseline Phase 
Phase 1 (baseline) of the BBC was designed to investigate the 
environmental and genetic determinants of preterm birth and low birth weight 
using rolling enrollment, and recruited 8,150 mother-infant pairs 1998 through 
September of 2013.  
Subject Recruitment and Data Collection: Eligible mother-infant pairs were 
recruited 1 to 3 days post-delivery in the Labor and Delivery Unit of the BMC. 
Cases were defined as births that were preterm (< 37 weeks gestation) or low 
birth weight (< 2,500 g), and controls as term births (> 37 weeks gestation) with 
birth weight > 3000 g. Cases and controls were enrolled in approximately a 1:2 
ratio and matched on delivery date, race/ethnicity, and maternal age (±5 years). 
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Exclusion: Pregnancies that resulted from in vitro fertilization or that 
involved multiple gestations, fetuses with chromosomal abnormalities or major 
birth defects, preterm deliveries due to maternal trauma, and women with 
congenital or acquired uterine lesions or incompetent cervix were excluded. 
Data Collection Modes: Three data collection modes/tools were used, 
including an enrollment log, a maternal questionnaire interview, and a medical 
record abstraction sheet. 
 The data collection team kept a log of enrolled mother-infant pairs to 
record maternal consent status and basic demographic information 
obtained from maternal reports and medical records, including 
mothers’ and infants’ dates of birth and infant sex. 
 A questionnaire was used to interview mothers about their general 
health, history of allergies, reproductive history, lifetime stress and 
stress during the index pregnancy, diet and medication use during the 
index pregnancy, physical activities before and during the index 
pregnancy, home environment (e.g., smoking), and household social 
and demographic information. 
 A medical record abstraction sheet was used by trained data collectors 
with clinical experience to collect information from medical records 
about the index pregnancy, including gestational age at birth and other 
obstetric outcomes (e.g. birth weight, type of delivery, gravidity and 
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parity, etc.), major pregnancy and obstetric complications (e.g. 
chorioamnionitis), use of prenatal care, medication use, ultrasound 
examination, and other physiological results. 
The same identification (ID) number was assigned to each mother-child pair 
for the three modes of data collection in the baseline phase of the BBC, ensuring 
that data from the three sources could be linked. 
3.1.2 Data Collection for Postnatal Follow-Up Phase 
Phase 2 (follow-up) data collection for the BBC began in 2004 in order to 
study infant and child health outcomes. The follow-up sample is a subset of the 
BBC, consisting of children who continued their pediatric care at the BMC.  
Recruitment and Data Collection: Beginning in 2004, mothers of children 
who were enrolled in Phase 1 of the BBC (including some those born before 
2004 and born since 2004) and who continued to receive pediatric care at the 
BMC were asked to participate in the follow-up study. Between 2004 and 2010, 
about 47% of baseline participants stayed at the BMC for pediatric care; of these, 
76% were approached, and of these, 94% participated in the follow-up data 
collection.1 Comparisons of the postnatal follow-up sample with the entire BBC 
showed that they are comparable in terms of maternal age, maternal education, 
parity, child sex, and delivery mode.2 
Data Collection Modes: Two data collection modes were used in the follow-
up phase: a series of maternal questionnaire interviews and an electronic 
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medical records (EMR) database obtained from the BMC system. 
 Mother-infant pairs were actively followed and approached in the BMC 
Pediatric Outpatient Building when the child was aged 6-12 months, 2 
years, 4 years, and 6 years or older, paralleling their pediatric primary 
care visit schedule. Mothers were asked to complete a questionnaire 
interview that covered the child’s health, family history of atopic 
diseases and asthma, parents and household social and demographic 
information, and the home environment. 
 Children enrolled in the follow-up phase also were passively followed 
using the EMR system, which routinely collects health care service 
information during sick and well visits to the BMC since October 2003. 
All EMR recorded diagnoses and medication prescriptions during sick 
visits (clinic, emergency department, hospitalization) to the BMC were 
obtained. The EMR diagnoses data included descriptions and ICD-9-CM3 
(or ICD-9, International Classification of Diseases, Ninth Revision, 
Clinical Modification) codes for primary and secondary diagnoses, time 
of visit, whether the child was admitted through an emergency 
department visit, and type and area of clinical service. The EMR 
outpatient prescription data included brand name, generic name and 
instructions for medications, time of visit, start date, stop date, 
changed date, refills, refill quantity, and refill date. The EMR inpatient 
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prescription data included brand name and instructions for 
medications, entry time, request time, stop time, and ID number in the 
BBC. In addition, dates of all well visits to BMC-affiliated clinics were 
obtained from the EMR to track whether the child was still reserving 
service at the BMC. 
The same identification (ID) number used in the baseline data collection 
was assigned to each mother-child pair during the postnatal follow-up data 
collection. 
3.1.3 Ethical Considerations 
The baseline data collection for the BBC has been funded by grants from the 
March of Dimes Perinatal Epidemiological Research Initiative (PERI) grants (PI: 
Wang, 20-FY02-5), the National Institute of Environmental Health Sciences (PI: 
Wang, R21 ES11666), and the Eunice Kennedy Shriver National Institute of Child 
Health and Human Development (PI: Wang, R01 HD41702). Written consent was 
obtained from all mothers who agreed to participate by obtaining their signature 
on consent forms written in their native language after a comprehensive spoken 
consent process. The Institutional Review Boards (IRB) at the BMC and the 
Massachusetts Department of Public Health approved the original baseline data 
collection protocol. 
Follow-up data collection for the BBC was supported in part by grants from 
the National Institute of Allergy and Infectious Diseases (NIAID) and private 
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foundations. The follow-up data collection protocol and consent process was 
approved by the Boston University Medical Center IRB.  
When Dr. Xiaobin Wang moved to Johns Hopkins University, both the 
baseline and postnatal follow-up data collection protocols were reviewed and 
approved by the Johns Hopkins Bloomberg School of Public Health IRB. 
I have completed all training in the ethics of health research required by the 
Bloomberg School of Public Health and was approved as a student investigator to use 
the BBC data for my dissertation research by the Bloomberg School of Public Health 
IRB. All findings from this dissertation will be reported in aggregate levels only to 
protect the confidentiality of the study participants. 
3.2 Analytic Sample for this Dissertation 
The base analytic sample for this dissertation includes 2,701 mother-child pairs 
enrolled in the BBC postnatal follow-up as of September, 2013. Although data 
collection for the BBC is ongoing, I chose September of 2013 as the cutoff 
recruitment date for my analytic sample, because both the baseline and follow-up 
data for this subset were available when I began my dissertation in December 2013. 
The sample size differs for each Specific Aim due to the distinct data 
requirements for each Aim’s analysis. The exact sample size and exclusion criterion 
for each Specific Aim are summarized in Figure 3-2 and described in sections 3.2.1 to 
3.3.3. Two features of the BBC data led to the use of different sub-samples for each 
aim. First, children included in the base analytic sample were followed for varied age 
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ranges, due to the ongoing recruitment of the BBC and the passively collected EMR 
data used for this dissertation. Children who participated in the Phase 2 data 
collection were born in different calendar years beginning in 1998. Thus the ages of 
the children varied from less than a year to 14 years when I chose September 2013 
as the end point of data collection. Second, for this dissertation, the data on asthma 
were all based on an EMR database obtained from the BMC, containing records from 
October 2003 to September 2013 for every child in the BBC. Therefore, by design, 
the follow-up period for each child began at the earliest recorded visit in this EMR 
database and ended at the latest recorded visit in this EMR database, which meant 
that the start of the EMR data varied for children born before October 2003 but was 
the same (from birth) for children born after October 2003. For this dissertation, I 
selected children whose EMR data fulfilled the required age range for each Specific 
Aim. 
3.2.1 Analytic Sample for Specific Aim 1 
The base sample for the analyses in Aim 1 includes 2,540 children with postnatal 
follow-ups ranging from six months to age 9 years duration. A total of 161 of children 
were excluded from the eligible 2,701 children due to the following reasons: first, 
being born post-term defined by births occur later than 42 weeks of gestational age 
(35 cases); second, no data for gestational age in medical record abstraction (1 case); 
third, no EMR data for any age between 0 to 5 years because born earlier than 
October 1998 or other reasons (27 cases); fourth, questionnaires in transit or in 
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process of data-entry (60 cases); fifth, missing values for important maternal 
explanatory variables, i.e. race/ethnicity, marital status, history of asthma, and 
smoking during pregnancy (38 cases). When the analyses were limited to children 
who were followed to ages 6-9 years the sample size was 1,072. 
3.2.2 Analytic Sample for Specific Aim 2 
For Aim 2, a single asthma measure with good measurement quality, recurrent 
asthma with two or more diagnoses of asthma under age 10 years, was selected as 
the outcome variable. Thus in addition to the exclusion criteria used for Specific Aim 
1, another 13 children were excluded due to missing values for important 
explanatory variables, maternal history of allergies and cesarean section delivery. 
Thus, the analytic sample reduced to 2,527. In addition, 66 children with two or more 
diagnoses of recurrent wheezing but no recurrent asthma diagnoses were excluded, 
to assure accurate distinctions between asthma cases and non-asthma cases. 
Diagnoses of recurrent wheezing may be due to asthma or to other pulmonary 
conditions, so excluding cases with only recurrent wheezing (defined by two 
diagnoses of wheezing) provided a cleaner reference group of non-asthma children. 
The sample size for Aim 2 is thus 2,461. 
3.2.3 Analytic Sample for Specific Aim 3 
To investigate the longitudinal patterns of asthma for Aim 3, children must be 
followed annually from birth to at least 6 years of age. Thus, the analyses for this Aim 
include the 550 children who met this criteria. A total of 1,990 children were 
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excluded because 1) they were born before October 2003, thus not followed from 
birth (n = 567), or 2) they were not followed to at least 6 years of age (n = 1,423). 
3.3 Measures 
3.3.1 Outcome: Childhood Asthma 
The asthma measures used in this dissertation were based on either physician 
diagnoses or medication prescriptions documented in the EMR data. For physician 
diagnosis, ICD-9 codes for primary and secondary diagnoses were used to identify 
asthma diagnoses, and the date of clinic visit was used to determine the age of 
assessment. The ICD-9 codes considered to indicate a diagnosis of asthma were 
asthma (493.*), wheezing (786.07), asthma exacerbation = asthma with status 
asthmaticus (493.01, 493.11, 493.21) and asthma with (acute) exacerbation (493.02, 
493.12, 493.22). 
 For medication prescriptions, asthma related medications were recognized 
using brand or generic names, according to the National Heart, Lung, and Blood 
Institute [NHLBI] guidelines4, the Healthcare Effectiveness Data and Information Set 
[HEDIS] coding rules5, and the Childhood Origins of Asthma Study [COAST] study6. 
Consultation with two experts with rich clinical experience in pediatric asthma was 
used to confirm cases of asthma and to decide about cases with uncertain drug name 
and/or dose. Dates of starting, stopping, changing, and refill were used to determine 
the age of assessment.  
These procedures produced a set of repeated indicators of asthma diagnosis for 
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each child, with each indicator indexed by the child’s age at assessment, and a 
corresponding set of repeated, age-indexed indicators of asthma medication 
prescriptions. Since the EMR data were derived from clinic visits, children can have 
multiple diagnoses or prescriptions at a particular age. 
The physician diagnoses and mediation prescription measures were used, along 
with other information, to generate about a dozen different measures of asthma, 
corresponding to various definitions in the literature. Each Aim uses the asthma 
measures most appropriate to address the objectives of the aim. 
The goal of Aim 1 was to compare the consistency of asthma measures and the 
preterm birth-asthma association by asthma measures for two age groups. To this 
end, eleven measures were defined according to clinical guidelines from the NHLBI4, 
a recent literature review7, and major tools and studies in the field (e.g., HEDIS5 and 
COAST6) (see Table 4-1 in chapter 4 for detailed explanations for each measure). Each 
of the measures was created using the EMR data on physician diagnosis or 
medication prescriptions when the child was between ages 0 and 5 years. To allow 
for differences in the clinical manifestation of asthma by age, a subset of 8 measures 
was created, using EMR data collected when the child was between ages 6 and 9 
years. Three wheezing diagnoses-based measures were not included for ages 6 to 9 
years due to low prevalence and poor validity. The 11 measures using data from ages 
0 to 5 were intended to reflect “early wheezing disorders”, while the 8 measures 
using data from ages 6 to 9 to reflect “school age asthma”. 
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The goal of Specific Aim 2 was to investigate the role of preterm birth in the 
development of childhood asthma. Thus a single measure of asthma with good 
validity—recurrent asthma defined by two physician diagnoses of asthma (ICD-9: 
493.*) – was selected. Consistency analyses for the asthma measures from Specific 
Aim 1 (see Chapter 4) showed that two physician diagnoses of asthma had high 
agreement with long-term control type medication use and yielded a moderate 
estimation for prevalence. This measure had high specificity and good sensitivity, 
which suggested that it was likely to capture the majority of children with true 
asthma, instead of children with wheezing symptoms due to other diseases or by 
error. These characteristics make it a good measure of asthma for association 
analysis. 
The focus of Specific Aim 3 was to determine the longitudinal patterns of 
childhood asthma and their associations with preterm birth. Thus, childhood asthma 
patterns were defined by repeated measures of asthma diagnosis (ICD-9: 493.*) or 
wheezing diagnosis (ICD-9: 786.07) from birth to at least age 6 years. 
Diagnoses of both asthma and wheezing were used to detect childhood asthma 
between ages 0-6 years for two reasons. First, while an asthma diagnosis is a strong 
indicator for having an asthma episode in childhood; wheezing is the key symptom 
for diagnosing asthma among children under age 6 years4,8. About 50% of children 
who had wheezed persisted to age 6 years9,10 and recurrent wheezing in the first 
three years strongly predicts asthma at age 6 years or older11. Although wheezing 
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may be a symptom or precursor of other diseases12, it is still used widely to indicate a 
risk of asthma in early childhood in studies focused on association13 and 
prevalence14. 
Second, according to the analyses on the age-specific prevalence trends of 
asthma diagnoses, wheezing diagnoses, and the combined measures of childhood 
asthma based on both asthma and wheezing diagnoses, the combined measures of 
childhood asthma showed a more stable age pattern (increasing by age), which was 
similar to the trend for asthma diagnoses (increasing by age), but different from the 
trend for wheezing diagnoses (decreasing by age). The distinct trends of asthma and 
wheezing diagnoses by age partially reflect the clinical terms that physicians were 
trained to use. See Chapter 6 for the related figures and discussions. 
In sum, diagnoses of asthma and wheezing each captured some non-overlapped 
information to indicate the risk of childhood asthma. Measures solely based on 
diagnoses of wheezing or asthma might be biased due to time-dependent 
manifestation and diagnosing guidelines for young children, which would bias the 
data patterns towards transient wheezing or late-onset asthma. 
3.3.2 Major Explanatory Variable: Preterm Birth 
Gestational age in weeks was the basis for defining preterm birth and degree of 
prematurity. Gestational age was defined based on early (< 20 weeks) prenatal 
ultrasound and the first day of the last menstrual period15, following a standard 
algorithm 16 commonly used in clinical studies17. 
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In this dissertation, three variables were used to measure prematurity: preterm 
birth status (a binary variable), degree of prematurity (a categorical variable), and 
gestational age in weeks (a continuous variable). Preterm birth is the principal 
measure used in this dissertation. Gestational age and degree of prematurity will be 
used to explore dose-response relationships between preterm birth and asthma in 
Specific Aims 1 and 2. 
Preterm birth was defined as a live birth at less than 37 completed weeks of 
gestation, while term birth was defined as a live birth at 37-41 completed weeks of 
gestation. 
Degree of prematurity was defined by gestational age at birth, where shorter 
gestational age indicated a higher degree of prematurity. Four degrees of 
prematurity were defined for Specific Aim 1: early preterm birth (20-31 weeks, 8.1%), 
late preterm birth (32-36 weeks, 20.2%), early term (37-38 weeks, 25.7%), and full 
term (39-41 weeks, 46.0%). This classification is mainly based on the 
recommendations from ACOG18,19, with some changes for late preterm birth and full 
term birth. As reviewed in Table 2-1, the ACOG recommended grouping gestational 
age of 31-33 weeks with neither early preterm20 nor late preterm.19 I assigned this 
period as late-preterm based on the WHO classifications. The ACOG recommended 
grouping births at 41 weeks as late term.18 I grouped them with full term to generate 
the reference group labeled “full term”, as the late term cases were too few in this 
analytical sample to analyze as a separate category. 
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Gestational age was used to investigate the mediating effects of prematurity in 
the pathways from prenatal risk factors to childhood asthma in Specific Aim 2, 
because analyses and interpretation with a continuous variable (mediator) is more 
straightforward than with a categorical variable. 
3.3.3 Other Explanatory Variables 
Additional explanatory variables were selected based on findings about major 
risk factors for preterm birth and/or asthma in the BBC,1,21 and in the literature,22,23 
and in preliminary analyses. As shown in the conceptual framework mentioned in 
Chapter 1 and 2, these explanatory variables fall into several groups: genetic 
predispositions, prenatal risk factors, perinatal risk factors, postnatal risk factors, 
control variables. These variables were generated from data collected in the 
maternal questionnaire interviews or the medical record abstraction. 
The secondary explanatory variables included in the analyses for each Specific 
Aim differed, reflecting the distinct purpose of each aim. The analyses for Specific 
Aim 1 included genetic predispositions, selected major risk factors, and control 
variables to control for spuriousness in the preterm birth-asthma association while 
comparing the various measures of asthma.  
In the analyses for Specific Aim 2, genetic predispositions, pre- and peri-natal1 
                                                             
1 Perinatal, in this dissertation, narrowly means around the time of birth or relating to the time 
immediately before, at, and immediately after birth, and is used to describe risk factors occurring 
very near to birth and/or at birth. 
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risk factors were included in the pathway analyses following the fetal origins of 
asthma perspective, and postnatal risk factors and child characteristics were included 
to control for potential spuriousness in the relationships among pre- and peri-natal 
risk factors, preterm birth, and asthma. 
For Specific Aim 3, the analyses of the effect of preterm birth on longitudinal 
patterns of asthma included genetic predispositions, a few selected major risk 
factors, and child sex to avoid spuriousness and provide more insights about the 
longitudinal patterns of asthma. Fewer variables where included in Specific Aim 3 to 
avoid potential over-adjusting due to smaller sample size, a multiple category 
outcome, and the use of latent regression analysis. 
Genetic Predispositions 
Maternal history of asthma was obtained from responses to the questions “Do 
you have a personal history of asthma?” and “If yes, was your asthma diagnosed by a 
doctor?” in the first postnatal follow-up questionnaire. The original responses were 
recoded into two groups: 1 = history of physician diagnosed asthma (if answered 
“Yes” to both questions), and 0 = no history of physician diagnosed asthma (if 
otherwise). The missing values were imputed using responses to the question “Do 
you or have you or ever had any history of asthma?” in the baseline questionnaire 
interview if available. 
Maternal history of allergies was obtained from responses to five questions 
from the first postnatal follow-up questionnaire that asked if the mother had 
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eczema, hay fever or seasonal allergy, drug allergy, environmental allergy, or food 
allergy. The original responses were recoded into two groups: 1 = had history of 
allergies (if answered “Yes” to any of the five questions), and 0 = no history of 
allergies (if otherwise). The missing values were imputed using the responses to 
these questions in the baseline questionnaire interview if available. 
Prenatal Risk Factors 
In the prenatal period, family socioeconomic status and maternal characteristics 
(social demographics, health history, pregnancy smoking, pregnancy stress, and 
pregnancy complications) were included for analyses. Information for these 
measures was obtained from the baseline questionnaire interview, except for 
pregnancy complications, for which the information was obtained from the baseline 
medical record abstraction. 
Low household income (1 = low income, 0 = high income) was created from two 
variables: 1) total household income last year before taxes (including public 
assistance), and 2) whether the mother was currently supported by Aid to Families 
with Dependent Children (AFDC). Low household income was coded as 1 when 
household income was lower than $20,000 or the mother was currently supported 
by AFDC, and coded as 0 when household income was higher than $20,000 and not 
currently supported by the AFDC. 
Maternal race/ethnicity was obtained from responses to the question “Which 
one of these groups best describes your racial background?” The original 8 responses 
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“Black/African American” “White” “Hispanic” “Asian” “Haitian” “Cape 
Verdian” ”Pacific Islander” ”Other” and responses of multiple (nixed) groups were 
recoded into four groups: 1 = black/African American (Haitian), 2 = white, 3= 
Hispanic, and 4 = others (Asian, Cape Verdian, Pacific islander, and mixed of any types 
that don’t belong to black, white, or Hispanic). 
Maternal education was obtained from responses to the question “what is the 
highest degree of school you have completed?” The original 5 responses, “No 
school/Elementary school” “Some secondary school [9th grade and above]” “High 
school graduate or GED [abbreviation for General Educational Development test]” 
“Some college” “College degree and above” were recoded into three groups: 0 = 
elementary or secondary school (“No school/Elementary school” “Some secondary 
school [9th grade and above]), 1 = high school/GED, and 2 = some college education 
and above. 
Mother unmarried was obtained from responses to the question “what is your 
present marital status?” The original five responses “Married” “Widowed” 
“Divorced” “Separated” “Single” were recoded into two groups: 0 = married 
(“Married”) , 1 = unmarried (“Widowed” “Divorced” “Separated” “Single”). 
Mother born in the U.S. was obtained from responses to the question “where 
were you born (the country)?” Responses were recoded to indicate mother born in 
the U.S., that is 1 = U.S. born and 0 = Foreign born. 
Pre-pregnancy BMI was generated based on self-reported height and weight 
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using the Quetelet’s formula24: 
𝑊𝑒𝑖𝑔ℎ𝑡 (𝑘𝑔)
𝐻𝑒𝑖𝑔ℎ𝑡 (𝑚)2
.Values were grouped as: 1 = underweight 
(BMI < 18.5), 2 = normal weight (18.5 ≤ BMI < 25.0), 3 = overweight (25.0 ≤ BMI < 
30.0), 4 = obese (30.0 ≤ BMI), following WHO recommendations.25,26 During the data 
cleaning process, extreme values of height and weight values were excluded. Height 
below or above 6 Standard Deviation [SD] (< 1.209 m or > 2.048 m), and weight 
below 2SD or above 6SD (< 33.3 kg or > 181.7 kg) were coded as missing values. 
Maternal smoking during pregnancy was obtained from responses to four 
questions asking whether the mother smoked/used tobacco in the six months before 
she found out she was pregnant, in the first three months of pregnancy, in the 
middle three months of pregnancy, and in the last three months of pregnancy. 
Responses were recoded into two measures: maternal continuous smoking during 
pregnancy (1 = smoked during the six months prior to pregnancy OR the first three 
months of pregnancy, AND smoked in the second or the third three months, 0 = 
otherwise), maternal quit smoking during pregnancy (1 = smoked only during the 6 
months prior to pregnancy or the first three months of pregnancy, but not during the 
second or the third three months, 0 = otherwise). 
Maternal high pregnancy stress was obtained from responses to the question 
“how would you characterize the amount of stress in your life during this 
pregnancy?” The original responses “Not stressful” “Average” “Very stressful” were 
recoded into two groups: 1 = high stress (very stressful), and 0 = low stress 
(Not/average stressful). 
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Maternal pregnancy complications. 12 complications were considered for 
inclusion: preeclampsia, eclampsia, chronic hypertension, placental abruption, 
placenta previa, incompetent cervix, diabetes, HEELP (H = Hemolysis, EL = Elevated 
liver Enzymes, LP = Low Platelet count) syndrome, oligohydramnios, polyhydramnios, 
meconium in amniotic fluid, and chorioamnionitis. Preliminary analyses showed that 
only four of them were potential predictors for asthma: preeclampsia, placental 
abruption, incompetent cervix, and chorioamnionitis. Among these, preeclampsia 
and chorioamnionitis are the risk factors are among the most prevalent 
complications (> 10% in this analytic sample). Therefore, preeclampsia and 
chorioamnionitis were included in the analyses. 
Preeclampsia is a type of severe hypertension in pregnancy featured by 
elevation of blood pressure after 20 weeks of gestational age and other symptoms.27 
Preeclampsia information was obtained from maternal medical record abstraction by 
a trained reviewer with rich clinical experience. 
Chorioamnionitis21, also referred to as in-utero infection or intra-amniotic 
infection, is “an acute inflammation of the membranes and chorion of the placenta, 
typically due to ascending polymicrobial bacterial infection in the setting of 
membrane rupture”.28 Chorioamnionitis was defined by two criteria in this 
dissertation: 1) presence of intrapartum maternal fever (> 38°C)29 during labor 
according to medical record review, or 2) presence of placental histological changes 
associated with chorioamnionitis determined by a hospital pathologist according to 
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criteria recommended by the American College of Pathologists.28 Detailed 
descriptions of the placental pathology criteria used in this cohort are available 
elsewhere.30 
Perinatal Risk Factors 
Type of delivery was included as an obstetric characteristic, and information was 
obtained from the medical record abstraction. The variable cesarean section delivery 
(C-section) was coded as 1 = cesarean section delivery, including all surgical 
deliveries, 0 = vaginal delivery, including normal spontaneous vaginal delivery 
(NSVD), vaginal birth after cesarean (VBAC), and vacuum or forceps assisted 
deliveries. 
Covariates 
 Three child characteristics were included in the analysis. Child’s sex was coed 
as 0 = female, 1 = male. Child’s age was included as a continuous variable, that is, 
measured as integers 0, 1 … 9 years, and within 1 year was defined as 365.25 days. 
Season of birth was a multiple category variable (spring = born March to May, 
summer = born June to August, autumn = born September to November, winter = 
born December to February) and also a binary variable born in summer/autumn (1 = 
summer or autumn, 0 = winter or spring). These data were obtained from the 
enrollment log maintained by the data collection team. 
Parity was obtained from maternal reports about pregnancy and delivery 
histories in the baseline questionnaire interview. The variable first born was coded as 
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1 = first born (parity was 0), and 0 = not first born (otherwise – parity greater than 0). 
Duration of follow-up was defined as the number of years from the date of the 
first EMR record to the date of the last EMR record (between October of 2003 and 
September of 2013, as described above). This variable was included to allow for the 
duration of observation. Since the BBC children entered the follow-up study at 
different ages, age alone does not capture the duration of follow-up. 
Maternal age was defined by mother’s age at the delivery of the study child, 
calculated as the time from maternal date of birth to infant date of birth recoded to 
age in years (one year = 365.25 days). 
Family member smoking was obtained from responses to three questions from 
the first postnatal follow-up questionnaire interview, asking whether the mother or 
the father had ever smoked cigarettes, cigars, or pipes, and how many other people 
who lived in the home smoked cigarettes only (not including mother and father of 
child). Since this measure serves as a less ideal indicator for exposure to 
environmental tobacco smoking from prenatal to postnatal period, it is only included 
as a control variable for maternal smoking during pregnancy. Family member 
smoking was coded as 1 = any family member smokes (including parents), 0 = no 
family member smokes. 
Two other variables that not included in main hypotheses testing were included 
for missing value analyses and imputation equations: maternal reported 
vaginal/genital/urinary tract infections and birth year of children. 
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Information about paternal social characteristics was not included in this 
dissertation for several reasons. First, questions about paternal information were not 
added to the maternal baseline interview until around mid-2000, thus not collected 
for children born during 1998 to mid-2000. Second, both the baseline and follow-up 
questionnaire interviews were conducted with mothers. These two features lead to 
over 10% of cases missing data for paternal characteristics. Third, the majority of the 
mothers were unmarried (66.3%), which suggests that maternal influence is more 
dominant in this sample. Compared with paternal history of asthma, maternal history 
of asthma is also of greater influence on increased risk of asthma among children.31 
Fourth, normally maternal and paternal social demographics are highly related. Thus, 
maternal characteristics were used as the main explanatory variables in this 
dissertation. 
3.4 Statistical Analysis 
3.4.1 Data Preparation 
This dissertation used BBC data from the five sources described in section 3.1: 
the enrollment log, the baseline maternal questionnaire, the baseline medical record 
abstraction sheet, the first follow-up child health questionnaire, and EMR data for 
the followed children. Several major data preparation steps were performed prior to 
data analysis. All preparation was done using Stata 12.0 statistical software (College 
Station, TX). 
3.4.1.1 Data Entry, Cleaning, and Management 
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Data entry and cleaning were conducted separately to prepare the raw data 
from each of the five data sources. The cleaned data from the five sources were then 
merged by unique BBC ID numbers, and recoded as described in section 3.3.3. 
The baseline enrollment log was maintained by the BBC data collection team 
using an excel file. For this dissertation, I converted the data to Stata files, and 
recoded the records with impossible dates, such as “01/01/1900” or infant birth 
dates prior to 01/01/1998 (when the BBC began) as missing. Missing dates for 
maternal and infant birth (both less than 0.5% out of 8,449 mother-infant pairs in the 
entire BBC) were filled with the corresponding data from the maternal 
questionnaires or the EMR. Missing values for infant sex (only 5 infants out of the 
whole cohort) were filled with the corresponding data from the EMR. 
The baseline maternal questionnaires were originally paper-based forms. 
TeleForm (Autonomy HP, Highland Park IL), digital optical recognition software for 
transferring data from paper-based forms to digital files, was used to convert the 
questionnaire data to electronic form during the autumn of 2013. Trained data entry 
operators at the Johns Hopkins Bloomberg School Public Health scanned the 
questionnaires to PDF files, used the TeleForm software for data recognition and 
entry from the PDF files, and then compared the results with the original 
questionnaires, correcting any recognition errors. A subset of the TeleForm- entered 
data were compared with manually entered data, and showed a lower error rate 
than the manually entered data. Thus, the TeleForm entered data were used as the 
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primary data for analysis. Unexpected values were checked and corrected as 
necessary after comparison with the original questionnaire. 
The medical record abstraction sheets and the first round of follow-up maternal 
questionnaires on child health also were originally paper-based forms. For the 
abstraction sheets, data from selected questions, such as pregnancy and obstetric 
complications were manually entered. TeleForm was used to enter the maternal 
follow-up questionnaire data during the autumn of 2013, following the same 
procedures described for the baseline maternal questionnaires. 
The EMR data were downloaded as three excel files (diagnosis records, inpatient 
prescription records, and outpatient prescription records) from the existing EMR 
system at BMC and its affiliated clinics. For the diagnosis records, each row contained 
discharge claims and/or diagnostic information for a child’s clinical or hospital visit, 
along with the child’s identifiers. For the prescription records, each row contained 
prescription information for each medication and child’s identifying information. 
Data rows with no diagnostic or prescription information were excluded, and visits 
before October 2003 and after September 2013 were excluded to ensure comparable 
periods of observation. 
 
3.4.1.2 Analysis and Handling of Missing Data 
Missing EMR Indicators of Physician Diagnosis or Prescribed Medication 
Descriptive analysis showed missing values for the repeated, age-indexed 
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measures of diagnoses and prescriptions created from the EMR. These missing 
values meant that there were no EMR data for that year of age; in other words, the 
child did not visit the BMC during the year he or she was that age. 
There are three approaches to missing data, which differ in the assumptions 
made about their cause: “missing completely at random”, “missing at random”, and 
“not missing at random”. First, “missing completely at random” (MCAR)32 assumes 
that the missing records or visits are a random sub-sample of the entire sample, such 
as would occur if they were missing due to record entry errors or rescheduled visits. 
This assumption is unlikely given the considerable amount of missing data and the 
known reason for the missing data is that the child didn’t visit the BMC in that year. 
The second type, “missing at random”(MAR),32 suggests that the missed records 
are due to observed variables. In this dataset, maternal education lower than high 
school was associated with missing data at ages 1 and 2 years, and early birth year 
(within the BBC) was associated with missed records at ages 1-6 years. There also 
seemed to be a pattern that children with negative diagnoses of asthma/wheezing or 
missed visits in the prior year were more likely to have missing values in a given year, 
compared with children with positive diagnoses in the prior year. These analyses thus 
generated some evidence for MAR. 
The pattern that earlier asthma status was related to later missing data 
indirectly indicates a third type of missing --“not missing at random” (NMAR).32,33 
NMAR suggests that the missing values are due to unobserved variables, i.e. 
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variables that are related to the missing values themselves. In this dataset, very 
healthy children might not visit the BMC for a year or more. NMAR is hard to be 
show using observed data, but can indirectly inferred.  
All three reasons may contribute to the missing values in the EMR records, but 
NMAR is likely to drive the majority of cases and is the one that may introduce biases 
in the estimation of associations. To address the problem of missing data, missing 
values of asthma measures were assigned to 0 in this dissertation, i.e. they were 
treated as if they had no diagnosis or prescription medication at that age. Sensitivity 
analyses with complete cases and Multiple Imputations by Chained Equations 
(MICE)34,35 were performed to check the performance of this method for children 
followed from birth to age 6 years. This subset was chosen because these children 
had the same follow-up durations, and so avoided complicating the missing data 
analysis for repeated measures of asthma. 
Among the 550 children followed from birth to age 6 years, 72.4% (n = 398) of 
children had no missing values at any ages. The missing rates for the repeated 
measures of childhood asthma (defined as in Specific Aim 3, having either asthma or 
wheezing diagnosis) ranged from 0% to 12.6% for different ages. Compared to the 
simple imputation method chosen for this dissertation, complete case analysis 
overestimated the incidence of childhood asthma by 3.4% and the age-specific 
prevalence by 0.7% to 2.6%. Analyses based on five datasets imputed by MICE 
overestimated the incidence of childhood asthma by an average of 2.5% and the age-
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specific prevalence by 0.3% to 2.2%. These results showed that the imputation 
method use in this dissertation is the most conservative method for estimating the 
risk of asthma, and that complete case analysis was the most biased toward 
overestimating the risk of asthma. Additional sensitivity analyses for each Specific 
Aim showed that the major findings were robust using any of the three imputation 
methods. 
Missing Explanatory Variables 
As described in Section 3.2.1 and Section 3.2.2, the relatively few cases missing 
data for explanatory variables with high importance were excluded from the analyses 
in this dissertation (see Figure 3-2). These variables included preterm birth, maternal 
race/ethnicity, maternal marital status, maternal pregnancy smoking, maternal 
history of asthma, maternal history of allergies, and C-section. In total, 38 cases were 
excluded based on this criteria (about 1.5% of the entire followed sample) for Aim 1, 
and another 13 cases were excluded for Aim 2. 
The missing rate for the remaining pre- and peri-natal variables were only 
included in analyses for Aim 2. Analyses for missing values were performed based on 
the 2,527 sample for Aim 2 before excluding the 66 cases with recurrent wheezing 
only, and fond the missing rate ranged from 0.4% to 10.0% for different variables 
(maternal education, 0.6%; low household income, 4.7%; mother born in the U.S., 
1.9%; pre-pregnancy BMI, 6.8%; maternal high pregnancy stress, 2.1%; preeclampsia, 
0.4%; chorioamnionitis, 10.0%). The missing data in most variables was due to non-
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responses from mothers. The high missing rate (10.0%) of chorioamnionitis was due 
to a number of medical record abstraction sheets pending data entry. Multivariate 
logistic regression analysis of missing statuses of these variables on other non-
missing variables showed that the missing patterns for most of these variables were 
dependent on some of the known data, except for preeclampsia. 
The relatively high missing rates for some variables and the informative missing 
patterns mean that two common strategies for dealing with missing data, using only 
complete cases (no missing data) and using all available cases (cases with missing 
values retained and assigned a unique code) may lead to biases. Therefore, Multiple 
Imputation by Chained Equations (MICE)34,35 based on non-missing variables were 
performed.to create five imputed datasets with some random variations. The non-
missing variables included in the imputation equations were child’s sex, age, born in 
summer/autumn, first born, family member smoking, maternal age, duration of 
follow-up, maternal race/ethnicity, mother unmarried, maternal continuous smoking, 
maternal quitting smoking during pregnancy, maternal histories of asthma and 
allergies, maternal reported vaginal/genital/urinary tract infections, and birth year. 
One the imputed dataset was used for main data analyses, while another four 
imputed datasets, the dataset with complete cases, and the dataset with all available 
cases were used for sensitivity data analyses. 
3.4.2 Analyses for Specific Aim 1 
Specific Aim 1 is to examine the consistency of various childhood asthma 
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measures, and to determine whether the association between preterm birth and 
childhood asthma varies by measurement of asthma, degree of prematurity, and age 
at asthma assessment. It has five objectives, which are summarized in Table 3-1 and 
listed below 
1a. To examine the agreement among eleven childhood asthma measures 
defined by type of EMR data (physician diagnosis vs. prescribed 
medication), clinical phenotype (wheezing vs. asthma, vs. asthma 
exacerbation), and number of episodes (single vs. multiple) at ages 0-5 
years; 
1b. To examine the agreement among eight childhood asthma measures 
defined by type of EMR data (physician diagnosis vs. prescribed 
medication), clinical phenotype (wheezing vs. asthma vs. asthma 
exacerbation), and number of episodes (single vs. multiple) at ages 6-9 
years; 
1c. To examine the agreement between eleven childhood asthma measures 
assessed at ages 0-5 years and two asthma measures assessed at ages 6-9 
years; 
1d. To assess the association between preterm birth and eleven measures of 
childhood asthma assessed when children were ages 0-5 years; 
1e. To assess the association between preterm birth and eight measures of 
childhood asthma assessed when children were ages 6-9 years. 
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Three key dimensions on which measures of asthma used in the research 
literature differ are type of EMR data (physician diagnosis or prescribed medications), 
clinical phenotype (asthma, wheezing, or asthma exacerbation), and number of 
episodes (single or multiple). Section 3.3.1 discussed the measurement of each of 
these dimensions and how they were combined to create multiple measures of 
asthma. Table 3-2 summarizes the resulting eleven measures of asthma for ages 0-5 
years (a-k) and the 8 measures of asthma for ages 6-9 years (l-s). 
For objectives 1a-1c, which are to examine the consistency of asthma measures, 
pairs of measures were assessed using Cohen's kappa coefficient36, which quantifies 
the agreement between a pair of measures on a scale from 0 to 1, with higher values 





𝑃𝑒 = 𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑 𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 𝑜𝑓 𝑎𝑔𝑟𝑒𝑒𝑚𝑒𝑛𝑡𝑠, 𝑃𝑜 =
𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 𝑜𝑓 𝑎𝑔𝑟𝑒𝑒𝑚𝑒𝑛𝑡𝑠 
Kappa coefficient values between 0.01 and 0.20 indicate slight agreement between 
the measures, 0.21– 0.40 indicate fair agreement, 0.41–0.60 indicate moderate 
agreement, 0.61–0.80 indicate substantial agreement, and 0.81–0.99 indicate almost 
perfect agreement.37,38 
The consistency of asthma measures was first examined by comparing measures 
assessed in the same age range, i.e. ages 0-5 years and ages 6-9 years (objectives 1a 
and 1b). For objective 1a, three sets of Kappa coefficients were used to compare 
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measures differing in three dimensions of information. First, for type of data, 28 pairs 
of measures were compared, each pair consisting of one diagnosis-based measure 
(a-g) and one medication-based measure (h-k). Second, for asthmatic outcomes, 9 
pairs of measures were compared, each pair consisting of one asthma measure (a-c) 
and one wheezing measure (d-f). Third, for number of episodes, the three asthma 
measures (a-c) were compared to each other and the three wheezing measures (d-f) 
were compared to each other. Asthma exacerbation was not included in the second 
and third sets of comparisons, as it was conceptually very different from asthma and 
wheezing and less frequently used in preterm birth-asthma studies. Thus agreement 
analyses would not be helpful in understanding its difference from asthma and 
wheezing or inconsistencies in the preterm-asthma association. 
For objective 1b, three sets of Kappa coefficients were used to compare 
measures differing in two dimensions of information. First, for type of data, 16 pairs 
of measures were compared, with each pair consisting of one diagnosis-based 
measure (l-o) and one medication-based measure (p-s). Second, for number of 
episodes, the three asthma measures (l-n) were compared to each other. 
The consistency between all asthma measures assessed at ages 0-5 years (a-k) 
and two asthma measures assessed at ages 6-9 years (l and m) was then examined 
(objective 1c)4,8. Had a least one diagnosis of asthma (l) and had two diagnosis of 
asthma (m) were chosen as key measures for ages 6-9 years, as they are considered 
to have good validity within this age range and are frequently used in 
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epidemiological studies. 
For objectives 1d-1e, the prevalence of asthma among preterm births and term 
births was compared for each measures of asthma stratified by age range at asthma 
assessment, using 95% confidence interval (CI) and chi-square tests, Multivariate 
logistic regression was then used to examine the association of preterm birth or 
degree of preterm birth with the 11 asthma measures assessed at ages 0-5 years and 
the 8 measures assessed at ages 6-9 years, adjusting for other explanatory variables 
(maternal age, maternal race/ethnicity, maternal education, mother unmarried, 
maternal history of asthma, maternal continuous smoking during pregnancy; child 
sex, child age, family member smoking). These covariates were included in each 
multivariate logistic regression model to control for spuriousness and assure 
comparability of models across asthma measures. To allow for differences in length 
of follow-up, duration of follow-up for each child was also included in the models. 
3.4.3 Analyses for Specific Aim 2 
Specific Aim 2 is to assess the role of preterm birth in the pathways from pre- 
and peri-natal variables to childhood asthma: mediating and/or modifying effects of 
preterm birth. It has three objectives: 
2a. To compare the relative importance of preterm birth compared to other 
pre- and peri-natal risk factors for childhood asthma; 
2b. To assess the degree to which the effects of prenatal risk factors on the risk 
of childhood asthma are explained (mediated) by preterm birth; 
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2c. To investigate whether preterm birth moderates the effects of pre- and 
peri-natal factors on the risk of childhood asthma. 
Prior to the main analyses, descriptive analyses were done to compare the 
characteristics of preterm and term children, and to compare the prevalence of 
preterm birth and asthma over each of the pre- and perinatal factors using Chi-
square tests to assess binary correlation. 
3.4.3.1 Analyses for Objective 2a: Relative Importance 
Tonidandel and colleagues39 described two traditional meanings of the 
“importance” of predictor variables: 1) whether the change in the outcome variable 
associated with a given change in the predictor variable is greater than the amount 
due to chance; and 2) the absolute size of the change in the outcome variable 
associated with a given change in the predictor variable. Thus statistical significance 
and effect size were used as criteria to evaluate the relative importance of each 
explanatory variable for asthma.40 
Multivariate logistic regression was performed to estimate the effects of 
preterm birth status (binary) and pre- and peri-natal risk factors on asthma. Seven 
groups of pre- and peri-natal risk factors were included: genetic predispositions, 
maternal social demographics, maternal smoking during pregnancy, pre-pregnancy 
BMI, maternal perceived stress during pregnancy, pregnancy complications, and 
obstetric characteristics. In addition, the models controlled for child’s sex and age, 
born in summer/autumn, first born in offsprings (parity), family member smoking, 
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maternal age, and duration of follow-up. 
Statistical significance for the effects of preterm birth status and the pre- and 
peri-natal risk factors was obtained from the multivariate logistic regressions directly. 
The effect sizes for preterm birth and the pre and perinatal risk factors were 
compared using two approaches: 1) odds ratios (OR); and 2) population attributable 
fraction (PAF).41 
Odds ratios express the ratio of the estimated odds of the outcome for the 
group exposed to the risk factor (𝑋𝑗 = 1) compared with the estimated odds of the 
outcome for the non-exposed group (𝑋𝑗 = 0), holding other explanatory variables 
constant. They were obtained by exponentiation of the coefficients from the 
multivariate logistic regressions (𝑂𝑅𝐽 = 𝑒
𝛽𝑗). The advantages of this approach are 
the relatively straightforward interpretation of OR and that no extra computation 
steps are required42. However, the disadvantages are that OR do not allow for the 
prevalence of the explanatory variable, and that OR only reflect the direct effect of 
the explanatory variable, and not its joint effects with other variables (as measures 
like relative weights do)39. 
The classic definition43,44 of the Population Attributable Fraction (PAF) is the 
proportionate reduction in the population prevalence of an outcome (here, asthma) 
that would occur if the explanatory factor of interest (e.g., preterm birth, mother’s 
smoking) were eliminated. 
For binary explanatory variables, PAF was calculated using the formula:41 
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𝑝𝑒(𝑅𝑅 − 1)
𝑝𝑒(𝑅𝑅 − 1) + 1
 
For multi-categorical explanatory variables of k levels, PAF was calculated as:41 
∑ (𝑝𝑖)(𝑅𝑅𝑖 − 1)
𝑘
𝑖=0




Prevalences of the explanatory variables (𝑝𝑒 and 𝑝𝑖) were obtained from the 
study sample and the relative risk ratios (𝑅𝑅 and 𝑅𝑅𝑖) of asthma were derived from 
the ORs described above, using a formula proposed by Zhang et al:45 
𝑅𝑅 =  
𝑂𝑅
(1 − 𝑃0) + (𝑃0 × 𝑂𝑅)
 
𝑃0= incidence of outcome (asthma) in the non-exposed group 
3.4.3.2 Analyses for Objective 2b: Mediation  
The analyses for objective 2b assess how much of the effect of a particular 
prenatal variable on asthma can be explained by the effect of preterm birth, that is, 
the extent to which preterm birth mediates the effect of the prenatal variable on 
asthma. Mediation was tested using both the classic approach developed by Baron 
and Kenny,46,47 and a new causal mediation analysis approach48 developed within the 
causal inference framework.49 The approaches share basic assumptions and the 
definition of a mediator, but differ in conceptualizations of direct and indirect effects, 
methods for estimating direct and indirect effects, and inferences that can be drawn 
from the results. 
The classic approach has been widely used in observational studies for 
continuous outcome variables, but rarely for binary outcomes due to the difficulty to 
interpret the results. The new approach provides results with stronger statistical and 
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clinical inferences for binary outcomes, but has not been applied in maternal and 
child health research yet. Therefore, I chose to use both approaches to ensure the 
comprehensiveness and reliability of the results. 
In the classic approach,47 a mediator refers to a variable that explains the 
relation between the independent variable and the dependent variable. Figure 3-3 
illustrates the assumptions underlying the approach adapted from Baron and Kenny47 
and Herr.50 Fundamentally, X and Y are linked by a set of sequential causal 
relationships: X causes M and M causes Y. Thus, X (explanatory variable) causes Y 
(outcome variable) at least partially through its effect on M (mediating variable). In 
the simple case illustrated in the figure, there are two additional assumptions: the 
relationships among X, M, and Y are not confounded by other variables and the 
relationship between X and M is not moderated by another variable. 
To test for mediation, three regression equations are fitted to estimate the 
bivariate relationships among the explanatory variable (X), potential mediator (M) 
and the outcome variable (Y). These equations are indicated in by Figure 3-3 by the 
notations ① (X and M), ② (M and Y), and ③ (X and Y). The notations a, b, c and 
refer to regression coefficients from these equations.  
Three terms are derived from these equations:51 
 The direct effect of X on Y, denoted 'c  in Figure 3-3, which is the effect 
of X on Y controlling for the effect of M on Y (note that 'c is not estimated 
by the three regression equations); 
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 The indirect effect of X on Y , calculated as *a b , which is the effect of X 
on Y through the effect of X on M; 
 The total effect of X on Y, calculated as *   'a b cc   , the effect of X on 
Y without controlling for the effect of M on Y. Simple mathematical 
manipulation shows that *  = 'a b c c . 
These regression coefficients (a, b, c, and c’) are usually full standardized 
(referred to as STD coefficients for short), which means multiplying a coefficient by 
the standard deviation (SD) of an explanatory variable of interest and 1 over the SD 
of the outcome (STD coefficient = coefficient ×
𝑆𝐷(𝑋)
𝑆𝐷(𝑌)
), so the coefficient is 
converted to a measure of association with more comparable units among 
explanatory variables. 
M is a mediator of the relationship between X and Y if three classic criteria are 
fulfilled: (1) X is significantly associated with M without controlling for Y (a is 
statistically significant); (2) X is significantly associated with Y without controlling for 
M (c is statistically significant); (3) M is significantly associated with Y adjusting for X 
(b is statistically significant) and the magnitude of the association between X and Y 
when controlling for M is smaller than the magnitude of the association between X 
and Y without controlling for M (total effect > direct effect, c > c’).47,52 
In addition, the Sobel test53 or bootstrapping54 is often used as a supplement to 
the classic approach to test for the presence of the indirect effect of X on Y ( *a b ). 
The confidence interval for the indirect effect is calculated to determine whether the 
112 
indirect effect is statistically significant ( *a b> 0). Simulation studies have suggested 
that bootstrapping is better than the Sobel method for estimating the distribution of 
the indirect effect, thus providing more accurate inference.54 Of note, recent 
publications have argued that an indirect effect may still exit even if the first (1) and 
second (2) classic criteria are not fulfilled. 
The outcome in this dissertation, asthma, is binary, thus the version of classic 
mediation analysis for binary outcomes was applied.51,55 While the basic steps were 
the same as the version for continuous outcome variables, multivariate logistic 
regression was used to estimate the associations among the prenatal explanatory 
variables, preterm birth, and childhood asthma. Of note, coefficients from logistic 
regression are log odds ratios instead of OR, which means that the STD coefficients 
and indirect effects for binary outcome variables are more abstract and more difficult 
to compared with those for continuous outcome variables. 
To apply the classic Baron and Kenny approach to testing for mediation in this 
dissertation, I performed the following steps (see Box 3-1): 
 Step 1: Fit a series of bivariate and multivariate regression models for 
childhood asthma, to establish an optimal association model (Model 1) 
between prenatal explanatory variables and childhood asthma. 
 Step 2: Fit a series of multivariate regression models on preterm birth, 
using the major prenatal explanatory variables for childhood asthma 
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found in Model 1, to determine the association between each 
explanatory variable and preterm birth (Model 2). 
 Step 3: Fit the optimal Model 1 controlling for preterm birth, to 
determine the adjusted associations between the prenatal explanatory 
variables and childhood asthma (Model 3). Then proceed to the next step 
if the association between preterm birth and childhood asthma is 
significant. 
 Step 4: Assess the mediating effects in the classic way, by comparing the 
difference in coefficients for prenatal explanatory variables in Model 1 
and Model 3. If c > c’, then a mediating effect of preterm birth in the 
relation between prenatal risk factors and childhood asthma can be 
inferred. This assessment is essential but limited by not providing 
confidence intervals or p-values for statistical inference. 
 Step 5: Assess the mediating effect by testing the indirect effect on Y via 
M. When statistical associations are estimated by logistic regression, the 
assumptions that a and b are independent for the Sobel test does not 
hold.56 Thus I used the bootstrapping approach.54 The indirect effect 
( *a b ), direct effect ( 'c ), and total effect (c ) were all obtained from STD 
coefficients from logistic regressions,55 the 95% percentile confidence 
interval for the indirect effect ( *a b ) was generated by bootstrapping54 
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with 1500 random samples from the original dataset. If the 95% 
percentile confidence interval or *a bdoes not cover 0, then reject the 
null hypothesis and accept the alternative hypothesis that there is a 
mediating effect of preterm birth in the relation between prenatal risk 
factors and childhood asthma. 
The causal mediation analysis approach49 shares the definition of a mediator 
and assumptions about sequential causal relationships (X causes Y through M) with 
the Baron and Kenny approach. But the causal mediation analysis approach derives 
from the causal inference framework, and emphasizes comparing outcomes between 
the treatment setting vs the “counterfactual”46 to estimate and decompose the total 
effect into direct and indirect effects. 
In the basic causal inference framework, variable X is conceptualized as a 
“treatment”, with X = x indicating membership in the treatment group, and X = x* 
indicating membership in the non-treatment or reference group. The non-treatment 
group can be called counterfactual when its members only differ in the value of the 
treatment variable X (everything else is the same as in the treatment group). Then 
the treatment effects can be assessed by comparing the outcome values in the 
treatment group and non-treatment group. In natural interventions, changes in X 
also lead to changes in M (m = FM[x] vs. m* = FM[x*]), so X and M are changing 
simultaneously, rather than M being held constant. Thus the estimated treatment 
effect is actually the total effect of X, including its direct effect and its indirect effect 
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through M, where x and m together determine the value of the outcome under 
treatment, and x* and m* determine the value of the outcome under non-
treatment. The causal relationship between X and M makes it hard to separate the 
direct effect of X (not exerts through M) and the indirect effect of X (exerts through 
M). 
To estimate the direct and indirect effects under the causal inference 
framework, one needs to find a way to manipulate the values of X and M so they do 
not change at the same time, i.e. change in M from treatment level m* to non-
treatment level m can be turned on or off regardless of whether the X equals x or x*. 
Then it is possible to estimate the direct effect of X by comparing the value of the 
outcome at treatment level x vs non-treatment level x* holding M constant (both are 
at m*), and to estimate the indirect effect of X through M on Y by comparing the 
value of outcome at treatment level m vs. non-treatment level m* holding X 
constant. 
However, such manipulation is almost impossible in natural settings. Causal 
mediation analysis provides a way of estimating the direct and indirect effects based 
on the conceptual (mathematics) manipulations of values for X and M. This approach 
provides results with more causal inferences than the classic Baron and Kenny 
approach, mainly because the classic approach does not estimate the direct and 
indirect effects based on counterfactuals. 
The causal mediation analysis approach defines and decomposes the effects of 
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X and M on Y as follows. Let Y (X = x) be the potential value Y when X is equal to x 
(treatment) and Y (X = x*) the potential value of Y when X equals x* (non-treatment). 
Let M (X = x) be the potential value of M when X equals x, and M (X = x*) the 
potential value of M when X equals x*. According to Pearl’s work49 as explained by 
Grotta and Bellocco,57 the total effect of X on Y can be decomposed into two 
components. 
 Natural Direct Effect (NDE), effect of treatment (X) on the outcome (Y), 
that is, the difference between the values of Y when X = x and X = x*, 
holding M at the non-treatment level of X, M(x*). This can be expressed as 
𝑁𝐷𝐸(x, 𝑥∗; 𝑌) = 𝐸[𝑌(𝑥, 𝑀(𝑥∗))] − 𝐸[𝑌(𝑥∗, 𝑀(𝑥∗)]         (4) 
 Natural Indirect Effect (NIE), the difference between the effect of M on the 
outcome (Y) when X = x, M (X = x), and the effect of M on the outcome (Y) 
when X = x*, M (X = x*), holding X equal to x. As an equation 
𝑁𝐼𝐸(x, 𝑥∗; 𝑌) = 𝐸[𝑌(𝑥, 𝑀(𝑥))] − 𝐸[𝑌(𝑥, 𝑀(𝑥∗)]           (5) 
 Total effect (TE), the effect of treatment (X) on the outcome (Y) that is, the 
difference between the values of Y when X = x and X = x*, when the value 
of M changes from M(x) to M(x) simultaneously. 
𝑇𝐸(x, 𝑥∗; 𝑌) = 𝑁𝐷𝐸(x, 𝑥∗; 𝑌) + 𝑁𝐼𝐸(x, 𝑥∗; 𝑌) 
= 𝐸[𝑌(𝑥, 𝑀(𝑥))] − 𝐸[𝑌(𝑥∗, 𝑀(𝑥∗)] 
= 𝐸[𝑌(𝑥)] − 𝐸[𝑌(𝑥∗)]                  (6) 
To apply this approach to logistic regression for binary outcomes when the 
outcome is rare, VanderWeele and Vansteelandt58 suggest that the total effect can be 
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decomposed in the same idea mentioned for the general setting, but using a 
multiplicative way as follows, where the OR of the total effect is equal to the product 
of the OR of the NDE and the OR of the NIE where the NDE is defined as the effect of 
X (X = x vs. X = x*) on Y when holding M constant at M(x*), and the NIE.is defined as 
the effect of M (M(x) = m vs M(x*) = m*) holding X constant at x. 
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According to the method by VanderWeele and Vansteelandt,58 the estimator for 
NDE is: 
𝑂𝑅𝑥,𝑥∗;𝑌
𝑁𝐷𝐸 ≈ exp{𝑐′(𝑥 − 𝑥∗)}                     (10) 
with 95% confidence interval given by, 
exp {log 𝑂𝑅𝑥,𝑥∗;𝑌
𝑁𝐷𝐸 ± 1.96(𝑥 − 𝑥∗)√𝜎𝑐′ } 
And the estimator for NIE is: 
𝑂𝑅𝑥,𝑥∗;𝑌
𝑁𝐼𝐸 ≈ exp{𝑎𝑏(𝑥 − 𝑥∗)}                     (11) 
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with 95% confidence interval given by, 
exp {log 𝑂𝑅𝑥,𝑥∗;𝑌
𝑁𝑖𝐸 ± 1.96(𝑥 − 𝑥∗)√𝑏2𝜎𝑎 + 𝑎2𝜎𝑏} 
where a, b, c’ are coefficients from logistic models, 𝜎𝑎is the variance of a, and 
𝜎𝑏 is the variance of b, 𝜎𝑐′ is the variance of c’. 
For this method, it can be showed with some math manipulations that the NDE 
and NIE can be converted to the direct and indirect effects estimated from the classic 
Baron and Kenny approach (c’ and a*b). However, compared to the classic Baron and 
Kenny approach with additional bootstrapping analysis to derive the indirect effect, 
the causal mediation approach has three advantages: 1) a more complete framework 
for causal inference; 2) clearer interpretation of the direct and indirect effects; 3) a 
more straightforward application to non-linear models. 
Although there are different decomposition methods under the causal inference 
framework,59-61 the VanderWeele and Vansteelandt method for logistic regression62 
was chosen due to three advantages that suits the analyses for objective 2b: 1) 
handling of binary outcome and mediator, 2) not computationally intensive, 3) 
decomposition in terms of OR. The two limitations of this method are that it 1) 
provides no sensitivity analyses routines, and 2) violates the assumption of rare 
outcome as asthma prevalence is above 10% in the BBC sample. 
To apply the classic causal inference approach to testing mediation in this 
dissertation, I relied on the models fitted for the classic Baron and Kenny approach 
(see Box 3-1) to establish the basic criteria for inferring that preterm birth mediated 
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the effect of a prenatal variable on asthma. I then estimated NDE and NIE for 
preterm birth long with their 95% confidence intervals and p-values based on models 
2 and 3 in Box 3-1, using the paramed command in Stata.62 
3.4.3.3 Analyses for Objective 2c: Moderation 
The analyses for objective 2c assess the extent to which the effect of a particular 
prenatal variable on asthma differs between children born preterm and children born 
term, that is, the extent to which preterm birth moderates the effect of the variable 
on the likelihood of asthma. I tested for moderation in several different ways, 
although all were based on the classic Baron and Kenny approach.47 
In the classic approach,47 a moderator is a variable that affects the direction 
and/or strength of the association between an explanatory variable (X) and the 
outcome variable (Y). That is, the effect of X on Y varies across values of a 
(moderator) variable (M). An extension of this definition is to expand it from a single 
explanatory variable (X) scenario to a set of explanatory variables (Xs) scenario, 
which is the effect of the set of Xs on Y varies across values of the moderator (M). 
Figure 3-4 illustrates the assumptions underlying moderation analyses, which 
are similar to those for mediation analyses. First, X causes M. Second, M has an 
effect on Y, and M can be manipulated. Third, M changes the effect of X on M. In the 
simple case illustrated in the figure, there are two additional assumptions: the 
relationships among X, M, and Y are not confounded by other variables and the 
relationship between X and M is not mediated by another variable. 
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The first thing to do to in moderation analysis is to establish that the 
explanatory variables(s) (X or Xs) and the potential moderator (M) are both 
associated with the outcome (Y). A regression model of Y on X (Xs) and M, controlling 
for other covariates if needed, is fitted to estimate the main effects of the 
explanatory variable(s) (Xs) and the potential moderator (M) on the outcome (Y). The 
notations c’’ and b’ in Figure 3-4 refer to these coefficients, respectively. This 
regression is equivalent to Model 3 in classic mediation analysis (see Box 3-1). 
To examine whether the effects of a set of explanatory variables (Xs) vary across 
values of the moderator, coefficients from regressions of the effect of the 
explanatory variables on the outcome, stratified by the values of the moderator, are 
compared. Tests for nested equations, such as the Chow test63 are used test whether 
the coefficients in the two regressions are significantly different. 
To test for moderation of one explanatory variable, the interaction effect of the 
explanatory variable and the potential moderator (i.e., the coefficient for X*M) on 
the outcome variable (Y) is assessed. A variable M can be inferred as a moderator of 
the relationship between X and Y if the interaction effect (d in Figure 3-4) on Y is 
significant (p-value less than 0.05). 
Thus, to test whether preterm birth moderates the effects of pre- and peri-natal 
explanatory variables on childhood asthma I performed the following steps: 
 Step 1: Fit a multivariate logistic regression of pre- and peri-natal 
explanatory variables and preterm birth on childhood asthma, to 
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establish the main effects of pre- and peri-natal explanatory variables 
and preterm birth on childhood asthma (equivalent to Model 3 in Box 3-
1). 
 Step 2: Fit two identical multivariable logistic regressions of asthma on a 
set of pre- and peri-natal explanatory variables, one for preterm births 
and one for term births (i.e., stratify by preterm birth and otherwise 
same as Model 2 in Box 3-1). Two criterion were used to determine 
whether preterm birth modified the effect of the set of explanatory 
variables on asthma. 
First, the Chow test for logistic regressions, which tests whether the two 
stratified models together (Model 13 and 14) fit the data significantly 
better than the non-stratified model (Model 3). If yes (p-value less than 
0.05), then it supports the idea that the pre and peri-natal effects on 
asthma are different in size or significance for preterm children 
compared with the effects for term children. If no, there is no indication 
of a moderating effect of preterm birth on the relationship between pre 
and peri-natal variables and asthma. 
Second, if the coefficient for a pre- and peri-natal explanatory variable 
differs between Model 13 and Model 14, there may be moderating effect 
of preterm birth the relation between that pre- and peri-natal 
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explanatory variable and asthma, though the conclusion is not always 
true.64 This is the weakest criterion used for preliminary exploration. 
 Step 3: Fit a series of logistic regressions of childhood asthma that 
include preterm birth, all pre and peri-natal explanatory variables, and a 
single interaction term between preterm birth and a pre and peri-natal 
explanatory variable (Model 15 in Box 3-2). In logistic regression, 
interactions can be interpreted as either multiplicative or additive. I thus 
tested the moderating effect of preterm birth in two ways: 
First, the multiplicative interpretation, interaction was measured by the 
significance level of the coefficient for the interaction term of preterm 
birth and the pre and perinatal variable(d in Figure 3-4 and Box 3-2)65: if 
the interaction coefficient is significant, then reject he null hypothesis 
and accept the alternative hypothesis that preterm birth changes the 
effect of the pre- and peri-natal variable on the risk of asthma; 
specifically, the coefficient of the pre- and peri-natal variable is multiplied 
by ed. 
Second, for additive interaction, interaction was measured by the cross 
difference of the predicted marginal probabilities for asthma among 
groups defined by preterm birth status and value of the (binary) 
explanatory variable.66 If the cross difference is significantly different 
from 0, then the null hypothesis is rejected and the alternative 
123 
hypothesis that preterm birth significantly changes the effect of the pre- 
and peri-natal variable on the risk of asthma is accepted. Specifically, the 
probability of asthma for the exposed group additionally increased by the 
amount of the cross difference for preterm children than that the 
increased amount for term children. 
The formula to calculate the cross difference is:66 
 (p11 - p00) – [(p01 – p00) – (p11 –p10)] = p11 - p01 - p10 + p00   (12) 
Where p11 = predicted probabilities of asthma for the subpopulation with 
prenatal explanatory factor = 1 and preterm birth status = 1; p01 = 
predicted probabilities of asthma for the subpopulation with prenatal 
explanatory factor = 0 and preterm birth status = 1; p10 = predicted 
probabilities of asthma for the subpopulation with prenatal explanatory 
factor =1 and preterm birth status = 0; p00 = predicted probabilities of 
asthma for the subpopulation with prenatal explanatory factor = 0 and 
preterm birth status = 0. 
The additive interactions were treated as the primary results for f two 
reasons. First, multiplicative interactions are not recommended for non-linear 
models.67 Second, the prevalence of asthma was generally higher than 10% 
for children in most subgroups in this study sample, which violated the 
assumption necessary to use OR to approximate relative risks.66 
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 Step 4: Fit a logistic regression of childhood asthma on preterm birth, all 
pre- and peri-natal explanatory variables, and all explanatory variable 
and preterm birth interactions terms (Model 15’). As noted, the tests 
above considered one explanatory variable at a time. However, the 
estimation of interactions, particularly the multiplicative scales, could be 
influenced by whether other interaction terms were included in the 
model. The results for both multiplicative and additive interactions were 
compared with the results from the Model 15 and Model 15’ series. This 
sensitivity analyses showed that the results did not differ much between 
Models 15 and 15’ for additive interactions, but varied substantially in 
terms statistical significance and effect size for multiplicative interactions, 
which further supported the use of the additive results as the main 
findings. 
3.4.4 Analyses for Specific Aim 3 
Specific Aim 3 is to characterize longitudinal (age) patterns of childhood asthma 
using both the TCRS classification and statistical modeling, and to determine whether 
these longitudinal patterns vary between children born preterm and children born 
term. It has four objectives: 
3e. To identify longitudinal patterns of childhood asthma using the original and 
modified TCRS classification rules; 
3f. To identify longitudinal patterns of childhood asthma using Longitudinal 
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Latent Class Analysis (LLCA); 
3g. To assess the relationship between preterm birth and longitudinal patterns 
of childhood asthma defined by the TCRS rules; 
3h. To assess the relationship between preterm birth and longitudinal patterns 
of childhood asthma defined by LLCA. 
3.4.4.1 Analyses for Objective 3a: Longitudinal Patterns of Asthma Using TCRS 
Classification Rules 
The original TCRS rule9 characterized longitudinal patterns of asthma by 
grouping children into four categories according to their history of wheezing in the 
first three years of life and their wheezing/asthma status at age 6. Thus the groups 
are: 1) no diagnoses of asthma/wheezing between ages 0 and 2 years and no 
diagnoses of asthma/wheezing at age 6 years (never had asthma/wheezing); 2) 
diagnoses of asthma/wheezing between ages 0 and 2 but no diagnoses of 
asthma/wheezing at age 6 years (transient early asthma/wheezing); 3) no 
asthma/wheezing diagnoses between ages 0 and 2 but a diagnosis at age 6 (late 
onset asthma/wheezing); and 4) diagnoses of asthma/wheezing at both ages 0-2 and 
age 6 (those with persistent wheezing). 
Since I had data for all ages between 0 and 6, I modified the original TCRS rules 
to incorporate diagnoses between ages 3-5 years, which I will refer to as the 
“modified TCRS rules”. Thus the modified classification rules were based on 
occurrence asthma at three ages: ages 0-2, ages 3-5, and age 6. Out of the 8 (23) 
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ensuing patterns of asthma, I combined patterns that had similar time course of 
diagnoses and risk factors in preliminary analysis and added two patterns: 5) no 
asthma/wheezing diagnoses between ages 0 and 2 but diagnoses between ages 3 
and 5 and at age 6 (middle onset asthma/wheezing); 6) no asthma/wheezing 
diagnoses between ages 0 and 2, diagnoses between ages 3 and 5 but no diagnosis 
at age 6 (late onset asthma/wheezing). Classification criteria for the original and the 
modified TCRS rules are summarized in Chapter 6, Table 6-2. 
3.4.4.2 Analyses for Objective 3a: Longitudinal Patterns of Asthma Using 
Longitudinal Latent Class Analysis 
Longitudinal patterns of asthma also were described using statistical methods, 
specifically, Longitudinal Latent Class Analysis (LLCA). LLCA is a type of Latent Class 
Analysis (LCA)68 and is used with longitudinal data consisting of repeated measures of 
the same outcome. It also is referred to as Repeated-Measures LCA (RMLCA).69 
Similar to standard LCA,70 LLCA hypothesizes that the observed population 
(here, children aged under 7 years) consists of discrete subpopulations characterized 
by patterns of outcome (here, asthma) occurrence over age, and that within each 
subpopulation the age-specific occurrences of the outcome differ only by random 
variability. LLCA estimates the number of subpopulations (“classes”), in this case 
longitudinal patterns of asthma, the distribution of the population among 
subpopulations, in this case, the prevalence of each longitudinal pattern of asthma, 
and the age-specific proportions with the outcome within each subpopulation 
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(“conditional probabilities”), in this case the proportion of children with asthma at 
each age within each class. LLCA on the longitudinal measures of asthma/wheezing 
was performed using Mplus 7 statistical software using maximum likelihood 
estimation. 
The model of LLCA and its likelihood function are specified in Box 3-3: The 
number of latent classes that best fit the observed data was determined by 
comparing a series of goodness-of-fit measures of models with different numbers of 
classes. Different goodness-of-fit measures were included as they were indicating 
different characteristics of the models. 
(1) Pearson’s chi-square,68 to assess whether the model predicts the observed 
age patterns of asthma accurately. The null hypothesis is that the model 
predicts accurately, the alternative hypothesis is that the model 
inadequately predicts the observed data. 
(2) Entropy,71 an indicator for assessment of classification uncertainty for latent 
classes, ranged from 0 to 1. 0 indicates poorly separated latent classes, while 
1 indicates perfectly separated latent classes. Generally, above 0.8 is 
considered indifferently good mode fitting. 
(3) Standardized (STD) residual, a measure assessing model prediction, 
measured as residuals for the predicted patterns of outcomes vs the 
observed patterns of outcomes for cells defined by each combination of 
outcome measures (2r number of cells). Ideally, no cells in which the STD 
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residual is greater than 1.96 indicates a good fit of the model to the 
observed data, while a larger number of cells in which the STD residual is 
greater than 1.96 indicates bad goodness-of-fit.72 However, if some cells are 
sparsely filled in the observed sample, it is it is expected to have a few cells 
with STD residual greater than 1.96. 
STD residual = ∑
𝑂 − 𝐸
√𝐸 × √1 − 𝐸/𝑛
2𝑟
 
(4) Information Statistics: the Akaike information criterion (AIC) and Bayesian 
information criterion (BIC) are two functions to measure model parsimony. 
Smaller values of AIC and BIC are favored, and indicate higher efficiency of 
the model performance with fewer parameters, i.e. the model produces 
higher estimation of likelihood with fewer parameters. A simulation study 
conducted by Nylund73 suggested that BIC performs better than AIC, 
particularly when the data are sparsely distributed: 
AIC = −2 × 𝐿𝐿 + 2 × 𝑠 
BIC = −2 × 𝐿𝐿 + 𝑠 × log (𝑁) 
LL = log-likelihood, s = number of parameters = k-1+k*r, N = sample size 
(5) Vuong-Lo-Mendell-Rubin likelihood ratio test (LMR),74 assessment of model 
fit for the k class version compared to the k-1 class version. Lo-Mendell-
Rubin74 found that the distribution of –2*LL follows a χ2 distribution with 
degree of freedom equal to the difference in number of parameters for the 
k-class model vs. the model with k-1 classes. However, Jeffries showed a 
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problem with the LMR proof, 75 so this measure should be used with 
caution. 
−2 × 𝐿𝐿𝑑𝑖𝑓𝑓 = (−2 × 𝐿𝐿𝑘−1 𝑐𝑙𝑎𝑠𝑠) − (−2 × 𝐿𝐿𝑘 𝑐𝑙𝑎𝑠𝑠 )  
~ 𝑑𝑖𝑠𝑡𝑟𝑖𝑏𝑢𝑡𝑖𝑜𝑛 𝑥2(𝑑𝑓 = 1 + 𝑟) 
(6) Bootstrapped likelihood ratio test (BLRT), assessment of fit for a model with 
k classes compared to a model with k-1 classes,76 with the distribution 
derived from bootstrapping with at least 500 random samples from the 
original dataset. MPLUS approximates a BLRT, as Nylund’s simulation study73 
suggested that BLRT performs the best among model fitting statistics. 
In addition to these statistical criteria, a priori theories (e.g. latent patterns 
reported by other studies) and small group size (n < 25) were also considered in 
model selection. To avoid local maximization, the computation processes for the 
models were run many times (100 to 1500) with different starting values, to make 
sure the highest log likelihood was well replicated and the results were reliable. 
3.4.4.3 Analyses for Objective 3c: Preterm Birth and Longitudinal Patterns of 
Asthma Using TCRS Rules 
Whether asthma patterns defined by the original and modified TCRS rules 
differed by preterm birth status was first tested using chi-square tests without 
adjusting for other explanatory variables. Next, multinomial logistic regressions of 
the original and the modified TCRS asthma patterns on preterm birth status were 
performed (Model A and Model B, respectively), adjusting for other explanatory 
130 
variables, including child sex and maternal characteristics (race/ethnicity, marital 
status, history of asthma and allergies, smoking during the index pregnancy). Box 3-4 
shows Model A; Model B is analogous. 
3.4.4.4 Analyses for Objective 3d: Preterm Birth and Longitudinal Patterns of 
Asthma Using Latent Analysis 
Whether the k class LLCA model for longitudinal patterns of asthma identified 
for all children was appropriate for both preterm and term children was evaluated in 
three ways: (i) whether the number of classes (k) that fit the data best was the same 
for both preterm and term children; (ii) whether the class-and-age-specific 
probabilities (πrk) of asthma for a given class (k) and age (r-1) were the same across 
subpopulations (“measurement invariance”)77, i.e. whether the shape of the 
estimated age patterns were the same across subpopulations; (iii) whether the class 
prevalence (ηk) for a class (k) were the same across subpopulations, i.e. whether the 
distributions of the k classes were the same across subpopulations. Box 3-5 
illustrates the three characteristics used to compare the LLCA models of asthma 
between preterm and term born children. 
For (i), the same set of procedures and goodness-of-fit measures described for 
identifying the best number of classes in objective 3b was used to identify the 
appropriate number of classes for preterm and term children. For (ii) and (iii), 
multiple-group LCA77,78 (or multiple-group LLCA in the longitudinal data setting) was 
used. Multiple-group LCA expands LCA by adding a grouping variable (in this study, 
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two groups: preterm vs term) to the model, and estimating patterns for k latent 
classes for each group (k*2 classes in this study) instead of k classes as in single 
group LCA. 
For (ii), measurement invariance77 was tested by the likelihood ratio test for two 
nested multiple-group LCA models: Model C allowing age-specific probabilities of 
asthma to vary across preterm birth status (group) vs. Model D constraining age-
specific probabilities of asthma to be equal across preterm birth status (group). If 
Model D performs not significantly worse than Model C, measurement invariance 
across groups holds and the k class LLCA model is appropriate for both preterm and 
term children. 
The test for (iii) was another likelihood ratio test for two nested multiple-group 
LCA models: Model D constraining age-specific probabilities of asthma to be equal 
across preterm birth status but allowing latent class prevalences to vary across 
preterm birth status vs. Model E constraining both age-specific probabilities and 
latent class prevalences to be equal across preterm birth status. If Model E performs 
not significantly worse than Model D, equivalence of latent class prevalences holds 
and suggests that the k classes are distributed the same among preterm and term 
children. 
Finally, Latent Class Regression (LCR)79 (or Longitudinal Latent Class Regression 
in the longitudinal data setting) was conducted to determine the association 
between preterm birth and different longitudinal patterns of childhood asthma, 
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adjusting for the same covariates mentioned above. LCR expands the scope of LCA to 
incorporate covariates with the assumption that within each longitudinal pattern of 
asthma, covariates are not associated with age-specific probabilities of asthma. LCR 
fitted the measurement model (i.e. LCA) and the association model (i.e. multinomial 
logistic regression) simultaneously, and reported two types of results: (i) 
characteristics of k asthma patterns, and (ii) association between preterm birth and 
the k asthma patterns. Box 3-6 illustrates the LCR model with the measurement part 
on the right half, and the structure part on the left. In Chapter 6, two models are 
fitted of 4-class (Model F) and 5-class (Model G) asthma patterns on preterm birth, 
separately. 
As mentioned above, all the LLCA, LCA, Multiple-LCA, and LCR models were 
fitted using Mplus statistical software, with up to 1500 random starts to make sure 
the best likelihood values were well replicated, thus to avoiding local maximization 
and assuring the model was well identified. If the best likelihood values were not 
replicated with 1500 random starts, the models were considered unstable and poorly 
identified. Sensitivity analyses with different handling of missing values of asthma 
outcomes for LCR were done as described in Section 3.4.1.  
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Figures and Tables and Boxes 
Figures 
Figure 3-1. Data Collection Phases of the Boston Birth Cohort Study  
 
Phase 1: Baseline Data Collection [at Birth] 
 Boston Medical Center 
 Mother-infant pairs enrolled within 1-3 days of delivery  
 Case: control = 1:2, where cases are births that were preterm (< 37 
weeks gestation) or low birth weight (< 2500 g), and controls are 
term births (> 37 weeks gestation) with birth weight > 3000 g.  
 Initiated in 1998 and ongoing since then 
 Data collection modes: 
Part 1: Enrollment log  
Part 2: Maternal questionnaire interview  
Part 3: Maternal and newborn medical record review and abstraction 
 
Phase 2: Postnatal Follow-Up Data Collection [Prospective Follow-Up]  
 Mother-infant pairs enrolled in phase 1 and who continued to 
receive pediatric care at the Boston Medical Center 
 Ongoing since 2004 
 Data collection modes: 
Part 1: Maternal questionnaire interviews about child’s health (when 
child aged 6-12 months, and 2, 4, and 6 years) 
Part 2: Child electronic medical records beginning in September 2003 
143 
 
Figure 3-2. Flow Chart Showing Exclusions and Sample Sizes for Each Specific Aim 




Figure 3-3. Classic Approach to Mediation Analysis 






Figure 3-4. Classic Approach to Moderation Analysis 
























Table 3-1. Summary of Aim 1 Objectives 
 Age of asthma assessment 
Age range of asthma measures  Age 0-5 years Age 6-9 years 
Age 0-5 years 1a -- 
Age 6-9 years 1c 1b 
 Preterm birth status 
Age range of asthma measures  Binary measure   Degree measure 
Age 0-5 years 1d 
Age 6-9 years 1e 
 
Table 3-2. Summary of Asthma Measures Used in Aim 1 
  




Age range of 
assessment 
Dimension 2: 
type of EMR data 
Dimension 3: number of episodes 
≥1 ≥2 ≥4 ≥1 ≥2 ≥4 ≥1 
Ages 0-5 years 
Diagnosis a b c d e f g 
Medication h, i   j   k 
Ages 6-9 years 
Diagnosis l m n * * * o 
Medication p,q   r   s 




Box 3-1. Equations to Test the Mediating Effect for Objective 2b of Aim 2 
logit(𝑌) = 𝑐0 +  𝑐1𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙 + 𝑐𝑋, and 𝑐 ≠ 0       (1) 
logit(𝑀) = 𝑎0 +  𝑎1𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙 + 𝑎𝑋, and 𝑎 ≠ 0      (2) 
logit(𝑌) = 𝑐0
′ +  𝑐1
′ 𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙 + 𝑐
′𝑋 + 𝑏𝑀, and 𝑏 ≠ 0 (3) 
If 𝑐 > 𝑐′ , then accept the mediating effect of M and reject the null 
hypothesis. 
If 𝑎 × 𝑏 ≠ 0, then accept the mediating effect of M and reject the null 
hypothesis. 
Notations 
Y = 1 if ever childhood asthma, 0 if no childhood asthma. 
M = 1 if preterm birth, 0 if term birth. 
𝑋= a list of binary variables of values 0 and 1 (multiple category variables are 
recoded into dummy variables): 
genetic predispositions (maternal history of asthma, maternal history of 
allergies), 
maternal social demographics (maternal race/ethnicity, mother unmarried, low 
family income, mother born in the U.S.), 
maternal smoking during pregnancy (continuous smoking, quit smoking), 
maternal health history (prepregnancy BMI), 
maternal high stress during pregnancy, 
pregnancy complications (preeclampsia and chorioamnionitis), 
obstetric characteristics (C-section). 
𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙= child’s sex and age, born in summer/autumn, first born in offsprings 




Box 3-2. Equations to Test the Moderating Effect for Objective 2c of Aim 2 
logit(𝑌) = 𝑐0
′′𝑃𝑇𝐵 +  𝑐1
′′𝑃𝑇𝐵𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙 + 𝑐
′′𝑃𝑇𝐵𝑋, if 𝑀 = 1(PTB)   (13) 
logit(𝑌) = 𝑐0
′′𝑇𝐵 +  𝑐1
′′𝑇𝐵𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙 + 𝑐
′′𝑇𝐵𝑋, if 𝑀 = 0 (TB)       (14) 
 For the likelihood ratio test for Model (3) nested in Models 4&5, if p-value < 
0.05, accept the overall moderating effect of M and reject null; 
If 𝑐′′𝑃𝑇𝐵 ≠ 𝑐′′𝑇𝐵, then there may be a moderating effect of M. 
logit(𝑌) = 𝑐0
′′ +  𝑐1
′′𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙 + 𝑐
′′𝑋 + 𝑏′𝑀 + 𝑑𝑀𝑋, and 𝑏′ ≠ 0   (15) 
If 𝑑 ≠ 0, then accept the moderating effect of M and reject the null 
hypothesis. 
If p11 - p01 - p10 + p00 ≠ 0, then accept the moderating effect of M and reject 
the null hypothesis. 
Notations 
Y = 1 if ever childhood asthma, 0 if no childhood asthma 
M = 1 if preterm birth, 0 if term birth 
𝑋= All binary variables of values 0 and 1, and multiple categorical variables as their 
original scale: 
genetic predispositions (maternal history of asthma, maternal history of 
allergies), 
maternal social demographics (maternal race/ethnicity, mother unmarried, low 
family income, mother born in the U.S.), 
maternal smoking during pregnancy (continuous smoking, quit smoking), 
maternal health history (prepregnancy BMI), 
maternal high stress during pregnancy, 
pregnancy complications (preeclampsia and chorioamnionitis), 
obstetric characteristics (C-section). 
𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙= child’s sex and age, born in summer/autumn, first born in offsprings 
(parity), family member smoking, maternal age, and duration of follow-up. 
For additive interaction testing: 
p11 = E[Y|X = 1, M = 1], 
p01 = E[Y|X = 0, M = 1], 
p10 = E[Y|X = 1, M = 0], 
p00 = E[Y|X = 0, M = 0]. 
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Box 3-3. Illustration for Longitudinal Latent Class Model and Likelihood Function 
Equation for Objective 3a of Aim 3 
Illustration for Latent Class Model 
 
Notations:  
u1, u2, … , ur = rth of binary (1/0) repeated variables for asthma u, r -1 = age at 
asthma measure assessment in this dissertation from age 0 to 6 years. 
𝜋𝑟𝑘 = Probability that ur =1, given class membership k. 
Categorical latent class c: c = k, k = 1, 2, … , k. 
ci = class membership of individual i. 
ηk= prevalence of latent class when c = k. 






ηk = Pr(ci = k) 






Box 3-4. Equations to Test Multivariate Logit Regression of Asthma Patterns on 
Preterm Birth for Objective 3c of Aim 3 
A number of j equations for Model A. 
logit(𝑌𝐴 = 1) = 𝑙𝑜𝑔𝑖𝑡 (
Pr[𝑌𝐴 = 1]
Pr[𝑌𝐴 = 0]
) = 𝛽0,1 +  𝛽1,1𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙 + 𝛽𝑃𝑇𝐵,1𝑃𝑇𝐵 
logit(𝑌𝐴 = 2) = 𝑙𝑜𝑔𝑖𝑡 (
Pr[𝑌𝐴 = 2]
Pr[𝑌𝐴 = 0]
) = 𝛽0,2 +  𝛽1,2𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙 + 𝛽𝑃𝑇𝐵,2𝑃𝑇𝐵 
… 
logit(𝑌𝐴 = 𝑗) = 𝑙𝑜𝑔𝑖𝑡 (
Pr[𝑌𝐴 = 𝑗]
Pr[𝑌𝐴 = 0]
) = 𝛽0,𝑗 +  𝛽1,𝑗𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙 + 𝛽𝑃𝑇𝐵,𝑗𝑃𝑇𝐵 
𝑌𝐴 = Longitudinal asthma patterns by the original TCRS rules of 4 groups, 𝑗
= 3 
𝑌𝐴 = 0, reference group as never asthma. 
𝑃𝑇𝐵 = 1 if preterm birth, 0 if term birth. 
𝑋𝑐𝑜𝑛𝑡𝑟𝑜𝑙 =  Child sex, maternal race or ethnicity, mother unmarried,  
maternal continued smoking during pregnancy, maternal history of asthma,  
maternal history of allergies. 
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Box 3-5. Comparing Latent Classes of Asthma between Preterm and Term Born 
Children for Objective 3d of Aim 3 
Updated from illustration in Box 3-3, three aspects were examined: 
(i) if kPTB= kTB; 
(ii) if πrkPTB=πrkTB 
(iii) if ηkPTB=ηkTB 
 
Notations:  
PTB = preterm birth children , TB = term birth children 
u1, u2, … , ur = rth of binary (1/0) repeated variables for asthma u, r -1 = age at 
asthma measure assessment in this dissertation from age 0 to 6 years. 
𝜋𝑟𝑘 = Probability that ur =1, given class membership k. 
Categorical latent class c: c = k, k = 1, 2, … , k. 
ci = class membership of individual i. 
ηk= prevalence of latent class when c = k. 
  





ηk = Pr(ci = k) 
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Box 3-6. Illustration for Latent Class Regression Analysis of Asthma Patterns on 
Preterm Birth for Objective 3d of Aim 3 
Illustrates a Latent Class Regression model with the measurement part on the right 




u1, u2, … , ur: r number of binary (1/0) repeated variables for asthma u. 
𝜋𝑟𝑘 = Probability that ur =1, given class membership k. 
Categorical latent class c: c = k, k = 1, 2, … , k. 
ci = class membership of individual i. 
ηk= prevalence of latent class c = k. 
 
 


























Preterm Birth and Childhood Asthma: the Role of Asthma Measures, 
Degree of Prematurity, and Age at Asthma Assessment2   
                                                             
2 Some results of this chapter, including Figure 4-1, Table 4-1, Table 4-6, Table 4-7, Table 4-8, and the 
relevant paragraphs are reprinted from a manuscript published in the American Journal of 
Respiratory and Critical Care Medicine with the permission of the American Thoracic Society. 
Copyright ©  2015 American Thoracic Society. Cite: He, H., Butz, A., Keet, C. A., Minkovitz, C. S., et al. 
(2015). Preterm Birth with Childhood Asthma: The Role of Degree of Prematurity and Asthma 
Definitions. Am J Respir Crit Care Med, 192(4), 520-523. The American Journal of Respiratory and 
Critical Care Medicine is an official journal of the American Thoracic Society. 
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4.1 Abstract 
Background: Emerging evidence suggests that infants born preterm are at increased 
risk of asthma in childhood, but findings to date are inconsistent. These 
inconsistencies may in part reflect differences among studies in three key domains: 
measurement of asthma, degree of preterm birth, and the age at which asthma is 
assessed. 
Objectives: To examine the consistency of various asthma measures, and investigate 
whether the preterm birth-asthma association varies by asthma measure, degree of 
prematurity, and age at asthma assessment. 
Design and Participants: Prospectively follow-up assessment of a patient-based birth 
cohort from Boston Medical Center through an electronic medical record system. 
2,540 children were followed up to different ages from less than a year to age 9 years 
with the median age of 5 years, among which only 1,072 were followed up to age 6 
to 9 years. 
Measures and Analyses: Eleven measures were created for ages 0-5 years and eight 
measures for ages 6-9 years based on electronic medical records of physician 
diagnoses and medical prescriptions. Prematurity was defined as both conventional 
preterm birth status (preterm, <37 weeks of gestation vs. term, 37-41 weeks) and 
categories reflecting degree of prematurity: early preterm (EP, 20-31 weeks), late 
preterm (LP, 32-36 weeks), early term (ET, 37-38 weeks) and full term (FT, 39-41 
weeks). Consistency of asthma measures was measured by Cohen’s Kappa coefficient 
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(Kappa), and associations between preterm birth and asthma were assessed by 
multivariate logistic regression. Analyses were conducted for age ranges 0-5 years 
and 6-9 years, separately. 
Results: Although agreement of pairwise asthma measures defined in different ways 
varied widely (Kappa: 0.16 ~ 0.85), children born preterm were at increased risk of 
asthma using each of the measures during ages 0-5 years (adjusted odds ratios 
[AORs] ranging from 1.8 [95% Confidence Interval(CI), 1.5-2.3] to 2.9 [95%CI, 1.8-
4.4]) and ages 6-9 years (AORs: 2.0 [95%CI, 1.3-3.0] to 2.9 [95%CI, 2.1-4.1]), 
compared with term born children. The highest risk of asthma was among children 
born early preterm followed by children born late preterm; the lowest risks were 
among children born early term and full-term. 
Conclusions: This manuscript confirms the measurement quality and value of an 
array of diagnosis- and medication-based measures for asthma. A dose-response 
association is observed between the degree of prematurity and asthma, which is 
robust to asthma measures and persists to school age. Preterm birth accounts for a 
substantial population attributable fraction (12% to 18%) of asthma at ages 6-9 years. 
 
Key words: childhood asthma, asthma measures, wheezing, preterm birth, degree of 
prematurity, prospective birth cohort  
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4.2 Introduction 
Emerging evidence suggests that infants born preterm are at increased risk of 
asthma in childhood.1-3 However, to date findings linking preterm birth and childhood 
asthma are inconsistent. Of the 30 major studies on the association published 
worldwide during 2003-2013, nearly a third reported null effects, while the others 
reported adjusted or unadjusted odds ratios ranging from 1.2 to 4.9.2,3 A review of 
the published studies suggests that inconsistencies in the preterm birth-asthma 
association may in part reflect differences among studies in three key domains: 
measurement of asthma, degree of preterm birth, and the age at which asthma is 
assessed. 
Because of its complex causes and evolving clinical manifestation from infancy 
to childhood, asthma has no universally agreed-upon definition.4 A recent review of 
the literature identified 60 working definitions of asthma.5 These definitions differ by 
clinical phenotype (recurrent wheezing6 vs. asthma7 vs. bronchial 
hyperresponsiveness5), type of medical records data (physician diagnosis6,8 vs. 
medication use9), and source of data (parental reports10 vs. medical records11). Meta-
analyses2,3 of the preterm-asthma relationship have discussed the potential role that 
different asthma measures play in producing heterogeneous results; however, to 
date, no study has examined the relationship between preterm birth and a broad 
array of asthma measures in a single, adequately powered, prospective birth cohort. 
A second potential source of ambiguity in published results may be differences 
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in the consistency and magnitude of the preterm-asthma relationship by degree of 
preterm birth. Most studies defined preterm birth as babies born at less than 37 
weeks of gestation. However, early preterm birth (<32 weeks) has been closely 
associated with asthma,2,12 while the association of late preterm birth (34-36 weeks) 
with asthma is less consistent,2,13 and the association between early term (37-38 
weeks) and asthma is understudied. 
Age differences in study samples may be a third factor contributing to 
inconsistent results. The clinical presentation of asthma varies by age, and asthma 
diagnoses are difficult to confirm in children under 6 years of age.14-16 For these 
reasons, childhood asthma diagnoses are often named early wheezing disorders at 
age 0-5 years.1 If asthma measures at young ages differ in meaning from measures at 
older ages, the observed relationship between preterm birth and asthma may also 
differ. A meta-analysis suggested that the preterm-asthma relationship was weaker in 
studies of older children and adolescents compared with studies of children under 
age 10 years.3 However, another meta-analysis found that the magnitude of the 
preterm-asthma association did not vary by age among children under age 18 years.2 
To address the above gaps, this manuscript examines the consistency of asthma 
measures that use different definitions, and investigates whether the association 
between preterm birth and childhood asthma varies by measurement of asthma, 
degree of preterm birth, and age at asthma assessment (0-5 years vs. 6-9 years). The 
objectives are: 
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1a. To examine the agreement among 11 childhood asthma measures defined 
by type of EMR data (physician diagnosis vs. prescribed medication), clinical 
phenotype (wheezing vs. asthma vs. asthma exacerbation), and number of 
episodes (single vs. multiple) at ages 0-5 years; 
1b. To examine the agreement among 8 childhood asthma measures defined by 
type of EMR data (physician diagnosis vs. prescribed medication), clinical 
phenotype (asthma vs. asthma exacerbation), and number of episodes 
(single vs. multiple) at ages 6-9 years; 
1c. To examine the agreement between 11 childhood asthma measures 
assessed at ages 0-5 years and 2 asthma measures assessed at ages 6-9 
years; 
1d. To assess the association between preterm birth and 11 measures of 
childhood asthma among children aged 0-5 years; 
1e. To assess the association between preterm birth and 8 measures of 
childhood asthma among children aged 6-9 years. 
4.3 Methods 
4.3.1 Sample 
This manuscript was based on data for 2,701 children followed prospectively in 
the Boston Birth Cohort (BBC) through 2013. The study design and data collection 
procedures of the BBC were detailed in Chapter 3. A total of 161 children were 
excluded from the analyses due to post-term birth (35 cases), missing information on 
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gestational age at birth (1 case), no electronic medical record (EMR) data in the age 
range of interest (27 cases), questionnaire data not available (60 cases), or missing 
values on major covariates (38 cases). Thus, the analytic sample for this manuscript 
included 2,540 children. Analyses were conducted for asthma outcomes assessed at 
ages 0-5 years (n = 2,540) and ages 6-9 years (n = 1,072), separately. 
4.3.2 Measures 
Eleven distinct asthma measures were created for ages 0-5 using EMR data 
obtained from the BMC. Asthma measures were defined according to clinical 
guidelines from the National Heart, Lung, and Blood Institute (NHLBI),15 a recent 
literature review,5 and major tools and studies in the field (e.g., the Healthcare 
Effectiveness Data and Information Set (HEDIS)17 and the Childhood Origins of 
Asthma Study (COAST)18 (see Table 4-1 for detailed explanations of each measure). 
Each of the measures was created using EMR data on physician diagnosis and 
medication prescriptions from clinic visits, urgent care visits, emergency department 
visits, and hospital admissions that occurred when the child was between ages 0 and 
5. The 11 measures of asthma vary by type of EMR data (physician diagnoses vs. 
medicine prescriptions), clinical phenotype (wheezing vs. asthma vs. asthma 
exacerbation), and number of episodes (single vs. multiple). To allow for differences 
in the clinical manifestation of asthma by age, I created a second set of 11 measures 
of asthma, using data collected when the child was between ages 6 and 9. Three of 
the asthma measures defined by wheezing diagnoses were excluded from the 
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analysis for ages 6-9 years due to low prevalence rate in preliminary analysis and 
poor validity. The 11 measures using data from ages 0 to 5 were intended to reflect 
“early wheezing disorders” (including wheezing and asthma diagnoses), while the 8 
measures using data from ages 6 to 9 were to reflect “school age asthma”. 
Preterm birth status was defined by a binary variable, where preterm birth 
indicated a live birth occurred at less than 37 weeks of completed gestational age, 
and term birth indicated a live birth occurred at 37-41 weeks.19 Degree of 
prematurity was categorized as early preterm (20-31 weeks), late preterm (32-36 
weeks), early term (37-38 weeks), and full term (39-41 weeks), based on ACOG 
recommendations19,20 and some changes to accommodate this analytical sample. 
Out the 2,540 analytic sample, 207 (8.1%) of the children were early preterm, 512 
(20.2%) were late preterm, 653 (25.7%) were early term, and 1,168 (46.0%) were full 
term. As in other clinical studies21, gestational age was measured by an algorithm 
combining measures from the first day of the last menstrual period and the early (< 
20 weeks) prenatal ultrasound.22 
Additional independent variables were included in analysis based on the 
existing literature, biological plausibility, and marginal binary relationship to asthma 
and preterm birth in the analytic sample (p < 0.2). These included maternal age, 
maternal race/ethnicity, maternal education, whether the mother was unmarried, 
maternal history of asthma, whether the mother smoked during the entire 
pregnancy, child’s sex, child’s age, and whether a family member smokes (see Table 
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4-6). These covariates were included in all multivariate models to control for 
spuriousness and assure comparability of models across asthma measures. 
4.3.3 Statistical Analysis 
For objectives 1a-1c, which are to examine the consistency of asthma measures, 
pairs of measures were assessed using Cohen's kappa coefficient,23 which quantifies 
the agreement between a pair of measures on a scale from 0 to 1, with higher values 
indicating greater agreement. Kappa coefficient values between 0.01 and 0.20 
indicate slight agreement between the measures, 0.21– 0.40 indicate fair agreement, 
0.41–0.60 indicate moderate agreement, 0.61–0.80 indicate substantial agreement, 
and 0.81–0.99 indicate almost perfect agreement.24 
The consistency of asthma measures was first examined by comparing measures 
assessed in the same age range, i.e. ages 0-5 years and ages 6-9 years (objectives 1a 
and 1b). For objective 1a, three sets of Kappa coefficients were used to compare 
measures differing in three dimensions of information. First, for type of data, 28 pairs 
of measures were compared, each pair consisting of one diagnosis-based measure 
and one medication-based measure. Second, for asthmatic outcomes, 9 pairs of 
measures were compared, each pair consisting of one asthma measure and one 
wheezing measure. Third, for number of episodes, the three asthma measures were 
compared to each other and the three wheezing measures were compared to each 
other. Asthma exacerbation was not included in the second and third sets of 
comparisons, as it was conceptually very different from asthma and wheezing and 
161 
less frequently used in preterm birth-asthma studies. Thus agreement analyses 
would not be helpful in understanding its difference from asthma and wheezing or 
inconsistencies in the preterm-asthma association. 
For objective 1b, three sets of Kappa coefficients were used to compare 
measures differing in two dimensions of information. First, for type of data, 16 pairs 
of measures were compared, with each pair consisting of one diagnosis-based 
measure and one medication- based measure. Second, for number of episodes, the 
three asthma measures were compared to each other. 
The consistency between all asthma measures assessed at ages 0-5 years and 
two asthma measures assessed at ages 6-9 years was then examined (objective 1c). 
Had a least one diagnosis of asthma and had two diagnosis of asthma were chosen as 
key measures for ages 6-9 years, as they are considered to have good validity within 
this age range and are frequently used in epidemiological studies.15,25 
For objectives 1d and 1e, the prevalence of asthma among preterm births and 
term births were first compared for each of the measures of asthma using chi-square 
tests with 95% confidence intervals (CI), stratified by age at asthma assessment. 
Second, multivariate logistic regression was used to examine the association of 
preterm birth and degree of preterm birth with the 11 asthma measures at ages 0-5 
years and the 8 measures at ages 6-9 years, adjusting for the potential confounders 
listed in the previous section. Because the BBC has been enrolling patients 
continuously, the children vary in the length of time they have been observed – from 
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less than one year to age nine years. To allow for these differences in length of 
follow-up, duration of follow-up for each child also was adjusted for in the statistical 
analyses. All the analyses were done using STATA data analysis software, version 12.0 
(College Station, TX). 
4.4 Results 
4.4.1 Consistency of Asthma Measures 
Table 4-2 presents the estimated kappa coefficients between diagnosis-based 
measures and medication-based measures of childhood asthma, by age of 
assessment. Results for ages 0-5 years (top half of Table 4-2) showed that diagnosis-
based measures of asthma and medication-based measures of asthma were 
moderately to substantially in agreement (kappa range: 0.44 ~ 0.76), that diagnosis-
based measures of wheezing and medication-based measures of asthma were 
slightly to moderately in agreement (kappa range: 0.16 ~ 0.52), and that the 
diagnosis-based measure of asthma exacerbation and medication-based measures of 
asthma were moderately to substantially in agreement (kappa range: 0.48 ~ 0.66). 
The degree of agreement between diagnosis-based measures and medication-
based measures of asthma assessed at ages 0 to 5 varied by clinical phenotype of 
childhood asthma and number of diagnoses. First, agreement was generally higher 
for diagnoses of asthma than diagnoses of wheezing or asthma exacerbation. 
Second, compared to other medication-based measures, long-term controller 
medication (the most stringent medication-based measure for asthma) yielded 
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higher agreement with most diagnosis-based measures. Third, among asthma 
measures based on number of diagnoses, the measure based on two or more 
diagnoses of asthma yielded the highest agreement with the measure based on long-
term controller medication. 
Results for ages 6-9 years (bottom half of Table 4-2) showed that diagnosis-
based measures of asthma and medication-based measures of asthma were 
moderately to substantially in agreement (kappa range: 0.47 ~ 0.78) and the 
diagnosis-based measure of asthma exacerbation and medication-based measures of 
asthma were moderately in agreement (kappa range: 0.45 ~ 0.62). Similar to ages 0-
5, agreement between diagnosis-based measures of asthma and medication-based 
measures was higher than for the diagnosis-based measure of asthma exacerbation 
and the medication-based measures. In contrast to ages 0-5, long-term controller 
medication did not show the strongest agreement with all diagnosis-based 
measures; long-term controller medication had the highest agreement with 
recurrent asthma with two or more diagnoses, but short-acting beta agonists 
(SABAs)/Long-term controller had the highest agreement with ever asthma 
diagnosis, and any oral steroid use had the highest agreement with recurrent asthma 
with four or more diagnoses and asthma exacerbation. 
Table 4-3 presents the estimated kappa coefficients between asthma diagnosis-
based measures and wheezing diagnosis-based measures of childhood asthma for 
ages 0-5 years. The highest kappa coefficient (kappa = 0.48) occurred in the 
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comparison of ever asthma (≥1 diagnosis) and ever wheezing (≥1 diagnosis), and the 
lowest kappa coefficient (kappa = 0.23) occurred in the comparison of ever asthma 
(≥1 diagnosis) and recurrent wheezing (≥4 diagnoses). Among wheezing diagnosis-
based measures, ever wheezing (≥1) and recurrent wheezing (≥2) had fair to 
moderate agreement with all three asthma diagnosis-based measures (kappa ranges: 
0.39 ~ 0.48), while recurrent wheezing (≥4) had fair agreement with asthma 
diagnosis-based measures (kappa ranges: 0.23 ~ 0.29). 
Table 4-4 presents the estimated kappa coefficients between diagnosis-based 
measures for wheezing and for asthma using different numbers of episodes, by age 
of assessment. The top half of Table 4-4 presents the kappa coefficients for measures 
assessed at ages 0-5 years, and the bottom half of the Table 4-4 presents the results 
for measures assessed at ages 6-9 years. Results for measures assessed at ages 0-5 
years showed that asthma diagnosis-based measures with 1, 2 and 4 diagnoses had 
substantial to almost perfect agreement (kappa ranges: 0.65 ~ 0.85) (top left part of 
Table 4-4); and wheezing diagnosis-based measures with 1, 2 and 4 diagnoses had 
fair to substantial agreement (kappa ranges: 0.29 ~ 0.59) (top right part of Table 4-4). 
Table 4-5 presents the estimated agreement between all asthma measures 
assessed at ages 0-5 years and two diagnosis-based measures of asthma at ages 6-9 
years. The  
estimated agreement with diagnosis of asthma at ages 6-9 years was moderate to 
substantial for diagnoses of asthma at ages 0-5 years (kappa: 0.58 ~ 0.65), moderate 
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for asthma medications at ages 0-5 years (kappa: 0.54 ~ 0.58), and slight to fair for 
wheezing diagnoses at ages 0-5 years (kappa: 0.12 ~ 0.34). Among the diagnosis-
based measures, recurrent asthma with two or more diagnoses at ages 0-5 years 
yielded the highest agreement with asthma diagnoses at ages 6-9 years (Kappa: 0.60 
~ 0.65). 
4.4.2 Prevalence of Asthma by Preterm Birth Status 
Figure 4-1 shows the percentage of preterm and non-preterm children with 
positive values on each of the measures of asthma. Panel a shows the measures 
created using data collected when the children were ages 0 to 5 (measuring early 
wheezing disorders), and all members of the analytic sample are included. Panel b 
shows the measures calculated from data collected when the children were ages 6 to 
9 (measuring school age asthma) and so includes only the subset of children followed 
to at least age 6. Compared with children born full term (black bar), children born 
preterm (grey bar) had a significantly higher prevalence (p < 0.001) of asthma on all 
measures at both ages of assessment. 
4.4.3 Association between Preterm Birth and Asthma by Asthma Measure, Degree 
of Prematurity, and Age at Asthma Assessment 
Adjusted odds ratios (AORs) for the eleven measures of asthma between ages 0 
to 5 and eight measures between ages 6 to 9 are shown in the first column of Table 
4-7. The relationships observed in Figure 4-1 between preterm birth and the 
measures of asthma remained significant after adjusting for a number of major 
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confounding variables. For all measures of asthma at both ages, the AORs of asthma 
were higher for preterm compared to term births (AORs range: 1.8 [95%CI, 1.5-2.3] 
to 2.90 [95%CI, 2.1-4.1]). The magnitudes of the AORs varied among the measures 
but these differences were not statistically significant. 
The remaining columns of Table 4-7 present AORs for the measures of asthma 
by degree of prematurity. A dose-response relationship was apparent between 
degree of prematurity and the measures of asthma: babies born early preterm had 
the highest risk of asthma relative to full term babies (AORs range: 3.2 [95%CI, 2.2-
4.5] to 6.2 [95%CI, 3.3-11.6] and babies born late preterm the second highest (AORs 
range: 1.5 [95%CI, 1.1-2.2] to 2.5 [95%CI, 1.6-3.8]). These associations were 
consistent across all the measures of asthma at both ages of assessment. Babies born 
early term showed slightly higher odds but the differences were not statistically 
significant, except for that of asthma exacerbation between ages 6 and 9 (AOR=1.8 
[95%CI, 1.1-3.2]). 
Given the varied length of follow-up due to the rolling enrollment design of the 
BBC the EMR data obtained only between October 2003 and September 2003 (see 
Section 3.2 for an clarification), an analysis was performed for the subset of children 
with continuous EMR data from birth (n = 1,973). Those analyses demonstrated 
similar or even higher preterm-asthma associations after adjusting for length of 
follow-up (Table 4-6). 
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4.5 Discussion 
4.5.1 Consistency and Differences of Asthma Measures 
The consistency analyses in this manuscript found that diagnosis-based 
measures and medication-based measures for asthma had moderate to substantial 
agreement among the high risk population at the BMC, a comprehensive health care 
system. The pattern that measures based on long term controller and oral steroid use 
had higher agreement with measures based on recurrent diagnoses of asthma (i.e., 
two or more diagnoses) than with measures based on a single diagnosis suggested 
that recurrent asthma is more appropriate for measuring persistent and severe 
asthma. The pattern that measures based on prescription of SABAs type of 
bronchodilators (i.e. any asthma medication and SABAs/Long-term controller) had 
higher agreement with measures based on a single diagnosis than with measures 
based on recurrent diagnoses of asthma suggested that measures based on a single 
diagnosis might capture more children with transient/mild symptoms or 
misclassifications. Furthermore, recurrent asthma with four or more diagnoses 
seemed to capture only the most persistent and severe cases. In sum, all the 
diagnosis-based measures of asthma showed acceptable reliability for measuring 
asthma, but varied in validity, because they captured asthma of different persistence 
and severity. 
For ages 0-5 years, the agreements between asthma and wheezing diagnosis-
based measures were just fair to moderate. As expected, compared with diagnosis-
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based measures for asthma, diagnosis-based measures for wheezing yielded similarly 
patterned but generally lower agreement with medication-based measures for 
asthma at ages 0-5 years. These results suggested that: 1) asthma and wheezing 
diagnoses overlap to some extent but not completely the identical under age 6; 2) 
wheezing diagnoses have some value for measuring asthma under age 6; but 3) 
wheezing diagnoses performed less accurately than asthma diagnoses when 
prescription of asthma medications were used as references. The measurement 
limitations of wheezing diagnoses are also confirmed when using asthma diagnoses 
at ages 6-9 years as references, which suggested that wheezing diagnoses, 
particularly recurrent wheezing with four or more diagnoses, might capture cases 
with different features than asthma diagnoses assessed under age 6 years.16,26 
Overall, these results have two implications. First, although labelling a child as 
asthmatic in early life is cautioned by some guidelines,15,16 in the BBC cohort a 
considerable number of children under age 6 are assigned the diagnoses of asthma 
with confirmed use of long-term control medication . This supports the validity of 
using physician diagnosis to detect asthmatic children in high risk population like the 
BBC. Second, diagnoses of asthma and wheezing are both indicators of asthma under 
age 6 years, but they tend to capture cases with different persistent and severity. 
Thus, asthma and wheezing diagnoses each have unique value for measuring the 
asthma in childhood asthma studies. 
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4.5.2 Robustness of Preterm Birth-Asthma Association 
The analyses in this manuscript found that the estimated prevalence of asthma 
and the AORs for the relationship between preterm birth and asthma ranged widely 
by asthma measures. However, the preterm birth effect was significant for all 
measures, and the effects were not significantly different from each other. This 
finding is consistent with meta-regression analyses2,3 showing that differing asthma 
measures do not explain the inconsistent findings about the preterm birth -asthma 
association. Since the measures of asthma in this manuscript reflect different 
severity and/or persistence of asthma, finding in this manuscript also suggest that 
children born preterm have a higher risk of all levels of asthma severity from 
mild/transient to severe/persistent. 
Results from this manuscript show a dose-response relationship between 
degree of preterm birth and asthma for all asthma measures. These findings lend 
support to the findings of large registration-based studies from Sweden,27,28 
Australia,29 and the United Kingdom.30 However, a meta-analysis based on merged 
European cohort studies found that the relationship between gestational age and 
school age asthma was less linear than that of early wheezing disorders.1 
Furthermore, another prospective cohort study found that early preterm and late 
preterm births faced similar levels of asthma risk in the first 5 years of life.13 The 
inconsistent results across studies may be due to variation in study designs 
(prospective cohort vs. retrospective cohort vs. cross-sectional), and the distinct 
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demographic and maternal and child health characteristics of the studied 
populations. 
The adverse birth effects of preterm on asthma were noted for both ages of 
assessment (0 to 5 years and 6 to 9 years). This finding is consistent with pooled 
estimates from European cohort studies1. However, the magnitudes of the preterm 
birth effects on asthma are higher in this analysis compared with the European 
pooled estimations for both early wheezing disorders (range of AORs = 1.9 ~ 2.9 vs. 
AOR =1.3) and school age asthma (range of AORs = 2.1 ~ 2.9 vs. AOR = 1.4). This may 
be explained by differences in severity of prematurity: The 5th to 95th percentile 
range of gestational age for the European studies was 37-41 weeks; while for the 
sample used in this manuscript the range was 30-41 weeks. Since the BBC, by design, 
has a higher fraction of preterm births than in the population, it likely includes more 
severe preterm births than other cohorts, and is thus better able to detect the effect 
of these early births. 
Based on the estimated AOR for preterm birth and asthma in this manuscript 
and the rate of preterm birth (about 16%) in the BMC obstetric patient population, 
the corresponding population attributable fraction at school age is 12% for a single 
diagnosis of asthma and 18% for recurrent asthma. Thus, preterm birth is one of the 
key risk factors for childhood asthma, particularly in the urban low-income 
population. 
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4.5.3 Strengths and Limitations 
The major strengths of analyses of this manuscript are the use of a large 
prospective birth cohort characterized by a high prevalence of preterm birth and high 
risk of asthma, the refined measures of preterm birth, and the multiple measures of 
asthma based on longitudinal EMR data spanning birth to school age. However, 
measurement assessment in this manuscript is limited by the lack of a gold standard 
to evaluate the asthma measures, and the absence of parent-reported measures of 
asthma and wheezing, which are widely used to study childhood asthma. A more 
detailed discussion is provided in Chapter 7. 
4.6 Conclusions 
 This chapter confirms the measurement quality and value of an array of 
diagnosis- and medication-based measures for asthma, and suggests a dose-
response association between degree of prematurity and asthma which is robust to 
the array of included asthma measures and persists from early childhood to school 
age. Preterm birth accounts for a substantial Population Attributable Fraction of 
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Figures and Tables 
 
Figure 4-1. Percetage of Childhood Asthma among Pretern Births vs. Term Births, 
Stratified by Age range 
Notes: (a) childhood asthma measures assessed between ages 0 to 5 years; (b) childhood asthma 
measures assessed between ages 6 to 9 years. Preterm group had higher percent of each asthma 
measure than term group (p < 0.001). 
Note for asthma measures: “Ever asthma (≥1)”= had at least 1 asthma diagnosis from electronic 
medical records during the specified ages; “Recurrent asthma (≥2) = had 2 or more asthma diagnoses 
during the specified ages; “Recurrent asthma (≥4)”= had 4 or more asthma diagnoses during follow-up 
time; “Ever wheezing (≥1)”= had at least 1 wheezing diagnosis during the specified ages; “Recurrent 
wheezing (≥2)”= had 2 or more wheezing diagnoses during the specified ages; “Recurrent wheezing 
(≥4)” = had 4 or more wheezing diagnoses during the specified ages; “Ever asthma exacerbation” = 
had an asthma exacerbation diagnosis during the specified ages; Please check Table 4-1 for more 
detailed description of asthma measures. 
Abbreviation: “SABAs”= short-acting β-agonists. 
Reprinted with the permission of the American Thoracic Society. Copyright ©  2015 American Thoracic 
Society. Cite: He, H., Butz, A., Keet, C. A., Minkovitz, C. S., et al. (2015). Preterm Birth with Childhood 
Asthma: The Role of Degree of Prematurity and Asthma Definitions. Am J Respir Crit Care Med, 192(4), 
520-523. The American Journal of Respiratory and Critical Care Medicine is an official journal of the 
American Thoracic Society. 
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Table 4-1. Working Definitions of Asthma Measures 
Measure 
Types 
Variable Labels Working Definitions 
Diagnosis 
Ever asthma (≥1) 
At least 1 positive asthma [ICD-9:493.xx] 
diagnosis from EMR record during 
specified followed ages 
Recurrent asthma (≥2) 
At least 2 positive asthma diagnoses from 
EMR record during specified followed ages 
Recurrent asthma (≥4) 
At least 4 positive asthma diagnoses from 
EMR record during specified followed ages 
Ever wheezing (≥1) 
At least 1 positive wheezing diagnosis 
[ICD-9: “786.07”] from EMR record during 
specified followed ages; 
Recurrent wheezing (≥2) 
At least 2 positive wheezing diagnoses 
during specified followed ages 
Recurrent wheezing (≥4) 
At least 4 positive wheezing diagnoses 
during specified followed ages 
Ever asthma 
exacerbation 
At least 1 asthma exacerbation diagnosis 
[ICD-9: “493.x1 -status asthmaticus” or 
“493.x2 - (acute) exacerbation)”] 
Medication 
Any asthma medication 
Any medications prescription record in 
EMR according to NHLBI guidelines of 
asthma medication [including albuterol] 
Long-term controller 
Any medications prescription record in 
EMR according to National Drug Code list 
of asthma medication from HEDIS 
measurements, i.e. inhaled corticosteroids 
and/or long-acting β-agonists for long-
term control of asthma [not albuterol] 
SABAs/long-term 
controller 
Modified from the COAST study, 
prescribed of short-acting beta agonists 
(SABAs) or long-term controller 
medications [including albuterol] 
Any oral steroid 
Ever prescribed of oral steroid listed for 
asthma control in NHLBI guideline during 
follow-up .[not albuterol] 
Note: The coding rules are appplied to both ages 0-5 years and ages 6-9 years. Reprinted with the 
permission of the American Thoracic Society. Copyright ©  2015 American Thoracic Society. Cite: He, 
H., Butz, A., Keet, C. A., Minkovitz, C. S., et al. (2015). Preterm Birth with Childhood Asthma: The Role 
of Degree of Prematurity and Asthma Definitions. Am J Respir Crit Care Med, 192(4), 520-523. The 
American Journal of Respiratory and Critical Care Medicine is an official journal of the American 
Thoracic Society. 
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Table 4-2. Agreement of Diagnosis-Based and Prescrition-Based Measures of Asthma 
  












wheezing (≥4)  
Ever asthma 
exacerbation 
(≥1) Prescriptions at ages 0-5 
Kappa ± se Kappa ± se Kappa ± se Kappa ± se Kappa ± se Kappa ± se Kappa ± se 
Any asthma medication 0.63  ± 0.02  0.57  ± 0.02  0.44  ± 0.02   0.50  ± 0.02  0.34  ± 0.02  0.16  ± 0.01   0.48  ± 0.02  
Long-term controller 0.69  ± 0.02  0.76  ± 0.02  0.72  ± 0.02   0.39  ± 0.02  0.42  ± 0.02  0.28  ± 0.02   0.66  ± 0.02  
SABAs/Long-term controller 0.66  ± 0.02  0.61  ± 0.02  0.46  ± 0.02   0.52  ± 0.02  0.36  ± 0.02  0.17  ± 0.01   0.51  ± 0.02  
Any oral steroid use 0.65  ± 0.02  0.67  ± 0.02  0.63  ± 0.02    0.44  ± 0.02  0.43  ± 0.02  0.27  ± 0.01    0.63  ± 0.02  
Prescriptions at ages 6-9 
Diagnoses at ages 6-9 years (n = 1,072) * 
Kappa ± se Kappa ± se Kappa ± se                Kappa ± se 
Any asthma medication 0.75  ± 0.03  0.70  ± 0.03  0.50  ± 0.03          0.45  ± 0.03 
Long-term controller 0.70  ± 0.03  0.75  ± 0.03  0.63  ± 0.03          0.58  ± 0.03 
SABAs/Long-term controller 0.78  ± 0.03  0.74  ± 0.03  0.55  ± 0.03          0.47  ± 0.03 
Any oral steroid use 0.47  ± 0.03  0.58  ± 0.03  0.64  ± 0.03                 0.62  ± 0.03 
Notes: All the p-values for kappa coefficients < 0.05. * Wheezing measures were excluded due to low prevalence during ages 6-9 years.  
 “Kappa ± se” = Cohen’s Kappa coefficient with its standard error; “SABAs”= short-acting β-agonists 




Table 4-3. Agreement of Diagnosis-Based Measures of Asthma and Diagnosis-Based Measures of Wheezing (n = 2,540)     
 Wheezing diagnoses ages 0-5 years 
Asthma diagnoses ages 0-5 
years  
Ever wheezing (≥1) Recurrent wheezing (≥2) Recurrent wheezing (≥4) 
Kappa ± se Kappa ± se Kappa ± se 
Ever asthma (≥1) 0.48 ± 0.02 0.40 ± 0.02 0.23 ± 0.01 
Recurrent asthma (≥2) 0.46 ± 0.02 0.41 ± 0.02 0.26 ± 0.01 
Recurrent asthma (≥4) 0.39 ± 0.02 0.43 ± 0.02 0.29 ± 0.02 
Notes: “Kappa ± se” = Cohen’s Kappa coefficient with its standard error. All the p-values for kappa coefficients < 0.05.  
“≥1”: more than 1 diagnosis; “≥2”: more than 2 diagnoses; “≥4”: more than 4 diagnoses. 
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Table 4-4. Agreement of Diagnosis-Based Measures of Asthma for Single vs. Multiple Episodes (n = 2,540) 
 Asthma diagnoses at ages 0-5 years  Wheezing diagnoses at ages 0-5 years 











Kappa ± se Kappa ± se Kappa ± se Kappa ± se 
Ever asthma (≥1) 0.85 ± 0.02 0.65 ± 0.02 Ever wheezing (≥1) 0.59 ± 0.02 0.29 ± 0.01 
Recurrent asthma (≥2)   0.79 ± 0.02 Recurrent wheezing (≥2)   0.57 ± 0.02 
Recurrent asthma (≥4)         Recurrent wheezing (≥4)         
Asthma diagnoses at ages 6-
9 years 
Asthma diagnoses at ages 6-9 (n = 1,072) 
 




(≥4)     
Kappa ± se Kappa ± se   
Ever asthma (≥1) 0.82 ± 0.03 0.57 ± 0.03      
Recurrent asthma (≥2)   0.73 ± 0.03      
Recurrent asthma (≥4)              
Notes: “Kappa ± se” = Cohen’s Kappa coefficient with its standard error. All the p-values for kappa < 0.05. Wheezing measures were excluded due to low prevalence during 
ages 6-9 years. “≥1”: more than 1 diagnosis; “≥2”: more than 2 diagnoses; “≥4” means more than 4 diagnoses.
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Table 4-5. Agreement of Asthma Measures Assessed at Aged 0-5 Years with 
Diagnosis-Based Asthma Measures Assessed at Ages 6-9 Years (n = 1,072) 
 
 
Diagnoses and prescriptions at ages 0-5 
Asthma diagnoses at ages 6-9 years 
Ever asthma  
(≥1)   
Recurrent asthma 
(≥2) 
Kappa ± se Kappa ± se 
Diagnosis 
Ever asthma (≥1) 0.64  ± 0.03   0.56  ± 0.03  
Recurrent asthma (≥2) 0.65  ± 0.03   0.60  ± 0.03  
Recurrent asthma (≥4) 0.58  ± 0.03   0.59  ± 0.03  
Ever wheezing (≥1) 0.34  ± 0.03   0.29  ± 0.03  
Recurrent wheezing (≥2) 0.24  ± 0.03   0.22  ± 0.03  
Recurrent wheezing (≥4) 0.12  ± 0.02   0.13  ± 0.02  
Ever asthma exacerbation  0.54  ± 0.03    0.54  ± 0.03  
Prescription  
Any asthma medication 0.54  ± 0.03   0.45  ± 0.03  
Long-term controller 0.58  ± 0.03   0.57  ± 0.03  
SABAs/Long-term controller 0.57  ± 0.03   0.48  ± 0.03  
Any oral steroid use 0.55  ± 0.03    0.54  ± 0.03  
Notes: “Kappa ± se” = Cohen’s Kappa coefficient with its standard error; “SABAs”= short-acting β-
agonists; “≥1” means more than 1 diagnosis; “≥2” means more than 2 diagnoses.
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Table 4-6. Characteristics of the Analytic Sample for Aim 1 
  Whole sample (n = 2,540)  
Whole sample  
(n = 2,540) 
Subsample:  
ages 6-9 years 
(n = 1,072) 
P-value:  




(n = 1,821) 
Preterm  
(n = 719) 
P-value:  
term vs.  
preterm 
 
    n % n %  n % n % 
Preterm birth - - - - -  719 28.3  320 29.9  0.140 
Degree of prematurity            
Early preterm (20-31 weeks) 207 28.8   -  207 8.1 80 7.5 0.068 
Late preterm (32-36 weeks) 512 71.2   -  512 20.2 240 22.4  
Early term (37-38 weeks)   653 35.9 -  653 25.7 279 26.0  
Full term (39-41 weeks)   1,168 64.1 -  1,168 46.0 473 44.1  
Child sex, male 898 49.3  374 52.0  0.220  1,272 50.1  542 50.6  0.679 
Maternal race/ethnicity            
 African American 1,067  58.6  439 61.1  0.192  1,506  59.3  710 66.2  <0.001  
 White 129  7.1  54 7.5    183  7.2  45 4.2   
 Hispanic  386  21.2  154 21.4    540  21.3  217 20.2   
 Others 239  13.1  72 10.0    311  12.2  100 9.3   
Mother unmarried 1,182  64.9  502 69.8  0.018  1,684  66.3  721 67.3  0.383 
Maternal education            
 Secondary school or below 502  27.6  208 28.9  0.184  710  28.0  326 30.4  <0.001  
 High school/GED 654  35.9  269 37.4    923  36.3  424 39.6   
 Some college and above 657  36.1  235 32.7    892  35.1  310 28.9   
Maternal history of asthma 234  12.9  124 17.2  0.004  358  14.1  167 15.6  0.066 
Maternal continuous smoking during pregnancy 183  10.0  103 14.3  0.002  286  11.3  114 10.6  0.394 
Family member smoking 547 30.0 256 35.6 0.007  803 31.6 365 34.1 0.024 
Maternal age, years (median, range) 28 (14-51) 29 (15-45) 0.072  28 (14-51) 29 (15-47) 0.741 
Child age, years (median, range) 5 (0-9) 5 (0-9) 0.699   5 (0-9) 8(6-9) <0.001  
183 
Note: Reprinted with the permission of the American Thoracic Society. Copyright ©  2015 American Thoracic Society. Cite: He, H., Butz, A., Keet, C. A., Minkovitz, C. S., et al. 
(2015). Preterm Birth with Childhood Asthma: The Role of Degree of Prematurity and Asthma Definitions. Am J Respir Crit Care Med, 192(4), 520-523. The American Journal 
of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society. 













Table 4-7. Adjusted Odds Ratios of Asthma Defined by Different Measure across Preterm Birth Categories among the Whole Analytic Sample 
    
Preterm birth (<37 wk) 
reference = term (37-41) 
  Degree of preterm birth, reference = full term (39-41 wk) 
 Early preterm, 20-31  Late preterm, 32-36  Early term, 37-38 
AOR (95%CI) P-value  AOR (95%CI) P-value   AOR (95%CI) P-value   AOR (95%CI) P-value 
Outcome = measures of asthma at ages 0-5 years (n = 2,540)            
Diagnosis 
Ever asthma (≥1) 2.45 (1.98-3.04) <0.001  5.90 (4.19-8.31) <0.001  1.70  (1.30 -2.23)  <0.001  1.05  (0.80 -1.38)  0.718  
Recurrent asthma (≥2) 2.28 (1.81-2.88) <0.001  4.13 (2.88-5.93) <0.001  1.70  (1.27 -2.28)  <0.001  0.95  (0.70 -1.29)  0.763  
Recurrent asthma (≥4) 2.00 (1.52-2.61) <0.001  4.09 (2.72-6.13) <0.001  1.54  (1.09 -2.19)  0.015  1.17  (0.83 -1.66)  0.364  
Ever wheezing (≥1) 1.85 (1.48-2.31) <0.001  3.15 (2.21-4.49) <0.001  1.67  (1.26 -2.20)  <0.001  1.27  (0.97 -1.66)  0.084  
Recurrent wheezing (≥2) 2.29 (1.71-3.09) <0.001  4.16 (2.66-6.51) <0.001  1.92  (1.31 -2.82)  <0.001  1.21  (0.82 -1.79)  0.339  
Recurrent wheezing (≥4) 2.85 (1.83-4.43) <0.001  6.17 (3.30-11.55) <0.001  2.12  (1.17 -3.82)  0.013  1.20  (0.64 -2.26)  0.567  
Ever asthma exacerbation  2.48 (1.94-3.17) <0.001   4.49 (3.08-6.55) <0.001   2.05  (1.50 -2.79)  <0.001   1.14  (0.82 -1.57)  0.435  
Medication 
Any asthma medication 2.22 (1.83-2.68) <0.001  5.74 (4.14-7.96) <0.001  1.68  (1.33 -2.12)  <0.001  1.22  (0.97 -1.52)  0.088  
Long-term controller 2.42 (1.89-3.09) <0.001  5.82 (4.03-8.39) <0.001  1.54  (1.12 -2.12)  0.008  1.00  (0.72 -1.39)  0.988  
SABAs/Long-term controller 2.26 (1.87-2.74) <0.001  5.60 (4.03-7.76) <0.001  1.73  (1.36 -2.19)  <0.001  1.21  (0.96 -1.52)  0.109  
Any oral steroid use 2.45 (1.95-3.08) <0.001  5.35 (3.76-7.60) <0.001   1.87  (1.39 -2.51)  <0.001   1.18  (0.87 -1.59)  0.292  
Outcome= measures of asthma at ages 6-9 years (n = 1,072)*            
Diagnosis 
Ever asthma (≥1) 2.28 (1.66-3.12) <0.001  4.92 (2.91-8.31) <0.001  2.04  (1.38 -3.01)  <0.001  1.46  (0.98 -2.16)  0.062  
Recurrent asthma (≥2) 2.94 (2.08-4.15) <0.001  5.68 (3.27-9.86) <0.001  2.46  (1.60 -3.80)  <0.001  1.22  (0.76 -1.95)  0.409  
Recurrent asthma (≥4) 2.40 (1.57-3.67) <0.001  3.92 (2.05-7.47) <0.001  1.97  (1.16 -3.36)  0.013  1.10  (0.61 -1.98)  0.744  
Ever asthma exacerbation  2.05 (1.35-3.12) <0.001   3.91 (2.04-7.50) <0.001   2.09  (1.21 -3.60)  0.008   1.83  (1.07 -3.15)  0.029  
Medication 
Any asthma medication 2.05 (1.51-2.77) <0.001  3.82 (2.28-6.41) <0.001  1.87  (1.29 -2.71)  <0.001  1.31  (0.90 -1.90)  0.163  
Long-term controller 2.64 (1.84-3.77) <0.001  3.57 (2.03-6.28) <0.001  2.26  (1.47 -3.49)  <0.001  0.99  (0.61 -1.61)  0.972  
SABAs/Long-term controller 2.17 (1.59-2.96) <0.001  4.00 (2.37-6.73) <0.001  2.02  (1.38 -2.96)  <0.001  1.35  (0.91 -1.99)  0.133  
Any oral steroid use 2.16 (1.39-3.36) <0.001   3.21 (1.68-6.15) <0.001   1.60  (0.93 -2.75)  0.092   0.90  (0.50 -1.65)  0.743  
Notes: Adjusted for maternal age, maternal race/ethnicity, maternal education, mother unmarried, maternal history of asthma, maternal continuous smoking during 
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pregnancy; child sex, child age, family member smoking, and followed years. * Wheezing measures were excluded due to low prevalence during ages 6-9 years.  
Abbreviations: “wk” = weeks; “SABAs”= short-acting β-agonists; “≥1” means more than 1 diagnosis; “≥2” means more than 2 diagnoses; “≥4” means more than 4 diagnoses. 
Reprinted with the permission of the American Thoracic Society. Copyright ©  2015 American Thoracic Society. Cite: He, H., Butz, A., Keet, C. A., Minkovitz, C. S., et al. 
(2015). Preterm Birth with Childhood Asthma: The Role of Degree of Prematurity and Asthma Definitions. Am J Respir Crit Care Med, 192(4), 520-523. The American Journal 
of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society. 
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Table 4-8. Adjusted Odds Ratios of Asthma Defined by Different Measure across Preterm Birth Categories among a Subset of the Analytic Sample 
    
Preterm birth (<37 wk) 
reference = term (37-41) 
  
  
Degree of prematurity, reference = Full term (39-41 wk) 
Early preterm, 20-31  
  
Late preterm, 32-36 
  
Early term, 37-38 
AOR (95%CI) P-value AOR (95%CI) P-value AOR (95%CI) P-value AOR (95%CI) P-value 
Outcome = measures of asthma at ages 0-5 years (n = 1,973)            
Diagnosis 
Ever asthma (≥1) 2.52  (1.96 -3.25)  <0.001   5.27  (3.52 -7.90)  <0.001  1.84  (1.34 -2.53)  <0.001  1.02  (0.74 -1.40)  0.914  
Recurrent asthma (≥2) 2.34  (1.77 -3.10)  <0.001   3.56  (2.30 -5.52)  <0.001  1.90  (1.35 -2.69)  <0.001  0.95  (0.66 -1.35)  0.760  
Recurrent asthma (≥4) 2.03  (1.47 -2.80)  <0.001   3.64  (2.22 -5.97)  <0.001  1.76  (1.17 -2.65)  0.007  1.22  (0.81 -1.83)  0.332  
Ever wheezing (≥1) 1.98  (1.55 -2.52)  <0.001   3.09  (2.09 -4.59)  <0.001  1.89  (1.40 -2.55)  <0.001  1.29  (0.97 -1.72)  0.084  
Recurrent wheezing (≥2) 2.33  (1.70 -3.18)  <0.001   4.03  (2.50 -6.50)  <0.001  2.05  (1.37 -3.06)  <0.001  1.25  (0.83 -1.88)  0.288  
Recurrent wheezing (≥4) 2.80  (1.76 -4.45)  <0.001   5.57  (2.87 -10.79)  <0.001  2.08  (1.13 -3.83)  0.019  1.11  (0.57 -2.15)  0.753  
Ever asthma exacerbation  2.53  (1.89 -3.38)  <0.001   3.78  (2.39 -5.96)  <0.001  2.20  (1.53 -3.15)  <0.001  1.05  (0.72 -1.54)  0.802  
Medication 
Any asthma medication 2.33  (1.87 -2.90)  <0.001   5.33  (3.67 -7.75)  <0.001  1.86  (1.42 -2.43)  <0.001  1.21  (0.94 -1.57)  0.134  
Long-term controller 2.56  (1.92 -3.40)  <0.001   5.34  (3.46 -8.23)  <0.001  1.84  (1.27 -2.65)  0.001  1.05  (0.72 -1.52)  0.811  
SABAs/Long-term controller 2.38  (1.91 -2.97)  <0.001   5.18  (3.56 -7.53)  <0.001  1.91  (1.45 -2.51)  <0.001  1.19  (0.92 -1.55)  0.183  
Any oral steroid use 2.50  (1.92 -3.25)  <0.001   4.73  (3.15 -7.11)  <0.001   1.97  (1.41 -2.75)  <0.001   1.10  (0.78 -1.54)  0.596  
Outcome= measures of asthma at ages 6-9 years (n = 550) *            
Diagnosis 
Ever asthma (≥1) 2.65  (1.67 -4.20)  <0.001   3.67  (1.64 -8.21)  0.002  2.56  (1.45 -4.52)  0.001  1.14  (0.63 -2.08)  0.663  
Recurrent asthma (≥2) 4.11  (2.38 -7.08)  <0.001   5.38  (2.26 -12.85)  <0.001  3.25  (1.66 -6.34)  0.001  0.77  (0.34 -1.72)  0.523  
Recurrent asthma (≥4) 3.03  (1.40 -6.53)  0.005   3.22  (1.02 -10.18)  0.047  2.13  (0.83 -5.42)  0.114  0.53  (0.15 -1.81)  0.311  
Ever asthma exacerbation  1.53  (0.74 -3.16)  0.251   3.09  (0.93 -10.26)  0.065  1.94  (0.73 -5.17)  0.186  2.15  (0.87 -5.30)  0.098  
Medication 
Any asthma medication 2.61  (1.65 -4.13)  <0.001   3.15  (1.39 -7.15)  0.006  2.73  (1.56 -4.78)  <0.001  1.18  (0.66 -2.14)  0.573  
Long-term controller 3.43  (1.96 -5.99)  <0.001   3.43  (1.33 -8.82)  0.011  3.08  (1.57 -6.02)  0.001  0.80  (0.35 -1.82)  0.591  
SABAs/Long-term controller 2.59  (1.63 -4.13)  <0.001   2.54  (1.10 -5.89)  0.029  2.83  (1.61 -4.99)  <0.001  1.13  (0.62 -2.08)  0.685  
Any oral steroid use 2.12  (0.93 -4.82)  0.072    2.16  (0.61 -7.66)  0.232   1.60  (0.59 -4.34)  0.357   0.62  (0.19 -1.95)  0.409  
Note: Selected children were those born since October 2003, i.e. had EMR data since birth. All estimations adjusted for maternal age, maternal race/ethnicity, maternal 
education, mother unmarried, maternal history of asthma, maternal continuous smoking during pregnancy; child sex, child age, family member smoking, and followed 
years.* Wheezing measures were excluded due to low prevalence during ages 6-9 years.  
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Abbreviations: “wk” = weeks; “SABAs”= short-acting β-agonists; “≥1” means more than 1 diagnosis; “≥2” means more than 2 diagnoses; “≥4” means more than 4 diagnoses.  
Reprinted with the permission of the American Thoracic Society. Copyright ©  2015 American Thoracic Society. Cite: He, H., Butz, A., Keet, C. A., Minkovitz, C. S., et al. 
(2015). Preterm Birth with Childhood Asthma: The Role of Degree of Prematurity and Asthma Definitions. Am J Respir Crit Care Med, 192(4), 520-523. The American Journal 














Background: Preterm birth is associated with an increased risk of childhood asthma, 
as well as pre- and peri-natal factors that increase the risk of childhood asthma. The 
relationships among pre- and peri-natal factors, preterm birth, and childhood asthma 
are poorly understood. 
Objectives: To quantify the importance of preterm birth relative to pre- and peri-
natal risk factors for the development of childhood asthma, and to investigate 
preterm birth as a mediator and/or moderator of the relationships between pre- and 
peri-natal factors and childhood asthma. 
Design and Participants: Prospectively follow-up assessment of a patient-based birth 
cohort from Boston Medical Center through an electronic medical record (EMR) 
system. 2,540 children were followed up to different ages from less than 1 to 9 years, 
among which only 2,461 were included for analysis. 
Measures and Analyses: Asthma was defined as having had two or more physician 
diagnoses of asthma recorded in EMR from less than 1 to 9 years. Preterm birth was 
defined as birth at less than 37 weeks of gestation. Pre- and peri-natal risk factors 
were drawn from maternal questionnaire interviews and medical records at birth. 
The relative importance of preterm birth was determined by comparing Adjusted 
Odds Ratios (AORs) from multivariate logistic regression, and the corresponding 
Population Attributable Fraction (PAF) in the analytic sample. The mediating effects 
were tested using both the classic Baron and Kenney’s approach and a causal 
mediation analysis approach. The moderating effects were tested for all pre- and 
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peri-natal factors together by stratified analyses and for individual factors by additive 
interaction analyses. 
Results: Preterm birth was ranked among the top three independent risk factors for 
asthma among those examined according to both AOR and PAF. Preterm birth and 
gestational age were mediators (p < 0.05) of the association between several 
prenatal variables and asthma, explaining almost all of the preeclampsia effect, a 
quarter to half of the chorioamnionitis effect. And to a lesser degree, gestational age 
mediated the maternal race/ethnicity and maternal history of asthma effects on 
asthma. Preterm birth significantly moderated the effects of several pre- and peri-
natal risk factors on asthma. Specifically, preterm birth worsened the adverse effects 
of maternal continuous smoking during pregnancy, maternal history of atopy, and 
cesarean section delivery. Similar patterns were observed when the analyses are 
stratified by child age range (under 6 years vs. 6-9 years). 
Conclusions: The results highlight the triple role of preterm birth in the development 
of childhood asthma: preterm birth is a major, independent risk factor of asthma, 
mediates the effects of several prenatal factors on the risk of asthma, and acts 
synergistically with several early life factors to increase the risk of asthma. 
 
Key words: preterm birth, childhood asthma, life-course, early origins, mediating 
effect, moderating effect 
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5.2 Introduction 
Preterm birth is an important risk factor for childhood asthma,1-3 and studies 
have shown a dose-response relationship between prematurity (both measured in 
categorical and continuous scales) and childhood asthma2. Childhood asthma is also 
associated with an array of pre- and peri-natal factors, such as maternal history of 
asthma,4 maternal smoking,5 pregnancy complications,6 and birth by cesarean 
section (C-section).7 Several of these pre- and peri-natal risk factors for asthma also 
increase the likelihood of preterm birth or are more likely in a preterm birth. For 
example, maternal smoking during pregnancy8 and chorioamnionitis9 increase the 
risk of both preterm birth and childhood asthma, and preterm deliveries are more 
likely to be by cesarean section (C-section),10 which also increases the risk of 
childhood asthma. The reviews of the early origins of asthma and the possible 
biological causes of asthma in Chapter 2 also suggest that the relationships between 
pre-and perineal factors and asthma may be explained (mediated) or differentiated 
(moderated) by the preterm birth. 
However, few studies have assessed the relationship between preterm birth and 
childhood asthma in the context of other pre- and peri-natal risk factors for asthma. 
The few studies related to the role of preterm birth in the pathways from pre- and 
peri-natal factors to asthma focus on either the joint effects of preterm birth and a 
prenatal factor or postnatal modifiable risk factors for children born preterm. Some 
studies have reported joint effects of preterm birth with maternal pregnancy 
smoking8 and chorioamnionitis9 on childhood asthma. These studies are limited in 
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terms of the measurement of childhood asthma (recurrent wheezing rather than 
physician diagnosed asthma) and age of cohort (average age less than 5 years). 
Moreover, the mediating or moderating effects of preterm birth on the association 
between some of the key pre- and peri-natal exposures and asthma in offspring have 
not been assessed yet, such as that for maternal history of asthma,4 pregnancy 
complications,6 and C-section.7 
Given the limited number and quality of previous studies, the extent to which 
preterm birth is an independent risk factor for childhood asthma and the extent to 
which it mediates or moderates the effects of other risk factors for childhood asthma 
are largely unknown. Clarifying the inter-relationships among pre- and peri-natal 
factors, preterm birth, and childhood asthma is vital for understanding the early-life 
origins of asthma. Knowledge of these causal pathways will help inform how clinical 
and public health services can be organized and delivered to reduce the burden of 
asthma. 
This manuscript will systematically examine the role of preterm birth and other 
pre- and peri-natal risk factors in the development of childhood asthma, focusing on 
three objectives: 2a) compare the relative importance of preterm birth and other 
pre- and peri-natal risk variables in the development of childhood asthma; 2b) 
investigate the degree to which the effects of prenatal risk factors on the risk of 
childhood asthma are explained (mediated) by preterm birth; 2c) investigate whether 
the effects of pre- and peri-natal risk factors on the risk of childhood asthma differ 
(are moderated) by preterm birth status. 
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5.3 Methods 
5.3.1 Data and Sample 
The data are from the Boston Birth Cohort (BBC), which was introduced in 
Chapter 3. Among the 2,701 BBC children in the postnatal follow-up, a total of 161 
children were excluded from the analyses due to data in process or missing for major 
variables. For this analysis, an additional 13 children were excluded due to missing 
values for maternal history of allergies (3 cases) and C-section delivery (10 cases). 
Another 66 children who had no diagnoses of asthma during the period of 
observation, but who did have two or more diagnoses of wheezing, were also 
excluded to ensure that no asthma cases were included in the reference (no 
childhood asthma) group. Thus, the analytic sample for this manuscript includes 
2,461 children ranging in age from less than a year to 9 years (median age 5 years). 
Sensitivity analyses were limited to children in two age ranges: less than a year to 5 
years (n = 2,460) and 6 to 9 years (n = 1,057). Of note, the older sample is just a 
subsample of the younger sample at another follow-up duration, excluding those 
who were not followed up to age 6 years. 
5.3.2 Measures 
The primary outcome was whether a child was ever diagnosed with asthma, 
defined as having two or more physician diagnoses of asthma (International 
Classification of Diseases, Ninth Revision[ICD-9]: 493) recorded in his or her 
electronic medical record (EMR) from less than one to age 9 years. This measure is 
thus based on a relatively stringent criterion for defining asthma. The prevalence of 
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asthma in the analytic sample (n = 2,461) using this measure was 18.4%. Sensitivity 
analyses were performed with two alternative measures: having two or more 
physician diagnoses of asthma between ages 0 and 5 years and having two or more 
physician diagnoses of asthma between ages 6 and 9 years. Analyses using the latter 
measure were restricted to children who had attained at least age 6 during the 
course of the study. By these two measures, prevalence of asthma was 16.4% (of 
2,460) between ages 0 and 5 years and 16.9% (of 1,057) between ages 6 and 9 years. 
Preterm birth was measured as birth at less than 37 weeks of gestation, while 
term birth was measured as birth at 37 to 41 weeks of gestation. This dichotomous 
measure was used as the major measure for prematurity because of its clinical 
relevance as a diagnosis, comparability of its importance with other binary risk 
factors and high interpretability, easiness for interpreting the moderating effects. 
However, bivariate analysis using the LOWESS (Locally Weighted Scatterplot 
Smoothing11,12) method showed that the relationship between gestational age and 
asthma assessed between ages 0 and 9 years was close to linear across the 
gestational ages in the analytic sample (see Appendix Figures 5-5, 5-6, 5-7). Since 
gestational age captures more variation in prematurity than a dichotomous measure, 
it was used in supplementary analyses to test for mediation. 
Pre- and peri-natal factors were selected based on the “fetal origins” 
perspective reviewed in Chapter 2, biological plausibility, and positive association 
with asthma in the analytic sample (p-value less than 0.2 in stepwise or simple 
logistic regressions). These pre- and peri-natal factors fell into seven groups. 
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1. Genetic predispositions: maternal history of asthma (yes vs no), and maternal 
history of allergic diseases (yes vs no, where allergies include eczema, 
allergetic rhinitis, food allergies and other allergies), based on maternal 
questionnaires of the first follow-up survey and the baseline survey at delivery. 
2. Maternal social demographics: race/ethnicity, education, mother unmarried 
(vs. married), low household income (annual household income lower than 
$20,000 or receipt of Aid to Families with Dependent Children), and mother 
born in the U.S. (vs. foreign born), based on maternal questionnaires of the 
baseline survey at delivery. 
3. Maternal smoking during pregnancy: maternal continuous smoking during 
pregnancy (smoked during the 6 months prior to pregnancy or the first 
trimester and during the second or third trimesters) and maternal quit 
smoking during pregnancy (smoked only during 6 months prior to pregnancy 
or the first trimester, but did not smoke during the second or third trimesters), 
based on maternal questionnaires of the baseline survey at delivery. 
4. Pre-pregnancy body mass index [BMI]: classified into four groups: 
underweight, BMI < 18.5; normal weight, 18.5 ≤ BMI < 25.0; overweight, 25.0 
≤ BMI < 30.0; obese, BMI ≤ 30.0,13,14 based on maternal questionnaires of the 
baseline survey at delivery. 
5. Maternal perceived stress during pregnancy: defined by mother’s response to 
the interview item: “The amount of stress in mother's life during the 
pregnancy with index (child)”, with response categories “Very stressful”, 
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“Average”, and “Not stressful”. The responses were recoded into high stress 
(“Very stressful”) and low stress (“Not stressful” or “Average”), based on 
maternal questionnaires of the baseline survey at delivery. 
6. Pregnancy complications: preeclampsia, assessed from standardized medical 
record abstraction by a trained data collector, and chorioamnionitis9 (also in-
utero infection) defined by Intrapartum fever (>38°C)15 from medical record 
abstraction or presence of placental histological changes associated with 
chorioamnionitis from pathologist’s report, according to criteria 
recommended by the American College of Pathologists.16 
7. Type of delivery was obtained from medical record abstraction, and coded as 
a binary variable to indicate a cesarean section delivery (C-section), yes vs. no. 
Other covariates included child’s sex and age, born in summer/autumn, first 
born offspring (parity), family member smoking, maternal age, and duration of 
follow-up. These factors were included as covariates but not main factors in pathway 
analyses (mediation and moderation analyses), because they potential influence 
estimates of the association between preterm birth and asthma, but not theorized as 
main elements in fetal origins of asthma (e.g. first born in offsprings is an element in 
the infant origins of asthma) or less ideally measured in this dataset (e.g. family 
member smoking). 
5.3.3 Missing Data Analyses and Handling 
Out of the 2,461 analytic sample, the missing rate for the pre- and peri-natal 
factors ranged from 0.4% to 10.0%. The missing data in most variables was due to 
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non-responses from mothers. The high missing rate (10.0%) of chorioamnionitis was 
due to a number of medical record abstraction sheets were pending for data entry. 
Multivariate logistic regression analysis of missing statuses of these variables on 
other non-missing variables showed that the missing patterns for most of these 
variables were informative by some of the known data, except for preeclampsia. 
Multiple Imputation by Chained Equations (MICE) 36,37 based on non-missing 
variables were performed. The non-missing variables included in MICE were child’s 
sex, age, born in summer/autumn, first born, family member smoking, maternal age, 
duration of follow-up, maternal race/ethnicity, mother unmarried, maternal 
continuous smoking, mother quitting smoking during pregnancy, maternal histories 
of asthma and allergy, maternal reported vaginal/genital/urinary tract infections, and 
birth year. I created five sets of imputations using the MICE and only one of them 
was used for the main analysis. Sensitivity analyses to evaluate the potential biases 
introduced by missing data were performed using another four imputed data sets, all 
available cases, and complete cases. 
5.3.4 Data Analysis 
Data analyses for objective 2a included four steps to compare the relative 
importance of preterm birth and pre- and peri-natal risk factors in the development 
of asthma. First, bivariate associations of preterm birth and pre- and peri-natal 
factors with asthma were examined using Chi-square tests. Second, multivariate 
logistic regression of asthma on preterm birth, pre- and peri-natal factors, and other 
covariates (Model A1) was performed, to examine the adjusted effects of preterm 
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birth and pre- and peri-natal factors on asthma. Third, the Population Attributable 
Fraction (PAF)17 of each explanatory variable for asthma was calculated, to measure 
proportion reduction in asthma prevalence if the explanatory variable was removed 
(the formulas were reviewed in section 3.4.3). Fourth, the relative importance of 
preterm birth and other pre- and peri-natal factors for asthma were ranked from high 
to low by values of AOR (effect size) and PAF (contribution to population burden). 
The analyses for objective 2b consisted of a series of steps to examine the 
degree to which the effects of prenatal risk factors on the risk of childhood asthma 
were explained (mediated) by preterm birth (see Chapter 3 for a detailed discussion 
of this methodology). First, I fit a multivariate regression model for the association 
between childhood asthma and the prenatal variables, to establish the associations 
between prenatal factors and asthma without controlling for preterm birth (Model B; 
prenatal variable coefficients noted by c). Next, I fit a multivariate logistic regression 
of preterm birth on the prenatal factors, to establish the association between the 
prenatal factors and preterm birth (Model C1; prenatal variable coefficients noted by 
a). Third, I fit a multivariate logistic regression of asthma on both prenatal factors and 
preterm birth to estimate the effects of the prenatal factors on asthma adjusting for 
preterm birth (Model A1, coefficients noted by b and c’, respectively). 
The next steps were to use these results to test the mediating effect of preterm 
birth for each prenatal variable following either the classic approach or the new 
causal mediation analyses approach. Thus the fourth step was to follow the classic 
mediation approach and compare the effects of each prenatal factor on asthma 
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estimated without controlling for preterm birth (Model B) and controlling for 
preterm birth (Model A1), to determine if the inclusion of preterm birth attenuated 
the effects of the prenatal factors on asthma (c’ < c), the criterion for mediation. 
Next, the indirect effect (a*b), was calculated for each prenatal variable based on 
fully standardized log odds ratios from Models A1 and C1. To test for significance, the 
95% percentile confidence interval was generated by bootstrapping with 1500 
random samples from the original dataset.18 Finally, following the causal mediation 
analyses, indirect, direct, and total effects were estimated based on the odds ratios 
from Models A1 and C1, using a method proposed by VanderWeele and 
Vansteelandt.19 I performed the same steps with models using gestational age 
instead of preterm birth asthma (Model A2, B, and C2). 
Data analyses for objective 2c was performed in two steps. First, the overall 
moderating effect of preterm birth on the association between pre- and peri-natal 
factors and asthma was explored. In this step, Model A1 from the mediation analysis 
was estimated separately for preterm and term children (Models D1 & D2). The 
likelihood ratio version of the Chow test20 for a non-stratified model (A1) nested in 
two stratified models (D1 & D2) was used to test whether the effects of the pre- and 
peri-natal factors on asthma in the stratified models were significantly different from 
those in the pooled (non-stratified) model. The AOR of asthma for each of the pre- 
and peri-natal factors from the stratified models were also compared to explore 
which pre- and peri-natal factors might be moderated by preterm birth. 
Second, the potential moderating effect of preterm birth was evaluated by 
200 
testing multiplicative and additive interactions for each pre- and peri-natal risk factor. 
A set of multivariate logistic regressions of childhood asthma on preterm birth, all 
pre- and peri-natal factors, and the interaction term of a single pre- or peri-natal 
factor and preterm birth were estimated (Model E). Multiplicative interaction was 
evaluated by the significance level of the interaction term.21 Additive interaction 
effects were calculated using the cross difference of the predicted probabilities of 
asthma for each factor for preterm and term children22. That is, cross differences 
were calculated from the AOR and predicted probabilities for four groups: 1) non-
exposed and term (noted as AOR00 and p00, reference group), 2) non-exposed and 
preterm (AOR01 and p01), 3) exposed and term (AOR10 and p10), and 3) exposed and 
preterm (AOR10 and p10). The cross difference for preterm vs term children is then  
(p11 - p00) – [(p01 – p00) – (p11 –p10)] = p11 - p01 - p10 + p00 
with confidence intervals based on the delta method and conversions from odds to 
probabilities using margins23,24 command in STATA. 
5.4 Results 
The distributions of all pre- and peri-natal factors and other covariates in the 
analytic sample are shown in Table 5-1. 
5.4.1 Objective 2a: Relative Importance of Preterm Birth and Pre- and Peri-natal 
Factors on Asthma 
Table 5-2 compares the prevalence of asthma by categories of the pre- and peri-
natal factors. Children born preterm had a two times higher prevalence of asthma 
between ages 0-9 years compared with their term born counterparts (29.2% vs. 
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14.2%, p < 0.001). Children with the following maternal characteristics also had a 
significantly higher prevalence of asthma: history of asthma or allergies, 
black/African American and Hispanic race/ethnicity, unmarried, low household 
income, born in the U.S., continuous or quitting smoking during pregnancy, 
underweight, overweight or obese before pregnancy, preeclampsia or 
chorioamnionitis during pregnancy, and index child delivered by C-section . 
Table 5-3 reports the adjusted OR of asthma for preterm birth and the pre- and 
peri-natal factors from a multivariate logistic regression (Model A1). Children born 
preterm had double the odds of asthma compared to their term born counterparts 
(AOR = 2.12, 95% CI: 1.67 – 2.70, p < 0.001). The AOR for preterm birth was the third 
highest of the variables included, following maternal history of asthma and maternal 
African American race/ethnicity. According to the PAF, preterm birth was the third 
highest contributor to the population burden of asthma (PAF = 19.0%), after 
maternal race/ethnicity (PAF = 49.9%) and mother unmarried (PAF = 19.4%). 
5.4.2 Objective 2b: Mediating Role of Preterm Birth in Relationships between 
Prenatal Factors and Asthma 
Table 5-4 summarizes the results for the analysis of the potential mediating role 
of preterm birth and gestational age in the relationships between prenatal risk 
factors and asthma. The top half of the table presents the results for the mediating 
effects of preterm birth, while the bottom half of table presents the results for the 
mediating effects of gestational age. There are three key measures for determining 
mediation. The first is the percentage reduction in the AOR for a prenatal risk factor 
202 
between the model without preterm birth or gestational age to the model 
controlling for preterm birth or gestational age. This is shown in the third column on 
the left, and was calculated using the first and second columns on the left. Second, 







), estimated using classic mediation analyses which is 
shown in the set of columns in the middle. Third, the indirect effect estimated by the 
causal mediation analyses, in the third column on the right. 
Based on the reduction in AOR and the indirect effects estimated using both 
approaches , the mediating effects of preterm birth are the strongest in the 
preeclampsia-asthma relationship and moderately strong in the chorioamnionitis-
asthma relationship. The top half of Table 5-4 shows that including preterm birth in 
the multivariate regression analysis decreased the AOR for preeclampsia by 24.3%. 
The indirect effect of preeclampsia through preterm birth estimated using the classic 
approach was significant (indirect effect = 0.053, 95%CI, 0.033-0.070) and explained 
about 92% of the total effect of preeclampsia on asthma. According to the causal 
mediation analyses, the indirect effect of preeclampsia was also significant (OR = 
1.36, p < 0.001), and indicated that preeclampsia increased the odds of asthma 1.36 
times through the pathway of preterm birth. 
For chorioamnionitis, the percent reduction in AOR was 13.8%, the indirect 
effect using the classic approach was significant (indirect effect = 0.031, 95%CI, 
0.020-0.046) and explained about 25% of the total effect of chorioamnionitis on 
asthma, and chorioamnionitis indirectly increased the risk of asthma 1.17 times (OR 
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= 1.17, p < 0.001) through the pathway of preterm birth. The effects of the other 
prenatal risk factors on asthma were not significantly mediated by preterm birth. 
The bottom half of Table 5-4 shows that the mediating effects of preterm birth 
in the preeclampsia-asthma relationship were even stronger when prematurity was 
measured by gestational age (AOR reduced 28.7% and higher indirect effects); the 
same was true for the chorioamnionitis–asthma relationship (AOR reduced 28.2% 
and higher indirect effects). In addition, gestational age mediated the effects of 
three additional prenatal variables: maternal black/African American (AOR reduced 
6.9%, indirect effect = 0.019 [95%CI, 0.002-0.038] and 8% of total effect, and odds of 
asthma increased 1.08 times, p < 0.05), maternal Hispanic (AOR reduced 9.3%, 
indirect effect = 0.021 [95%CI, 0.005-0.039] and 12% of total effect, odds of asthma 
increased 1.10 times), and maternal history of asthma (AOR reduced 2.2%, indirect 
effect = 0.010 [95%CI, 0.000-0.021] and 5% of total effect, and odds of asthma 
increased 1.06 times).  
The multivariate logistic regression models of childhood asthma (Model B), 
preterm birth (Model C1), and gestational age (Model C2) on all the pre- and peri-
natal factors are reported in Appendix Table 5-7. Appendix Table 5-8 presents the 
results of sensitivity analyses for the treatment of missing explanatory variables. The 
causal mediation analyses was repeated using only complete cases, all cases, and the 
four other sets of imputations produced by MICE. The results showed that, 
compared with the results from the chosen imputed dataset (Table 5-4), the main 
effect of preterm birth was slightly lower in the complete cases analyses, but similar 
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in the all cases analyses and the other imputed datasets analyses. Similarly, the AOR 
reduction rates and indirect effects of preterm birth were slightly different in 
complete cases analyses, but mostly similar in the all cases analyses and the other 
imputed datasets analyses. 
5.4.3 Objective 2c: Moderating Effects of Preterm Birth on the Relationships 
between Pre- and Peri-natal Factors and Asthma 
Table 5-5 presents the stratified multivariate regression analyses for preterm 
and term children (Models D1 and D2). The results show that different sets of 
variables are significant risk factors for preterm and term children, suggesting that 
preterm birth may moderate the effect of pre- and peri-natal factors on asthma. 
Likelihood ratio tests of nested models somewhat supported the overall moderating 
effect of preterm birth on the set of pre- and peri-natal risk factors for asthma 
(Likelihood ratio test for Model A1 nested in Models D1 & D2, Chi-square = 38.51, df 
= 26, p = 0.054). The risk factors shared by preterm and term children were maternal 
history of asthma, maternal race/ethnicity, and chorioamnionitis. The unique risk 
factors for preterm children were maternal continuous smoking during pregnancy 
(marginally significant, p = 0.051), maternal history of allergies, and C-section 
delivery; and the unique risk factors for term born children were mother unmarried, 
low household income, and, marginally, mother born in the U.S. (p = 0.085). 
Table 5-6 shows additive interaction effects of preterm birth with pre and peri-
natal risk factors .Three pre- and peri-natal risk factors had significant additive 
interaction effects with preterm birth; these are illustrated in Figure 5-1. Preterm 
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birth increased the proportion with asthma by 27% (p < 0.001) among continuous 
smoking mothers, which was significantly higher than the increased proportion (13%, 
p < 0.001) among non-continuous smoking mothers (27% - 13% = 14%, p = 0.011). 
Preterm birth increased the proportion with asthma by 21% (p < 0.001) among 
allergic mothers, which was significantly higher than the increased proportion with 
asthma (11%, p < 0.001) among non-allergic mothers (21% - 11% = 10%, p = 0.007). 
Preterm birth increased the proportion with asthma by 20% (p < 0.001) among C-
section delivered children, which was significantly higher than the increased 
proportion with asthma (11%, p < 0.001) among non-allergic mothers (20% - 11% = 
9%, p = 0.008). 
The results of additive interactions from Model F (including all the potential 
bivariate interactions with preterm birth simultaneously) were very similar to the 
results reported from Model F (Table 5-6) and are thus not presented to avoid 
duplication. However, multiplicative interactions from Model E and Model F were 
less consistent, and thus not reported due to the unreliability of this method25. 
Appendix Table 5-9 presents the results of sensitivity analyses for the treatment 
of missing explanatory variables. The additive interaction analyses was repeated 
using only complete cases, all cases, and the four other sets of imputations produced 
by MICE. Compared with the results in Table 5-6, the effects of preterm birth were 
slightly different for complete cases analyses, but similar for all cases and other 
imputed datasets analyses. 
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5.4.4 Summary of Results by Age Range 
The roles of prematurity (measured both by preterm birth and gestational age) 
in the development of asthma are summarized graphically in Figure 5-2 for asthma 
assessed under age 10 years. The analyses by age at asthma assessment were also 
conducted. The results for asthma assessed under 6 years and at ages 6-9 years are 
summarized in Figure 5-3 and Figure 5-4, but not presented in tables to avoid 
duplications. 
As shown in Figure 5-2, preterm birth plays three roles in the relationships 
between pre- and peri-natal factors and asthma: 1) independent risk factor, 2) 
mediator for some prenatal effects, and 3) moderator for some pre- and peri-natal 
effects. Furthermore, the results can be summarized into three types (weak (<25%), 
moderate (25-75%), strong (>75%)) of mediating pathways from pre- and peri-natal 
risk factors to preterm birth to asthma, and two types (negative, positive) of 
moderation of the effects of pre- and peri-natal factors on asthma by preterm birth . 
For asthma assessed at ages 0-5, the main effect of preterm birth (AOR = 2.09, p 
< 0.001) and its mediating and moderating effects were similar for asthma assessed 
between ages age 0-9. For asthma assessed at ages 6-9, the effect of preterm birth 
was still significant (AOR = 2.79, p < 0.001), but the main effects of some pre- and 
peri-natal risk factors became insignificant. When assessed at ages 6-9, the mediating 
effects of preterm birth on the relationships between chorioamnionitis/preeclampsia 
and asthma became larger, and the moderating effects of prematurity on the 
relationship between C-section and asthma become larger. 
207 
5.5 Discussion 
5.5.1 Preterm Birth is among the Most Important Pre- and Peri-natal Factors for 
Asthma 
The findings in this manuscript indicate that preterm birth is a risk factor for 
asthma among children under age 10, and is among the top three strongest risk 
factors among the pre- and peri-natal factors examined in this manuscript. If 
demographic variables were excluded from the rankings of AOR and PAF, preterm 
birth would have the second highest effect size in terms of AOR value, and highest 
contribution to the population burden of asthma in the analytic sample. These 
findings are consistent with other studies and show that preterm birth is an 
important and independent risk factor for childhood asthma1,2, and underscore the 
vital role of preterm birth in the development of asthma in low-income urban 
population. Strengths and limitations of relative importance analyses are discussed in 
section 3.5.4. 
5.5.2 Preterm Birth Mediates the Effects of Some Prenatal Risk Factors on Asthma 
Prematurity (measured both by preterm birth and gestational age) mediated the 
impact of four prenatal factors on asthma, but to different degrees: it strongly 
mediated the effect of preeclampsia, moderately meditated the effect of 
chorioamnionitis, and weakly mediated the relationships between maternal African 
American and Hispanic race/ethnicity. Preeclampsia is characterized by “arising 
hypertension (diastolic blood pressure ≥ 90 mm Hg) and proteinuria (≥ 300 mg in 24 
hours) with an onset at or after 20 weeks of gestation”,26 and affects about 3.4% of 
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pregnancies in the United States.27 Given the progressive nature of preeclampsia, it 
often leads to a preterm birth.28 Preeclampsia has previously been identified as a risk 
factor for asthma medication use29 and wheezing6,30 in childhood, but no prior 
studies reported the mediating effect of preterm birth in the preeclampsia-asthma 
relationship. However, one study found that preterm birth mediated the effect of 
preeclampsia on neonatal health (respiratory distress syndrome at neonatal intensive 
care unit admission).31 
The moderate mediating effect of preterm birth on the association between 
chorioamnionitis and asthma found in this manuscript is consistent with the joint 
effect of chorioamnionitis and early preterm birth on recurrent wheezing and 
physician-diagnosed asthma identified in a previous study.9 The indirect effect 
through prematurity is consistent with the fact that chorioamnionitis is a common 
cause for preterm birth32,33 and that preterm birth increased the risk of asthma.1,2 
However, preterm birth or gestational age only partially mediated the 
chorioamnionitis effect on asthma, which suggests that chorioamnionitis may also 
increase the risk of asthma directly. This direct effect is also consistent with literature 
that suggest chorioamnionitis a risk factor for bronchopulmonary dysplasia (BPD)34,35 
and fetal lung development.32 The finding that chorioamnionitis increased the risk of 
asthma even among term born children, which is consistent with previous studies on 
recurrent wheezing9 but different from previous studies on having ever had 
asthma.9,36 The inconsistency may be the result of different definitions of asthma, 
prevalence of chorioamnionitis and other characteristics of the study populations. 
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Gestational age weakly mediated the maternal history of asthma effects on 
asthma in offspring. This finding is consistent with previous meta-analyses that found 
that maternal asthma, maternal asthma exacerbations, and maternal oral 
corticosteroid use to increase the risk of preterm birth,37,38 and that maternal asthma 
increased the risk of asthma in offspring.4 Maternal asthma may increase the risk of 
preterm birth through hypoxic mechanisms,39 hypertensive conditions,40 and 
inflammation response process,41 The weak mediating effect in this cohort may be 
because the rate of asthma attacks is often low42 during pregnancy, and because 
asthma control in pregnancy may control the asthmatic symptoms and reduce 
preterm birth rate.43 In addition, a large proportion of the effect of maternal history 
of asthma on asthma in offspring may be exerted through other factors, such as 
genetics or shared environment.44,45 
Gestational age weakly mediated the effects of maternal black/African American 
and Hispanic race/ethnicity on asthma, which is consistent with another study that 
found the black-white difference in childhood asthma prevalence was attenuated 
after adjusting for prematurity.46 However, the fact that maternal race/ethnicity is 
significantly associated with gestational age but not preterm birth suggests that 
degree of prematurity among preterm children is a stronger mediator than a binary 
measure of prematurity. This pattern may also be due to the relatively small 
race/ethnic dipartites in preterm birth in the BBC. 
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5.5.3 Preterm Birth Moderates the Effects of Some Pre- and Peri-natal Risk Factors 
on Asthma 
This manuscript reports that three pre- and perinatal factors (maternal history 
of allergies, maternal continuous smoking during pregnancy, and C-section delivery) 
interact additively with preterm birth to affect asthma. Maternal history of allergies 
has been reported as a risk factor for asthma in offspring.47,48 However, no studies 
reported an interaction with preterm birth. A recent study in the Puerto Rican 
population reported that prematurity requiring Neonatal intensive Care Unit (NICU) 
admission increased the risk of asthma in atopic (≥1 positive allergen-specific 
Immunoglobulin E [IgE]) children, but not in non-atopic children.49 This suggests that 
genetic predisposition might influence the risk of asthma together with other 
susceptibilities to airway inflammation in preterm born children, rather than causing 
the asthmatic symptoms on its own. 
Maternal smoking during pregnancy has been identified as a risk factor for both 
preterm birth10 and asthma.50-52 However, only two studies have discussed the 
moderation of smoking by preterm birth; these studies found a significant interaction 
between maternal pregnancy smoking and preterm birth.53,54 Maternal smoking 
might influence early development of immune system53 and lung function55 
increasing susceptibility to asthma. Consistent with previous studies, findings from 
this manuscript suggest that the adverse effect of maternal pregnancy smoking 
become more pronounced when children are born preterm rather than term. 
A meta-analysis reported that delivery by (elective or emergency)7 C-section 
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slightly but significantly alleviated the risk of childhood asthma.56 But no studies have 
tested the interaction between preterm birth and C-section delivery in affecting 
asthma. Findings from this manuscript support of the hypothesis that the C-section 
effect might be partially explained by degree of prematurity, but not preterm birth. 
Delivery mode is also hypothesized to influence risk of asthma by altering innate 
immune system by decreasing the exposure to colonization of the infant intestine57 
and early development of gut microbiome.58 These findings partially support this 
hypothesis but suggest that the effect of C-section is conditioned on preterm birth, 
i.e. other predisposed susceptibility to airway inflammation. 
The moderating effect of preterm birth on the adverse effects of mother 
unmarried and low household income on asthma were supported by the stratified 
analyses but not by the additive interaction analyses. These results are partially 
consistent with the previous studies that have found mother unmarried59 and low 
household income60 associated with increased risk of asthma in offspring. The effects 
of these maternal social demographic factors might be explained by their relations to 
psychosocial, environmental, life-style, genetic and other factors. However, the non-
significant effect of mother unmarried and low household income on childhood 
asthma in preterm children has never been reported before. I checked the internal 
validity of my analyses and found that the lack of significance was not likely due to 
the distribution of marital status or income in the sample or collinearity among 
maternal social demographic factors. The absence of relationships between mother 
unmarried and low household income with asthma among preterm children may 
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reflect the already high risk of preterm children.  
The moderating effect of preterm birth on the adverse effects of mother born in 
the U.S. on child asthma was also supported by stratified analysis but not by the 
additive interaction analyses. This result is partially consistent with studies reporting 
that children with U.S. born parents have a higher risk of asthma.61,62 The literature 
suggests that the effect mother’s nativity on asthma in offspring might be explained 
by the “Healthy Migrant Effect”,63 the “Hygiene Hypothesis”,64 and better asthma 
management behaviors.65 In this analytic sample, mothers born in the U.S. are more 
likely to be low income and unmarried than their foreign born counterparts. 
Supplemental analyses showed that the adverse effect of mother born in the U.S. on 
asthma were partially explained by maternal pregnancy smoking and maternal 
history of asthma and allergies. However, in the analyses in this manuscript, the 
effect of maternal nativity became weaker and insignificant among preterm children. 
Besides the effect explained by other pre- and peri-natal risk factors, the adverse 
effect of mother born in the U.S. may be masked by a higher predisposed risk for 
asthma in preterm children. 
5.5.4 Strengths and Limitations 
The major strength of the analyses in this manuscript lie in the depth and rigor 
of the hypothesis testing for the three key questions regarding the inter-relationships 
of pre and peri-natal factors, preterm birth, and childhood asthma. 
The analytic sample is well-suited to assess the effects of preterm birth and 
other pre- and peri-natal variables on asthma due to the high prevalence of preterm 
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birth in the BMC patient population,66 and recruitment of a higher proportion of 
children born preterm or low birth weight for the BBC cohort (28% preterm birth, 
mean of gestational age ± standard deviation = 33.4 ± 3.4). The BMC patient 
population experiences high rate of asthma and so are an especially important group 
to investigate. However, this also means that the analytic sample is less suited to 
assess the PAF of preterm birth for the general American population, though U.S. is 
ranked the highest in terms of preterm birth rate67 and among the highest in terms 
of asthma prevalence68 in developing countries. 
Using the causal approach to test the mediating effect of preterm birth, 
addressed the difficulty of interpreting and testing mediating effects using the classic 
approach to mediation analyses. However, results from causal mediation analyses 
are limited to some extent, by relying on the odds of asthma to approximate the risk 
of asthma when the outcome (asthma) is not rare in the analytic sample. See more 
discussion in Chapter 7. 
3.6 Conclusions 
Findings of this manuscript highlight the triple roles of preterm birth in the 
development of childhood asthma: preterm birth is a major and independent risk 
factor of asthma; it mediates several common prenatal risk factors on asthma; and it 
acts synergistically with several pre- and peri-natal risk factors to increase the risk of 
asthma. These findings provide strong evidence for the fetal origins of asthma and 
suggest that asthma is potentially preventable with effective early life interventions. 
Such interventions may help to reduce the incidence of preterm birth rate as well as 
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Figure 5-1. Additive Interactions of Pre- and Peri-natal Factors and Preterm Birth on 
Asthma for Children under Age 10 Years (n = 2,461) 
Panel (a) for additive interaction of maternal contiuous smoking during pregnancy and preterm birth, 
(b) for maternal history of allegies and preterm birth, (c) for cesarean section (C-section) and preterm 
birth. All the predicted marginal probabilities of asthma were estimated using Model E series: 
multivariate logistic regression of asthma on pre- and peri-natal factors and their interaction terms 
with preterm birth each at a time, adjusting for other covariates. 95% confidence interval was derived 
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Figure 5-2. Pathways from Pre- and Peri-natal Factors to Childhood Asthma Assessed at Ages 0-9 Years through prematurity (n = 2,461) 
Notes: 
(1) P-values of association: *, p < 0.05; ***, p < 0.001; ?, null or inconsistent significance 
(2) Negative interaction *: adverse effects of these factors were significant only in term born children but not in preterm children, multiplicative scale, and additive scale; 
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Figure 5-3. Pathways from Pre- and Peri-natal Factors to Childhood Asthma Assessed at Ages 0-5 Years through prematurity (n = 2,460) 
Notes: 
(1) P-values of association: *, p < 0.05; ***, p < 0.001; ?, null or inconsistent significance 
(2) Negative interaction *: adverse effects of these factors were significant only in term born children but not in preterm children, multiplicative scale, and additive scale; 
(3) Positive interaction *: adverse effects of these factors were significant only in preterm born children but not in term born children, multiplicative scale, and additive 
scale. 
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Figure 5-4. Pathways from Pre- and Peri-natal Factors to Childhood Asthma Assessed at Ages 6-9 Years through prematurity (n = 1,057) 
Notes: Crossed-out variables not significantly associated with asthma 
(1) P-values of association: *, p < 0.05; ***, p < 0.001; ?, null or inconsistent significance; (2) Negative interaction *: adverse effects of these factors were significant only in 
term born children but not in preterm children, multiplicative scale, and additive scale; (3) Positive interaction *: adverse effects of these factors were significant only in 
preterm born children but not in term born children, multiplicative scale, and additive scale. 
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Figure 5-5. LOWESS Regressions of Logit of Asthma and Probability of Asthma Assessed at 
Ages 0-9 Years on Gestational Age of Weeks (n = 2,461) 
Notes: Asthma were defined as two diagnoses of asthma assessed at ages 0-9 years. LOWESS = Locally 




Figure 5-6. LOWESS Regressions of Logit of Asthma and Probability of Asthma Assessed at 
Ages 0-5 Years on Gestational Age of Weeks (n = 2,460) 
Notes: Asthma were defined as two diagnoses of asthma assessed at ages 0-5 years. LOWESS = Locally 




Figure 5-7. LOWESS Regressions of Logit of Asthma and Probability of Asthma Assessed at 
Ages 6-9 Years on Gestational Age of Weeks (n = 1,057) 
Notes: Asthma were defined as two diagnoses of asthma assessed at ages 6-9 years. LOWESS = Locally 






Table 5-1. Characteristics of the Analytic Sample and Subsamples by Preterm Birth Status 
 
Total 
(n = 2,461) 
 
Preterm 
(n = 696) 
Term 
(n = 1,765) 
Preterm 
vs term 
  n Col %  n Col % n Col % P-value* 
Genetic predispositions         
Maternal history of asthma 343  13.9  119  17.1  224  12.7  0.004  
Maternal history of allergies 867  35.2  271  38.9  596  33.8  0.016  
Maternal social demographics        
Maternal race/ethnicity         
Black/African American 1,458  59.2  424  60.9  1,034  58.6  0.323  
White 173  7.0  48  6.9  125  7.1   
Hispanic 528  21.5  152  21.8  376  21.3   
Others 302  12.3  72  10.3  230  13.0   
Maternal education         
Elementary/secondary 700  28.4  206  29.6  494  28.0  0.240  
High school/GED 891  36.2  262  37.6  629  35.6   
Some college/above 870  35.4  228  32.8  642  36.4   
Mother unmarried 1,629  66.2  485  69.7  1,144  64.8  0.021  
Low household income 1,151  46.8  351  50.4  800  45.3  0.022  
Mother born in the U.S. 953  38.7  298  42.8  655  37.1  0.009  
Maternal pregnancy smoking         
Continuous smoking during pregnancy 280  11.4  99  14.2  181  10.3  0.005  
Quit smoking during pregnancy 186  7.6  65  9.3  121  6.9  0.036  
Pre-pregnancy body mass index         
Underweight 104  4.2  31  4.5  73  4.1  0.039  
Normal 1,095  44.5  282  40.5  813  46.1   
Overweight 680  27.6  218  31.3  462  26.2   
Obese 582  23.6  165  23.7  417  23.6   
Maternal high pregnancy stress 444  18.0  140  20.1  304  17.2  0.093  
Pregnancy complications         
Preeclampsia 272  11.1  171  24.6  101  5.7  <0.001  
Chorioamnionitis 378  15.4  161  23.1  217  12.3  <0.001  
Type of delivery         
Cesarean section delivery 891  36.2  320  46.0  571  32.4  <0.001  
Other covariates         
Summer/autumn born 1,322  53.7  367  52.7  955  54.1  0.537  
First born in offsprings 1,027  41.7  293  42.1  734  41.6  0.817  
Family member smoking 776  31.5  246  35.3  530  30.0  0.011  
Child sex, male 1,240  50.4  360  51.7  880  49.9  0.404  
Gestational age, week (median, range) 38 (23-42)  35 (23-37) 39 (37-42) <0.001  
Child age, year (median, range) 5 (0-9)  5 (0-9) 5 (0-9) 0.084  
Duration of follow-up, year (median, 
range) 
6 (1-10)  6 (1-10) 6 (1-10) 0.091  
Maternal age, year (median, range) 29 (14-51)   29 (15-45) 28 (14-51) 0.105  
Note: Col = column. GED: General Education Development test  
*P-values were derived from chi-square tests or Analyses Of Variance (ANOVA) tests.  
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Table 5-2. Bivariate Associations of Pre- and Peri-natal Factors with Asthma Status for 
Children under Age 10 Years 
 
Asthma  
(n = 2,008)   
No Asthma  
(n = 453)   
Asthma vs. 
No Asthma 
  n Row % n Row % P-value* 
Preterm Birth        
Term 250  14.2   1,515  85.8   <0.001  
Preterm 203  29.2    493  70.8      
Maternal history of asthma        
No 323  15.3   1,795  84.7   <0.001  
Yes 130  37.9   213  62.1    
Maternal history of allergies        
No 238  14.9   1,356  85.1   <0.001  
Yes 215  24.8    652  75.2      
Maternal race/ethnicity        
Black/African American 314  21.5   1,144  78.5   <0.001  
White 18  10.4   155  89.6    
Hispanic 83  15.7   445  84.3    
Others 38  12.6   264  87.4    
Maternal education        
Elementary/secondary 122  17.4   578  82.6   0.223  
High school/GED 180  20.2   711  79.8    
Some college/above 151  17.4   719  82.6    
Mother unmarried        
Unmarried 106  12.7   726  87.3   <0.001  
Married 347  21.3   1,282  78.7    
Low household income        
No 195  14.9   1,115  85.1   <0.001  
Yes 258  22.4   893  77.6    
Mother born in the U.S.        
No 215  14.3   1,293  85.7   <0.001  
Yes 238  25.0    715  75.0      
Maternal continuous smoking  
during pregnancy 
     
 
No 380  17.4   1,801  82.6   <0.001  
Yes 73  26.1   207  73.9    
Maternal quit smoking during 
pregnancy 
      
 
No 405  17.8   1,870  82.2   0.007  
Yes 48  25.8    138  74.2      
Pre-pregnancy body mass index        
Underweight 19  18.3   85  81.7   0.011  
Normal 171  15.6   924  84.4    
Overweight 137  20.1   543  79.9    
Obese 126  21.6    456  78.4      




(n = 2,008)   
No Asthma  
(n = 453)   
Asthma vs. 
No Asthma 
  n Row % n Row % P-value* 
Maternal high pregnancy stress 
Low stress 348  17.3   1,669  82.7   0.002  
High stress 105  23.6    339  76.4      
Preeclampsia        
No 390  17.8   1,799  82.2   0.032  
Yes 63  23.2   209  76.8    
Chorioamnionitis        
No 347  16.7   1,736  83.3   <0.001  
Yes 106  28.0    272  72.0      
Cesarean section delivery        
No 268  17.1   1,302  82.9   0.023  
Yes 185  20.8    706  79.2      
Abbreviations: GED: General Education Development test. *P-values were derived from chi-square tests. 
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Table 5-3. Adjusted Odds Ratios from Multivariate Logistic Regression of Asthma on 
Preterm Birth and Pre- and Peri-natal Factors for Children under Age 10 Years (n = 2,461) 
 Model A1: Outcome = Asthma 






Preterm birth 2.12*** [1.67,2.70] 3 19.0% 3 
Genetic predispositions      
Maternal history of asthma 2.74*** [2.04,3.68] 1 13.9% 4 
Maternal history of allergies 1.28+ [0.99,1.64] 10 7.5% 9 
Maternal social demographics      
Maternal race/ethnicity      
Black/African American 2.54** [1.44,4.47] 2 49.9% 1 
White 1      
Hispanic 2.12* [1.13,3.95] 4   
Others 1.97* [1.01,3.85] 5   
Maternal education      
Elementary/secondary 1    9.3% 7 
High school/GED 1.15  [0.86,1.53] 17   
Some college/above 1.21  [0.89,1.65] 14   
Mother unmarried 1.44* [1.09,1.91] 8 19.4% 2 
Low household income 1.27* [1.01,1.61] 11 9.4% 6 
Mother born in the U.S. 1.35+ [1.00,1.83] 9 10.0% 5 
Maternal pregnancy smoking      
Maternal continuous smoking during 
pregnancy 
1.46+ [0.97,2.20] 
7 3.9% 12 
Maternal quit smoking during pregnancy 1.34  [0.89,2.03] 13 2.0% 13 
Pre-pregnancy body mass index      
Underweight 1.13  [0.63,2.02] 18 7.8% 8 
Normal 1      
Overweight 1.20  [0.91,1.57] 15   
Obese 1.15  [0.86,1.53] 16   
Maternal high pregnancy stress 1.03  [0.78,1.37] 20 0.4% 14 
Pregnancy complications      
Preeclampsia 1.03  [0.72,1.47] 19 0.3% 15 
Chorioamnionitis 1.62** [1.21,2.16] 6 6.7% 10 
Type of delivery      
Cesarean section delivery 1.23+ [0.97,1.56] 12 6.7% 11 
Notes: Model A1: Multivariate logistic regression of asthma on preterm birth and pre- and peri-natal 
factors, adjusting for other covariates (child’s sex and age, born in summer/autumn, first born in 
offsprings family member smoking, maternal age, and duration of follow-up); 
Abbreviations: AOR: adjusted odds ratio. CI: confidence interval. PAF: Population Attributable Fraction 
based on characteristics of the analytic sample. GED: General Education Development test. 
P-values: + p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001 
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Table 5-4. Mediating Effects of Prematurity on Associations between Prenatal Factors and Asthma for Children under Age 10 Years (n = 2,461) 




Classic mediation analyses 
 
Causal mediation analyses 
 
without PTB with PTB 








OR AOR AOR 
Preterm birth  2.12***              
Maternal Race/ethnicity, ref =White 1 1              
Black/African American 2.52** 2.54** 0.8% 0.008 [-0.011 ,0.031] 0.03  1.03  2.54  *** 2.61  *** 
Hispanic 2.16* 2.12* -1.9% 0.011 [-0.007 ,0.033] 0.06  1.05  2.12  * 2.22  *
Maternal continuous smoking  
during pregnancy 
1.51* 1.46+ -3.3% 0.008 [-0.003 ,0.021] 0.11  1.05  1.46  + 1.53  *** 
Maternal history of asthma 2.76*** 2.74*** -0.7% 0.007 [-0.003 ,0.018] 0.04  1.04  2.74  *** 2.84  *** 
Preeclampsia 1.36+ 1.03 -24.3% 0.053* [0.033 ,0.070] 0.92  1.36  *** 1.03  1.40  +
Chorioamnionitis 1.88*** 1.62** -13.8%  0.031* [0.020 ,0.046] 0.25   1.17  *** 1.62  *** 1.89  *** 





Classic mediation analyses 
 
Causal mediation analyses 
 
without GA with GA 








OR AOR AOR 
Gestational age, week  0.88***              
Maternal Race/ethnicity. ref =White 1 1              
Black/African American 2.52** 2.35** -6.7% 0.019* [0.002 ,0.038] 0.08  1.08  * 2.35  ** 2.54  *** 
Hispanic 2.16* 1.96* -9.3% 0.021* [0.005 ,0.039] 0.12  1.10  * 1.96  * 2.15  *
Maternal continuous smoking  
during pregnancy 
1.51* 1.47+ -2.6% 0.007 [-0.004 ,0.020] 0.10  1.04  1.47  + 1.53  *
Maternal history of asthma 2.76*** 2.70*** -2.2% 0.010* [0.000 ,0.021] 0.05  1.06  * 2.70  *** 2.85  *** 
Preeclampsia 1.36+ 0.97 -28.7% 0.059* [0.043 ,0.079] 1.10  1.42  *** 0.97  1.38  +
Chorioamnionitis 1.88*** 1.35+ -28.2%  0.053* [0.035 ,0.073] 0.48   1.31  *** 1.35  + 1.78  *** 
Notes: Model B: Multivariate logistic regression of asthma on pre- and peri-natal factors and other covariates; Model A: Multivariate logistic regression of asthma on 
preterm birth (PTB, A1) and on gestational age (GA, A2), pre- and peri-natal factors, and other covariates. Abbreviations: AOR: adjusted odds ratio. CI: confidence interval. 
Definitions of indirect, direct and total effects were defined in the methods section. ref = reference. P-values: + p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Table 5-5. Adjusted Odds Ratios from Multivariate Logistic Regression of Asthma on Pre- 
and Peri-natal Factors Stratified by Preterm Birth Status for Children under Age 10 years 
 
Model D1: Among  
preterm (n = 696)   
Model D2. Among  
term (n = 1,765) 
  AOR [95%CI] AOR [95%CI] 
Genetic predispositions      
Maternal history of asthma 2.45*** [1.49,4.02]  3.03*** [2.09,4.42] 
Maternal history of allergies 1.59* [1.06,2.39]  1.08  [0.78,1.51] 
Maternal social demographics      
Maternal race/ethnicity      
Black/African American 2.85* [1.19,6.84]  2.58* [1.17,5.67] 
White 1   1  
Hispanic 2.13  [0.80,5.72]  2.30+ [0.98,5.40] 
Others 2.01  [0.69,5.84]  2.02  [0.82,5.00] 
Maternal education      
Elementary/secondary 1   1  
High school/GED 1.25  [0.77,2.04]  1.10  [0.76,1.58] 
Some college/above 1.28  [0.76,2.15]  1.18  [0.80,1.74] 
Mother unmarried 1.17  [0.74,1.85]  1.63** [1.12,2.36] 
Low household income 1.07  [0.72,1.58]  1.43* [1.06,1.93] 
Mother born in the U.S. 1.34  [0.80,2.22]  1.41+ [0.95,2.08] 
Maternal pregnancy smoking      
Maternal continuous smoking during 
pregnancy 
1.90+ [1.00,3.63]  1.21  [0.69,2.11] 
Maternal quit smoking during pregnancy 0.68  [0.34,1.37]  2.01** [1.20,3.36] 
Pre-pregnancy body mass index      
Underweight 1.56  [0.62,3.91]  0.93  [0.42,2.03] 
Normal 1   1  
Overweight 1.33  [0.85,2.07]  1.11  [0.77,1.59] 
Obese 1.05  [0.65,1.72]  1.23  [0.84,1.78] 
Maternal high pregnancy stress 1.06  [0.67,1.68]  0.98  [0.68,1.41] 
Pregnancy complications      
Preeclampsia 1.19  [0.76,1.89]  0.70  [0.35,1.38] 
Chorioamnionitis 1.84** [1.18,2.85]  1.54* [1.02,2.33] 
Type of delivery      
Cesarean section delivery 1.87** [1.26,2.77]   0.97  [0.70,1.33] 
Model D1: Multivariate logistic regression of childhood asthma on pre- and peri-natal factors adjusted 
for other covariates for preterm children; 
Model D2: Multivariate logistic regression of childhood asthma on pre- and peri-natal factors adjusted 
for other covariates for term children; 
Abbreviations: AOR: adjusted odds ratio. CI: confidence interval. GED: General Education 
Development test. 
P-values: + p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001 
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Table 5-6. Additive Interaction Effects of Pre- and Peri-natal Factors and Preterm Birth on Asthma for Children under Age 10 Years (n = 2,461) 
Pre- and peri-natal factors 
Model E: with interaction term each 
at a time 
Preterm or 
term 
Odds ratios of asthma 
  
Predicted marginal 
probabilities of asthma  
  
Differences for 
preterm vs. term   
Cross-differences for 
preterm vs term  





Not continuous smoking Term (00) 1.00        0.14*** [0.12,  0.16]                  
 Preterm (01) 1.96***  [1.51  ,2.55]   0.27*** [0.24,  0.30]  0.13*** [0.09  ,0.17]      
Continuous smoking Term (10) 1.17  [0.70  ,1.94]  0.17*** [0.11,  0.22]         




No asthma Term (00) 1.00       0.12*** [0.10,  0.13]              
 Preterm (01) 2.25***  [1.72  ,2.94]   0.25*** [0.22,  0.28]   0.14*** [0.10  ,0.17]     
Yes asthma Term (10) 3.03***  [2.11  ,4.35]   0.32*** [0.26,  0.38]        




No allergies Term (00) 1.00       0.12*** [0.10,  0.14]              
 Preterm (01) 1.92***  [1.40  ,2.62]   0.23*** [0.19,  0.27]   0.11*** [0.07  ,0.15]     
Yes allergies Term (10) 1.16  [0.85  ,1.59]   0.18*** [0.15,  0.21]        
  Preterm (11) 2.82***  [1.99  ,4.00]    0.39*** [0.34,  0.44]    0.21*** [0.15  ,0.27]    0.10**  [0.03  ,0.17] 
Chorioam- 
nionitis 
No chorioamnionitis Term (00) 1.00       0.13*** [0.12,  0.15]              
 Preterm (01) 2.04***  [1.55  ,2.68]   0.26*** [0.23,  0.29]   0.13*** [0.09  ,0.16]     
Chorioamnionitis Term (10) 1.49+  [0.99  ,2.22]   0.19*** [0.14,  0.24]        
  Preterm (11) 3.61***  [2.47  ,5.28]    0.40*** [0.33,  0.47]    0.20*** [0.12  ,0.29]    0.08  [-0.01  ,0.17] 
Type of 
delivery  
Not cesarean section Term (00) 1.00       0.14*** [0.13,  0.16]              
 Preterm (01) 1.57*  [1.15  ,2.14]   0.25*** [0.21,  0.29]   0.11*** [0.06  ,0.15]     
Cesarean section Term (10) 0.91  [0.67  ,1.25]   0.13*** [0.11,  0.16]        
  Preterm (11) 3.00***  [2.15  ,4.19]    0.34*** [0.29,  0.38]    0.20*** [0.15  ,0.26]    0.09**  [0.02  ,0.16] 
All the odds ratios and predicted marginal probabilities of asthma were estimated using Model E series: multivariate logistic regression of asthma on pre- and peri-natal 
factors and their interaction terms with preterm birth each at a time, adjusting for other covariates. Abbreviations: AOR: adjusted odds ratio. CI: confidence interval. p = 
probability. Cross difference = p11 - p01 - p10 + p00; 95%CI was from delta method based on probability. P-values: * < 0.05, ** < 0.01, *** < 0.001.
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Table 5-7. Adjusted Odds Ratios from Multivariate Logistic Regression of Asthma, Preterm 
Birth, and Gestational Age on Pre- and Peri-natal Factors for Children under Age 10 Years (n 
= 2,461) 
 
Model B: Outcome = 
asthma at ages 0-9  
Model C: Outcome = Prematurity 
C1: Preterm birth C2: Gestational age 
AOR [95%CI] AOR [95%CI] AOR [95%CI] 
Genetic predispositions        
Maternal history of asthma 2.76*** [2.06,3.69]  1.23  [0.93,1.63] -0.44* [-0.82,-0.05] 
Maternal history of allergies 1.32* [1.03,1.69]  1.14  [0.92,1.42] -0.20  [-0.49,0.09] 
Maternal social demographics      
Maternal race/ethnicity        
Black/African American 2.52** [1.44,4.41]  1.18  [0.79,1.76] -0.59* [-1.12,-0.06] 
White 1   1  1  
Hispanic 2.16* [1.17,4.00]  1.32  [0.84,2.07] -0.74* [-1.34,-0.14] 
Others 1.93* [1.00,3.74]  0.98  [0.60,1.58] -0.30  [-0.93,0.33] 
Maternal education        
Elementary/secondary 1   1  1  
High school/GED 1.14  [0.86,1.51]  0.86  [0.68,1.10] 0.15  [-0.17,0.47] 
Some college/above 1.18  [0.87,1.59]  0.81+ [0.62,1.04] 0.11  [-0.23,0.45] 
Mother unmarried 1.45** [1.10,1.92]  1.15  [0.92,1.45] -0.11  [-0.41,0.19] 
Low household income 1.30* [1.03,1.64]  1.11  [0.91,1.36] -0.16  [-0.42,0.10] 
Mother born in the U.S. 1.37* [1.01,1.85]  1.17  [0.90,1.52] -0.23  [-0.58,0.11] 
Maternal pregnancy smoking        
Maternal continuous smoking 
during pregnancy 
1.51* [1.01,2.27]  1.29  [0.90,1.85] -0.32  [-0.82,0.18] 
Maternal quit smoking during 
pregnancy 
1.38  [0.92,2.08]  1.20  [0.83,1.75] -0.11  [-0.63,0.40] 
Pre-pregnancy body mass index        
Underweight 1.20  [0.68,2.13]  1.33  [0.84,2.12] -0.53  [-1.17,0.11] 
Normal 1   1  1  
Overweight 1.22  [0.93,1.60]  1.19  [0.94,1.49] -0.22  [-0.53,0.09] 
Obese 1.12  [0.84,1.50]  0.81+ [0.63,1.04] 0.18  [-0.15,0.51] 
Maternal high pregnancy stress 1.03  [0.78,1.37]  1.06  [0.83,1.36] -0.16  [-0.50,0.17] 
Pregnancy complications        
Preeclampsia 1.36+ [0.97,1.91]  5.75*** [4.35,7.62] -2.76*** [-3.16,-2.35] 
Chorioamnionitis 1.88*** [1.41,2.49]  2.40*** [1.88,3.07] -2.14*** [-2.49,-1.79] 
Type of delivery        
Cesarean section delivery 1.28* [1.01,1.62]   1.49*** [1.22,1.81] -0.84*** [-1.11,-0.57] 
Model B: Multivariate logistic regression of asthma on preterm birth and pre- and peri-natal factors, 
adjusting for other covariates; Model C: Multivariate logistic regression of preterm birth (B1) or of 
gestational age of weeks (B2), and pre- and peri-natal factors, adjusting for other covariates. 
Abbreviations: AOR: adjusted odds ratio. CI: confidence interval. PAF: Population Attributable Fraction 
based on characteristics of the analytic sample. GED: General Education Development test. 
P-values: + p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001
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Table 5-8. Sensitivity Analyses for Mediating Effects of Prematurity on Effects of Prenatal Factors on Asthma for Children under 10 Years 
Complete cases analyses 

















analyses for GA 
AOR AOR % Indirect effect OR   AOR AOR % Indirect effect OR 
Preterm birth/gestational age  2.04**      0.88***    
Maternal race/ethnicity, ref = White 1 1     1 1    
Black/African American 2.39** 2.34** -2.1% 1.04    2.39** 2.21* -7.5% 1.09  * 
Hispanic 2.04* 1.94+ -4.9% 1.07    2.04* 1.83+ -10.3% 1.11  * 
Maternal continuous smoking during 
pregnancy 
1.58* 1.54+ -2.5% 1.02    1.58* 1.52+ -3.8% 1.04   
Maternal history of asthma 2.68*** 2.63*** -1.9% 1.04    2.68*** 2.55*** -4.9% 1.08  * 
Preeclampsia 1.23 0.94 -23.6% 1.34  ***  1.23 0.86 -30.1% 1.42  *** 
Chorioamnionitis 1.92*** 1.66** -13.5% 1.16  ***  1.92*** 1.35+ -29.7% 1.34  *** 
All data analyses  

















analyses for GA 
  AOR AOR % Indirect effect OR   AOR AOR % Indirect effect OR 
Preterm birth/gestational age  2.13***      0.88***    
Maternal race/ethnicity, ref = White 1 1     1 1    
Black/African American 2.57*** 2.57** 0.0% 1.03    2.57*** 2.37** -7.8% 1.08  * 
Hispanic 2.24* 2.19* -2.2% 1.05    2.24* 2.02* -9.8% 1.10  * 
Maternal continuous smoking during 
pregnancy 
1.49+ 1.44+ -3.4% 1.05    1.49+ 1.44+ -3.4% 1.04   
Maternal history of asthma 2.82*** 2.76*** -2.1% 1.05    2.82*** 2.68*** -5.0% 1.07  * 
Preeclampsia 1.40+ 1.07 -23.6% 1.35  ***  1.40+ 1.01 -27.9% 1.40  *** 
Chorioamnionitis 2.05*** 1.75*** -14.6% 1.19  ***  2.05*** 1.44* -29.8% 1.35  *** 
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MICE imputed dataset 1  

















analyses for GA 
  AOR AOR % Indirect effect OR   AOR AOR % Indirect effect OR 
Preterm birth/gestational age  2.11***      0.88***    
Maternal race/ethnicity, ref = White 1 1     1 1    
Black/African American 2.60*** 2.60*** 0.0% 1.03    2.60*** 2.39** -8.1% 1.08  * 
Hispanic 2.25* 2.19* -2.7% 1.05    2.25* 2.02* -10.2% 1.10  * 
Maternal continuous smoking during 
pregnancy 
1.49+ 1.45+ -2.7% 1.04    1.49+ 1.45+ -2.7% 1.03   
Maternal history of asthma 2.81*** 2.78*** -1.1% 1.04    2.81*** 2.71*** -3.6% 1.07  * 
Preeclampsia 1.37+ 1.04 -24.1% 1.36  ***  1.37+ 0.97 -29.2% 1.42  *** 
Chorioamnionitis 1.96*** 1.67*** -14.8% 1.18  ***  1.96*** 1.39* -29.1% 1.33  *** 
MICE imputed datasets 2  

















analyses for GA 
  AOR AOR % Indirect effect OR   AOR AOR % Indirect effect OR 
Preterm birth/gestational age  2.12***      0.88***    
Maternal race/ethnicity, ref = White 1 1     1 1    
Black/African American 2.57*** 2.57** 0.0% 1.03    2.57*** 2.37** -7.8% 1.08  * 
Hispanic 2.23* 2.16* -3.1% 1.05    2.23* 2.00* -10.3% 1.11  * 
Maternal continuous smoking during 
pregnancy 
1.51* 1.46+ -3.3% 1.04    1.51* 1.47+ -2.6% 1.04   
Maternal history of asthma 2.80*** 2.77*** -1.1% 1.04    2.80*** 2.70*** -3.6% 1.07  * 
Preeclampsia 1.35+ 1.02 -24.4% 1.36  ***  1.35+ 0.96 -28.9% 1.42  *** 
Chorioamnionitis 1.94*** 1.65*** -14.9% 1.18  ***  1.94*** 1.38* -28.9% 1.32  *** 
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MICE imputed dataset 3  

















analyses for GA 
  AOR AOR % Indirect effect OR   AOR AOR % Indirect effect OR 
Preterm birth/gestational age  2.11***      0.88***    
Maternal race/ethnicity, ref = White 1 1     1 1    
Black/African American 2.59*** 2.59*** 0.0% 1.03    2.59*** 2.39** -7.7% 1.08  * 
Hispanic 2.27** 2.21* -2.6% 1.06    2.27** 2.03* -10.6% 1.11  * 
Maternal continuous smoking during 
pregnancy 
1.50+ 1.45+ -3.3% 1.04    1.50+ 1.46+ -2.7% 1.04   
Maternal history of asthma 2.78*** 2.75*** -1.1% 1.04    2.78*** 2.69*** -3.2% 1.07  * 
Preeclampsia 1.37+ 1.03 -24.8% 1.36  ***  1.37+ 0.97 -29.2% 1.42  *** 
Chorioamnionitis 1.97*** 1.67*** -15.2% 1.18  ***  1.97*** 1.40* -28.9% 1.32  *** 
MICE imputed dataset 4  

















analyses for GA 
  AOR AOR % Indirect effect OR   AOR AOR % Indirect effect OR 
Preterm birth/gestational age  2.14***      0.88***    
Maternal race/ethnicity, ref = White 1 1     1 1    
Black/African American 2.54** 2.56** 0.8% 1.03    2.54** 2.37** -6.7% 1.08  * 
Hispanic 2.23* 2.18* -2.2% 1.05    2.23* 2.01* -9.9% 1.10  * 
Maternal continuous smoking during 
pregnancy 
1.49+ 1.45+ -2.7% 1.04    1.49+ 1.46+ -2.0% 1.03   
Maternal history of asthma 2.75*** 2.72*** -1.1% 1.04    2.75*** 2.67*** -2.9% 1.06  * 
Preeclampsia 1.35+ 1.01 -25.2% 1.37  ***  1.35+ 0.95 -29.6% 1.43  *** 
Chorioamnionitis 1.84*** 1.57** -14.7% 1.19  ***   1.84*** 1.3 -29.3% 1.34  *** 
Model B: Multivariate logistic regression of asthma on pre- and peri-natal factors and other covariates; Model A: Multivariate logistic regression of asthma on preterm birth 
(PTB, A1) and gestational age of weeks (GA, A2), pre- and peri-natal factors, and other covariates. Abbreviations: AOR: adjusted odds ratio. Definitions of indirect, direct and 
total effects were defined in the methods section. MICE = Multiple Imputation Chained Equations. ref = reference. P-values: + p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001.   
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Table 5-9. Sensitivity Analyses for Additive Interactions of Preterm Birth and Pre- and Peri-natal Factors on Asthma for Children under Age 10 Years 
Pre- and peri-natal factors  




probabilities of asthma   
Differences for preterm 
vs. term children  
Cross-differences for 
preterm vs term children 
p   [95%CI]   p   [95%CI]   p   [95%CI] 
Complete cases analyses (n = 1,984)                
Maternal smoking 
during pregnancy 
Not continuous smoking Term (00) 0.14  ***  0.12  0.16            
 Preterm (01) 0.26  ***  0.23  0.30   0.12  ***  0.08  0.16       
Continuous smoking Term (10) 0.16  ***  0.10  0.21            
  Preterm (11) 0.45  ***  0.36  0.55    0.30  ***  0.19  0.41    0.18  **  0.06  0.29  
Maternal history of 
asthma 
No asthma Term (00) 0.12  ***  0.10  0.14                    
 Preterm (01) 0.25  ***  0.21  0.28   0.13  ***  0.09  0.17       
Yes asthma Term (10) 0.31  ***  0.25  0.37            
  Preterm (11) 0.49  ***  0.40  0.58    0.18  **  0.07  0.29    0.05    -0.07  0.17  
Maternal history of 
allergies 
No allergies Term (00) 0.13  ***  0.11  0.15                    
 Preterm (01) 0.22  ***  0.18  0.26   0.10  ***  0.05  0.14       
Yes allergies Term (10) 0.18  ***  0.15  0.21            
  Preterm (11) 0.39  ***  0.33  0.44    0.21  ***  0.14  0.27    0.11  ** 0.03  0.19  
Chorioamnionitis 
No chorioamnionitis Term (00) 0.13  ***  0.12  0.15                    
 Preterm (01) 0.26  ***  0.23  0.30   0.13  ***  0.09  0.17       
Chorioamnionitis Term (10) 0.22  ***  0.16  0.28            
  Preterm (11) 0.38  ***  0.30  0.45    0.16  *** 0.07  0.26    0.03    -0.07  0.14  
Type of delivery 
Not cesarean section Term (00) 0.14  ***  0.12  0.16            
 Preterm (01) 0.25  ***  0.21  0.29   0.11  ***  0.06  0.16       
Cesarean section Term (10) 0.15  ***  0.12  0.18            
  Preterm (11) 0.33  ***  0.28  0.38    0.18  ***  0.12  0.24    0.07   0.00  0.15  
242 
Pre- and peri-natal factors Model E: with 




probabilities of asthma   
Differences for preterm 
vs. term children  
Cross-differences for 
preterm vs term children 
p   [95%CI]   p   [95%CI]   p   [95%CI] 
All available cases analyses (n = 2,461)                
Maternal smoking 
during pregnancy 
Not continuous smoking Term (00) 0.14  ***  0.12  0.16            
 Preterm (01) 0.27  ***  0.24  0.30   0.13  ***  0.09  0.17       
Continuous smoking Term (10) 0.17  ***  0.12  0.22            
  Preterm (11) 0.43  ***  0.35  0.52    0.27  ***  0.17  0.37    0.14  * 0.03  0.25  
Maternal history of 
asthma 
No asthma Term (00) 0.12  ***  0.10  0.13                    
 Preterm (01) 0.25  ***  0.22  0.28   0.14  ***  0.10  0.17       
Yes asthma Term (10) 0.32  ***  0.26  0.38            
  Preterm (11) 0.49  ***  0.40  0.57    0.17  ***  0.06  0.27    0.03   -0.08  0.14  
Maternal history of 
allergies 
No allergies Term (00) 0.12  ***  0.10  0.14                    
 Preterm (01) 0.23  ***  0.19  0.27   0.11  ***  0.07  0.15       
Yes allergies Term (10) 0.18  ***  0.15  0.21            
  Preterm (11) 0.39  ***  0.34  0.44    0.21  ***  0.15  0.27    0.10  **  0.03  0.17  
Chorioamnionitis 
No chorioamnionitis Term (00) 0.14  ***  0.12  0.15                    
 Preterm (01) 0.26  ***  0.22  0.29   0.12  ***  0.08  0.16       
Chorioamnionitis Term (10) 0.21  ***  0.16  0.27            
  Preterm (11) 0.40  ***  0.33  0.47    0.19  ***  0.10  0.28    0.07   -0.03  0.16  
Type of delivery 
Not cesarean section Term (00) 0.14  ***  0.13  0.16                    
 Preterm (01) 0.25  ***  0.21  0.29   0.11  ***  0.06  0.15       
Cesarean section Term (10) 0.13  ***  0.11  0.16            
  Preterm (11) 0.34  ***  0.29  0.38    0.20  ***  0.15  0.26    0.09  **  0.03  0.16  
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Pre- and peri-natal factors Model E: with 




probabilities of asthma   
Differences for preterm 
vs. term children  
Cross-differences for 
preterm vs term children 
p   [95%CI]   p   [95%CI]   p   [95%CI] 
MICE imputation analyses 1 (n = 2,461)                
Maternal smoking 
during pregnancy 
Not continuous smoking Term (00) 0.14  ***  0.12  0.16            
 Preterm (01) 0.27  ***  0.24  0.30   0.13  ***  0.09  0.17       
Continuous smoking Term (10) 0.17  ***  0.11  0.22            
  Preterm (11) 0.43  ***  0.35  0.52    0.27  ***  0.17  0.37    0.14  *  0.03  0.25  
Maternal history of 
asthma 
No asthma Term (00) 0.12  ***  0.10  0.13                    
 Preterm (01) 0.25  ***  0.22  0.28   0.14  ***  0.10  0.17       
Yes asthma Term (10) 0.32  ***  0.26  0.38            
  Preterm (11) 0.49  ***  0.40  0.57    0.17  ***  0.06  0.27    0.03   -0.08  0.14  
Maternal history of 
allergies 
No allergies Term (00) 0.12  ***  0.10  0.14                    
 Preterm (01) 0.23  ***  0.19  0.27   0.11  ***  0.07  0.15       
Yes allergies Term (10) 0.18  ***  0.15  0.21            
  Preterm (11) 0.39  ***  0.34  0.44    0.21  ***  0.15  0.27    0.10  **  0.03  0.17  
Chorioamnionitis 
No chorioamnionitis Term (00) 0.14  ***  0.12  0.15                    
 Preterm (01) 0.26  ***  0.22  0.29   0.12  ***  0.08  0.16       
Chorioamnionitis Term (10) 0.19  ***  0.14  0.24            
  Preterm (11) 0.41  ***  0.34  0.48    0.22  ***  0.13  0.30    0.09   0.00  0.19  
Type of delivery 
Not cesarean section Term (00) 0.14  ***  0.13  0.16                    
 Preterm (01) 0.25  ***  0.21  0.29   0.11  ***  0.06  0.15       
Cesarean section Term (10) 0.13  ***  0.11  0.16            
  Preterm (11) 0.34  ***  0.29  0.38    0.20  ***  0.15  0.26    0.09  ** 0.02  0.16  
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Pre- and peri-natal factors Model E: with 




probabilities of asthma   
Differences for preterm 
vs. term children  
Cross-differences for 
preterm vs term children 
p   [95%CI]   p   [95%CI]   p   [95%CI] 
MICE imputation analyses 2 (n = 2,461)                
Maternal smoking 
during pregnancy 
Not continuous smoking Term (00) 0.14  ***  0.12  0.16            
 Preterm (01) 0.27  ***  0.24  0.30   0.13  ***  0.09  0.17       
Continuous smoking Term (10) 0.17  ***  0.11  0.22            
  Preterm (11) 0.43  ***  0.35  0.52    0.27  ***  0.17  0.37    0.14  *  0.03  0.25  
Maternal history of 
asthma 
No asthma Term (00) 0.12  ***  0.10  0.13                    
 Preterm (01) 0.25  ***  0.22  0.28   0.14  ***  0.10  0.17       
Yes asthma Term (10) 0.32  ***  0.26  0.38            
  Preterm (11) 0.49  ***  0.40  0.57    0.17  ***  0.06  0.27    0.03    -0.08  0.14  
Maternal history of 
allergies 
No allergies Term (00) 0.12  ***  0.10  0.14                    
 Preterm (01) 0.23  ***  0.19  0.27   0.11  ***  0.07  0.15       
Had allergies Term (10) 0.18  ***  0.15  0.21            
  Preterm (11) 0.39  ***  0.34  0.44    0.21  ***  0.15  0.27    0.10  ** 0.03  0.17  
Chorioamnionitis 
No chorioamnionitis Term (00) 0.14  ***  0.12  0.15                    
 Preterm (01) 0.26  ***  0.22  0.29   0.12  ***  0.09  0.16       
Chorioamnionitis Term (10) 0.19  ***  0.14  0.24            
  Preterm (11) 0.40  ***  0.33  0.46    0.21  ***  0.12  0.29    0.08   -0.01  0.18  
Type of delivery 
Not cesarean section Term (00) 0.14  ***  0.13  0.16                    
 Preterm (01) 0.25  ***  0.21  0.29   0.11  ***  0.06  0.15       
Cesarean section Term (10) 0.13  ***  0.11  0.16            
  Preterm (11) 0.34  ***  0.29  0.38    0.20  ***  0.15  0.26    0.09  ** 0.02  0.16  
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Pre- and peri-natal factors Model E: with 




probabilities of asthma   
Differences for preterm 
vs. term children  
Cross-differences for 
preterm vs term children 
p   [95%CI]   p   [95%CI]   p   [95%CI] 
MICE imputation analyses 3 (n = 2,461)                
Maternal smoking 
during pregnancy 
Not continuous smoking Term (00) 0.14  ***  0.12  0.16            
 Preterm (01) 0.27  ***  0.24  0.30   0.13  ***  0.09  0.17       
Continuous smoking Term (10) 0.17  ***  0.11  0.22            
  Preterm (11) 0.43  ***  0.35  0.52    0.27  ***  0.17  0.37    0.14  *  0.03  0.25  
Maternal history of 
asthma 
No asthma Term (00) 0.12  ***  0.10  0.13                    
 Preterm (01) 0.25  ***  0.22  0.28   0.14  ***  0.10  0.17       
Yes asthma Term (10) 0.32  ***  0.26  0.38            
  Preterm (11) 0.49  ***  0.40  0.57    0.17  ***  0.06  0.27    0.03    -0.08  0.14  
Maternal history of 
allergies 
No allergies Term (00) 0.12  ***  0.10  0.14                    
 Preterm (01) 0.23  ***  0.19  0.27   0.11  ***  0.07  0.15       
Yes allergies Term (10) 0.18  ***  0.15  0.21            
  Preterm (11) 0.39  ***  0.34  0.44    0.21  ***  0.15  0.27    0.10  ** 0.03  0.17  
Chorioamnionitis 
No chorioamnionitis Term (00) 0.14  ***  0.12  0.15                    
 Preterm (01) 0.26  ***  0.22  0.29   0.12  ***  0.09  0.16       
Chorioamnionitis Term (10) 0.19  ***  0.14  0.24            
  Preterm (11) 0.40  ***  0.33  0.47    0.21  ***  0.12  0.29    0.09   -0.01  0.18  
Type of delivery 
Not cesarean section Term (00) 0.14  ***  0.13  0.16                    
 Preterm (01) 0.25  ***  0.21  0.29   0.11  ***  0.06  0.15       
Cesarean section Term (10) 0.13  ***  0.11  0.16            
  Preterm (11) 0.34  ***  0.29  0.38    0.20  ***  0.15  0.26    0.09  ** 0.02  0.16  
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Pre- and peri-natal factors Model E: with 




probabilities of asthma    
Differences for preterm 
vs. term children   
Cross-differences for 
preterm vs term children 
p   [95%CI]   p   [95%CI]   p   [95%CI] 
MICE imputation analyses 4 (n = 2,461)                             
Maternal smoking 
during pregnancy 
Not continuous smoking Term (00) 0.14  ***  0.12  0.16            
 Preterm (01) 0.27  ***  0.24  0.30   0.13  ***  0.09  0.17       
Continuous smoking Term (10) 0.17  ***  0.11  0.22            
  Preterm (11) 0.43  ***  0.35  0.52    0.27  ***  0.17  0.37    0.14  *  0.03  0.25  
Maternal history of 
asthma 
No asthma Term (00) 0.12  ***  0.10  0.13             
 Preterm (01) 0.25  ***  0.22  0.28   0.14  ***  0.10  0.17       
Yes asthma Term (10) 0.32  ***  0.26  0.38            
  Preterm (11) 0.49  ***  0.40  0.57    0.17  ***  0.06  0.27    0.03    -0.08  0.14  
Maternal history of 
allergies 
No allergies Term (00) 0.12  ***  0.10  0.14                    
 Preterm (01) 0.23  ***  0.19  0.27   0.11  ***  0.07  0.15       
Yes allergies Term (10) 0.18  ***  0.15  0.21            
  Preterm (11) 0.39  ***  0.34  0.44    0.21  ***  0.15  0.27    0.10  ** 0.03  0.17  
Chorioamnionitis 
No chorioamnionitis Term (00) 0.13  ***  0.12  0.15                    
 Preterm (01) 0.26  ***  0.23  0.30   0.13  ***  0.09  0.16       
Chorioamnionitis Term (10) 0.19  ***  0.14  0.24            
  Preterm (11) 0.39  ***  0.32  0.46    0.20  ***  0.11  0.28    0.07   -0.02  0.17  
Type of delivery 
Not cesarean section Term (00) 0.14  ***  0.13  0.16                    
 Preterm (01) 0.25  ***  0.21  0.29   0.11  ***  0.06  0.15       
Cesarean section Term (10) 0.13  ***  0.11  0.16            
  Preterm (11) 0.34  ***  0.29  0.38    0.20  ***  0.15  0.26    0.09  ** 0.02  0.16  
All the odds ratios and predicted marginal probabilities of asthma were estimated using Model E series: multivariate logistic regression of asthma on pre- and peri-natal 
factors and their interaction terms with preterm birth each at a time, adjusting for other covariates. AOR: adjusted odds ratio. CI: confidence interval. p = probability. Cross 















Preterm Birth and Longitudinal Patterns of Childhood Asthma in the 




Background: Asthma is a syndrome with varied onset and duration over childhood. 
Longitudinal patterns (phenotypes) of wheezing (a common symptom of asthma) 
defined by time course have been identified in survey data. Whether these 
longitudinal patterns can be characterized using both asthma and wheezing 
diagnoses in electronic medical record (EMR) data is unknown. Furthermore, 
whether the association between preterm birth and asthma varies by longitudinal 
patterns of asthma has not been well-studied. 
Objectives: To define longitudinal patterns of childhood asthma (“childhood asthma 
patterns” for short) using physician diagnoses of asthma and wheezing in EMR data, 
and to examine whether these longitudinal patterns of childhood asthma vary 
between children born term and preterm. 
Design and Participants: The analytic sample included 550 children from the Boston 
Birth Cohort who had repeated EMR data at different ages from birth to age 6 years 
during the period from October 2003 to September 2013. 
Measures and Analyses: Childhood asthma was measured at each age, defined by 
having at least one diagnosis of asthma (International Classification of Diseases, 
Ninth Revision [ICD-9]: 493) or wheezing (ICD-9: 786.07) at that age. Childhood 
asthma patterns were defined using two approaches: (1) applying the original and 
modified classification rules from the Tucson Children’s Respiratory Study (TCRS); (2) 
applying longitudinal latent class analysis (LLCA). Multinomial logistic regression 
analysis and Latent Class Regression (LCR) were used to assess the associations 
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between preterm birth and the childhood asthma patterns identified by the TCRS 
and LLCA approaches, respectively, adjusting for pertinent covariates. 
Results: For childhood asthma patterns defined by the modified TCRS rules, children 
born preterm were more likely to have persistent asthma (22.4% vs. 6.9%, adjusted 
odds ratio [AOR] = 4.20, p < 0.001) and transient early asthma (16.0% vs. 10.2%, AOR 
= 2.07, p < 0.05), and no more likely to have late-onset asthma, middle-onset asthma, 
or transient middle asthma compared to children born term. Associations using the 
original TCRS rules showed the same results, though with slightly attenuated odds 
ratios. For childhood asthma patterns defined by a 4-class LLCA, children born 
preterm were more likely to have persistent asthma (10% vs. 2%, AOR = 8.52, p < 
0.001) and middle-onset asthma (15% vs. 6%, AOR = 3.64, p < 0.001), but no more 
likely to have late-onset asthma compared to children born term. 
Conclusions: Longitudinal patterns of childhood asthma can be identified by the 
TCRS rules (both original and modified), and by the LLCA approach using physician 
diagnoses of asthma and wheezing documented in the EMR. Preterm birth is 
significantly associated with persistent childhood asthma defined by both methods, 
with transient early asthma by the TCRS rules, and with middle-onset asthma by the 
LLCA approach only. Preterm birth is not significantly associated with asthma 
between ages 3-5 years and asthma occurring at age 6 years. 
 
Key words: preterm birth, longitudinal patterns of childhood asthma, latent class 




6.2.1 Longitudinal Patterns of Childhood Asthma 
Childhood asthma is a heterogeneous disease with varied onset and duration 
during the first decade of life.1 Longitudinal patterns of childhood asthma (also called 
“asthma phenotypes” in the literature5; here will be called “childhood asthma 
patterns”) have been described in several birth cohort studies1,2 using parent’s 
reports about the age of onset and duration of wheezing symptoms. Wheezing is a 
common symptom of asthma and often used to study childhood asthma3,4 due to the 
difficulty of obtaining reliable asthma diagnoses in the first 6 years of life,5 and the 
predictive power of early wheezing (ages 1 to 3 years) for school age asthma (ages 6 
to 9 years).6,7 These studies found that different childhood asthma patterns are 
associated with different clinical manifestations, risk factors, and potential etiological 
mechanisms.8 
Martinez et al. introduced a 4-pattern classification rule for wheezing based on 
the Tucson Children’s Respiratory Study (TCRS).9 The TCRS wheezing patterns are: 
early transient, late-onset, persistent, and no wheezing, defined by the occurrence of 
wheezing symptoms between ages 0-2 years and at age 6 years.9 They have also 
found that, compared with non-wheezing children, those with early transient 
wheezing were more likely to have mothers who smoked but not mothers with 
history of asthma, while those with persistent wheezing were more likely to be atopic 
and have mothers with history of asthma.9 The TCRS classification rules only consider 
wheezing symptoms at two time points (first 3 years and age 6 years) and do not 
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consider ages 3-5 years. Thus, some potentially distinct longitudinal patterns, such as 
a pattern of wheezing symptoms only between ages 3-5 years are not included. 
Recent cohort studies have used longitudinal latent class analysis (LLCA)10-13 to 
identify asthma patterns. This approach is more data-driven than the TCRS approach, 
as it summarized the patterns found in the data. Results from these LLCA studies 
have not only confirmed the TCRS pattern with some variations, but have also 
discovered novel patterns.11,14 Whether these longitudinal patterns, which are based 
on measures of wheezing, are the same as would be found using measures of 
asthma, such as a physician diagnosis of asthma, is unknown. 
6.2.2 Preterm Birth and Longitudinal Patterns of Childhood Asthma 
Previous studies3,15 including my own research already presented in this 
dissertation, have found that preterm term birth (live births at less than 37 
completed weeks of gestation16) is associated with increased risk of childhood 
asthma (including recurrent wheezing and asthma).3,17 However, it remains unclear 
whether preterm birth contributes differently to various longitudinal patterns of 
childhood asthma defined by repeated measures of asthma diagnoses. 
Given that preterm birth affects lung structure and function and increases 
susceptibility to postnatal viral and bacterial infections and environmental insults,16 a 
natural hypothesis is that preterm birth is most strongly associated with childhood 
asthma patterns that feature early onset and long duration. Distinguishing various 
longitudinal patterns of childhood asthma and their associations with preterm birth 




Only one study has examined the relationship between prematurity and 
wheezing patterns. It found a significant association between gestational age at birth 
and transient early wheezing, based on the data from the Prevention and Incidence 
of Asthma and Mite Allergy (PIAMA) birth cohort in Netherlands.13 But the cohort 
was not ideal for this purpose, as the average gestational age is high (about 40 
weeks) and the preterm birth rate is low (4.7%), and the even lower for early preterm 
birth (< 28 weeks).18 These features of the cohort may have limited the ability to 
detect the impact of preterm birth. 
The aim of this manuscript is to establish the relationship between preterm 
birth and longitudinal patterns of childhood asthma. I will address this important 
research gap by (1) characterizing longitudinal patterns of childhood asthma using 
both the TCRS classification and statistical modeling, and (2) determining whether 
these longitudinal patterns vary between children born preterm ad children born 
term. 
6.3 Methods 
6.3.1 Data and Sample 
This manuscript used data from the Boston Birth Cohort (BBC), a prospective 
cohort drawn from an urban, poor, multiethnic patient population. Since 1998, the 
BBC has recruited mother-infant pairs who delivered at the Boston Medical Center 
(BMC), collecting data using maternal questionnaire interviews and medical record 
abstraction. A subset of the BBC children who continued to receive pediatric care at 
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BMC were followed prospectively. For the followed children, electronic medical 
records (EMR) of all sick and well pediatric visits from birth to at least 6 years during 
the period of October of 2003 to September of 2013 were obtained. The cohort and 
the data collection protocols are described in depth in Chapter 3 and in multiple 
publications.19-21 The study was approved by appropriate institutional review boards. 
Among the 2,701 children being followed in the BBC, this manuscript only 
included those who had EMR data available from birth (i.e., were born after October 
2003) to at least age 6 years. Thus, the analytic sample for this manuscript was 
narrowed to 550 children, after excluding 35 children born post-term (≥ 42 weeks of 
gestation), 126 children with no questionnaire data for major covariates due to 
uncompleted data entry or non-response, 567 children born before October of 2003, 
and 1,423 children born after October of 2003 but not followed to at least age 6 
years. 
6.3.2 Measures 
Childhood asthma was defined by a diagnosis of asthma (ICD9-CM: 493.xx) or 
wheezing (ICD9-CM: 786.07) in the EMR between ages 0-6 years. These diagnoses 
were not obtained at a set of fixed time points for each child, because they were 
records of clinic visits. To obtain a dataset consisting of repeated binary measures of 
childhood asthma at comparable time points, the diagnoses data were recoded to 
correspond to year of age. Thus a set of variables Yij were created for each child, 
where i = the ith child, j = age 0,1,2,3,4,5,6. Age was calculated from dates of birth 
and clinic visits so that age 0 = 0~11.99 months, age 1 = 12.00~23.99 months … age 6 
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= 72.00~83.99 months). For each binary measure of childhood asthma, Yij =1 
indicated that the ith child had at least one diagnosis of asthma or wheezing at age j, 
and Yij = 0 indicated that the ith child had neither a diagnosis of asthma nor a 
diagnosis wheezing at age j. Since the repeated measures Yij combined diagnoses of 
asthma and wheezing, naming them appropriately was challenging. To be concise 
and to emphasize the clinical nature of the measures, Yij was labelled as childhood 
asthma or asthma for short. 
Asthma and wheezing diagnoses were both used to detect childhood asthma 
between ages 0-6 years for two reasons. First, while an asthma diagnosis is a strong 
indicator for having an asthma episode in childhood; wheezing is the key symptom 
for diagnosing asthma among children under age 6 years.22,23 About 50% of children 
who had wheezed persisted to age 6 years9,24 and recurrent wheezing in first three 
years strongly predicts asthma at age 6 years or older.6 Although wheezing may be a 
symptom or precursor of other diseases,25 it is still used widely in studies focused on 
association3 and prevalence4 to indicate a risk of asthma in early childhood. 
Second, according to the prevalence of asthma and wheezing diagnoses by age 
(Figure 6-1), the probability of a diagnoses of asthma increases with age (Figure 6-
1b), while the probability of a diagnoses of wheezing decreases with age (Figure 6-
1c). In contrast, measures using both asthma and wheezing showed a stable age 
pattern (Figure 6-1a), which was similar to the trend for asthma diagnoses. The 
distinct trends of asthma and wheezing diagnoses by age partially reflect the clinical 
terms that physicians were trained to use. Due to the difficulty of performing valid 
255 
 
clinical checks in young children to confirm airflow limitation and inflammation,5 
physicians are advised to label a child under age 3 years with “asthma” with 
caution.22,26 So a true asthma case confirmed later could be diagnosed as wheezing 
at early ages and vice versa. In sum, diagnoses of asthma and wheezing each 
captured some non-overlapped information to indicate the risk of childhood asthma. 
Measures solely based on diagnoses of wheezing or asthma might be biased due to 
time dependent manifestation and diagnosing guidelines for young children, which 
would bias the data patterns towards transient wheezing or late-onset asthma. 
After recoding the diagnoses data, 72.4% (n = 398) of children had no missing 
values at any ages, i.e. had yearly visits to BMC. The missing rates for the repeated 
measures of childhood asthma ranged from 0% to 12.6% by ages. These missing 
values meant that there were no EMR data showing that the child paid any visits to 
the BMC during the index age. Missingness analyses showed that the missing are 
likely to be “not missing at random” (NMAR),27,28 which means they are due to 
unobserved variables. For example, in this dataset, very healthy children who were 
not sick might not visit the BMC for a long time. 
To address the problem of missing data, missing values for childhood asthma 
were assigned a negative diagnoses of asthma or wheezing (i.e. Yij = 0). Sensitivity 
analyses were performed to test whether this decision affected the substantive 
results. 
Preterm birth was defined as a live birth at less than 37 complete weeks of 
gestational age, and term birth was defined as a live birth at 37-41 weeks of 
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gestational age, following guidelines from the American College of Obstetricians and 
Gynecologists Committee (ACOG).29 Gestational age was obtained from medical 
record abstraction, and defined by an widely used algorithm30 of early prenatal (< 20 
weeks) ultrasound and the first day of the last menstrual period.19 
Other covariates included in these analyses were child sex and maternal 
characteristics, including age, race/ethnicity, history of asthma, history of allergies, 
and continuous smoking during the index pregnancy. Other variables were not 
included in the association analyses due to insignificant effects in bivariate analyses, 
but included for missing value analyses, such as child birth year and season, duration 
of follow-up in the BBC, maternal marital status and education, low household 
income, and family member smoking. 
6.3.3 Data Analysis 
First, the age-specific prevalences of childhood asthma were compared across 
preterm birth status. Age-specific proportions with 95% confidence intervals were 
estimated for childhood asthma, asthma diagnosis, and wheezing diagnosis, 
respectively. Kaplan-Meier survival probabilities for no diagnosis by age were 
estimated, with and without adjusting for covariates, for the above three outcome 
measures. 
Second, based on the repeated measures of asthma, longitudinal patterns of 
childhood asthma were identified using two approaches: the Tucson Children’s 
Respiratory Study (TCRS) classification rules9 and Longitudinal Latent Class Analysis 
(LLCA).31 The original TCRS rules9 grouped children into four longitudinal patterns by 
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their history of wheezing in the first three years of life (ages 0-2) and at age 6: 
children with no asthma at either ages 0-2 years or age 6 years were assigned to the 
“never asthma” pattern; children with positive asthma at ages 0-2 but not at age 6 
were labelled “transient early asthma”; children with no asthma at ages 0-2 but 
positive asthma at age 6 were labeled “late-onset asthma”; and children with 
positive asthma at both ages 0-2 and age 6 were labeled “persistent asthma”. 
Because I had data for ages 3-5 years, I updated the original TCRS rules by 
incorporating diagnoses during ages 3-5 years. My modification added two patterns: 
5) no asthma/wheezing diagnoses between ages 0 and 2 but diagnoses between 
ages 3 and 5 and at age 6 (middle onset asthma/wheezing); 6) no asthma/wheezing 
diagnoses between ages 0 and 2, diagnoses between ages 3 and 5 but no diagnosis 
at age 6 (late onset asthma/wheezing) Classification criteria for the original and the 
modified TCRS rules are summarized in Table 6-2.Longitudinal patterns of childhood 
asthma were also identified by applying Longitudinal Latent Class Analysis31 on the 
repeated measures of asthma. LLCA is a kind of latent class analysis (LCA)32 applied to 
longitudinal data of repeated measures, which is also referred to as repeated-
measures LCA (RMLCA).31 Assuming that the population of children under 7 years of 
age comprises a set of discrete subpopulations characterized by unique age-specific 
patterns of asthma LLCA estimates the number of longitudinal patterns of asthma 
(“classes”), the prevalence of each pattern, and the proportion of children with 
asthma at each age within each pattern (“conditional probabilities”). 
The number of classes that best fit the was determined by comparing a series of 
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goodness-of-fit measures for models with various numbers of classes: (1) Pearson’s 
chi-square,32 to assess whether the model predicts the observed age patterns of 
asthma accurately(2) entropy,33 an indicator for assessment of model classification 
on classes (above 0.8 is considered good); (3) standardized (STD) residuals, which 
compare the observed asthma patterns with the modeled asthma patterns (not more 
than 1.96 is preferred)34; (4) the Akaike information criterion (AIC)35 and Bayesian 
information criterion (BIC),36 two measures of model efficiency, that is higher 
likelihoods with fewer parameters;37,38 (5) Vuong-Lo-Mendell-Rubin likelihood ratio 
test (VLRT)39 and bootstrapped likelihood ratio test (BLRT), two tests to check the 
fitness of a model of the k-class version compared to the k-1 class version based on 
log-likelihoods. (6) Bootstrapped likelihood ratio test (BLRT),40 assessment of fit for a 
model with k classes compared to a model with k-1 classes, with distribution derived 
from bootstrapping with at least 500 random samples from the original dataset. BLRT 
was used as one of the key selection criteria, as a simulation study suggested that 
BLRT out-performed all other measures.38 In addition, a priori theories (e.g. patterns 
reported by other studies) and small group size (n < 25) were also considered when 
selecting the final model of k latent classes. 
Third, differences in longitudinal patterns of childhood asthma patterns across 
preterm birth status (preterm vs. term) were evaluated. The relationship between 
longitudinal patterns defined by the TCRS rules and preterm birth status was tested 
by chi-square test not adjusting for covariates, and then by multinomial logistic 
regression adjusting for covariates, including child sex and maternal characteristics 
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(race/ethnicity, history of asthma, history of allergies, smoking during the index 
pregnancy). 
For childhood asthma patterns defined by LLCA, three model characteristics 
were sequentially evaluated to check if the k class model identified for all children 
was appropriate for both preterm and term children: (i) whether the number of 
classes (k) that fit the data best was the same for both preterm and term children; (ii) 
whether the age-specific probabilities (πrk) of asthma for a given class (k) and age (r-
1) were the same across subpopulations (“measurement invariance”41);(iii) whether 
the class prevalence (ηk) for a class (k) were the same across subpopulations, i.e. 
whether the distributions of the k classes were the same across subpopulations. 
For aspect (i), the same set of procedures and goodness-of-fit measures from 
step two were used to identify the appropriate number of classes for preterm and 
term children. For aspects (ii) and (iii), multiple-group LCA41,42 was used. Multiple-
group LCA expands LCA by adding a grouping variable for subpopulations (in this 
study, two groups: preterm vs term) to the model, and estimating patterns for k 
latent classes for each group (k*2 classes in this study) instead of k classes as in 
single-group LCA. 
For aspect (ii), measurement invariance41 was tested by the likelihood ratio test 
for two nested multiple-group LCA models: Model C allowing age-specific 
probabilities of asthma vary across preterm birth status vs. Model D constraining 
age-specific probabilities of asthma to be equal across preterm birth status. If Model 
D performs not significantly worse than Model C, measurement invariance across 
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groups holds and the k class LLCA model is appropriate for both preterm and term 
children. 
The test for aspect (iii) was another likelihood ratio test for two nested multiple-
group LCA models: Model D constraining age-specific probabilities of asthma to be 
equal across preterm birth status but allowing latent class prevalences to vary across 
preterm birth status vs. Model E constraining both age-specific probabilities and 
latent class prevalences to be equal across preterm birth status. If Model E performs 
not significantly worse than Model D, equivalence of latent class prevalences holds 
and suggests that the k classes are distributed the same across preterm birth status. 
Finally, latent class regression (LCR)43 was conducted to determine the 
association between preterm birth and different longitudinal patterns of childhood 
asthma, adjusting for the same covariates mentioned above. LCR expands the scope 
of LCA to incorporate covariates in models with the assumption that, within each 
longitudinal pattern of asthma, covariates are not associated with age-specific 
probabilities of asthma. LCR fitted the measurement model (i.e. LCA) and the 
association model (i.e. multinomial logistic regression) simultaneously, and reported 
two types of results: (i) characteristics of k asthma patterns, and (ii) association 
between preterm birth and the k asthma patterns. A global test for the overall effect 
of each variable on childhood asthma was performed using a likelihood ratio test of 
nested models. Sensitivity analyses for differences in the treatment of missing values 
of asthma were performed for the LCR as described in Chapter 3. 
All data management and analyses were done using STATA 12.0 statistical 
261 
 
analysis software (College Station, TX), except for latent analyses. LLCA, multi-group 
LCA, and LCR were performed using Mplus 7 statistical software (Los Angeles, CA). All 
latent analyses were fitted with at least 100 random starts to increase stability and 
avoid local maxima. Each model was checked for potential local maxima and refitted 
with up to 1000 random starts to improve model fitting. 
6.4 Results 
Table 6-1 summarizes the frequencies and proportions of covariates for the total 
sample and by preterm birth status. For the total sample (n = 550), proportions of 
asthma increased from 11.3% at the first year to 17.6% at ages 5 and 6 years; and 
28.4% (n = 156) the children were born at preterm birth. Chi-square test results 
showed that preterm children were significantly more likely to have mothers with 
histories of asthma and allergies, but not significantly different on sex, maternal race, 
or maternal continuous smoking during pregnancy. 
6.4.1 Descriptive Analyses of Childhood Asthma for Preterm and Term Children 
Figure 6-1 presents the proportions of children with childhood asthma (asthma 
or wheezing diagnoses, panel a), with asthma diagnoses only (panel b), and wheezing 
diagnoses only (panel c) at each age for preterm and term children. As shown in 
Figure 6-1a, the age specific proportions with childhood asthma are significantly 
higher for preterm children compared with term children at all ages in the first 7 
years of life. This pattern is also true for diagnoses of asthma (Figure 6-1b). These 
results suggested that the disparities in childhood asthma between term and 
preterm children occurred in the first year of life and persisted to age 6 years. 
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Figure 6-2 summarizes the results of unadjusted and adjusted Kaplan-Meier 
estimates of childhood asthma by preterm birth status. The proportion without a first 
diagnosis of childhood asthma decreased significantly faster for preterm children 
compared with term children in unadjusted analysis, as measured by childhood 
asthma (asthma or wheezing diagnoses), only asthma diagnoses, and only wheezing 
diagnoses (Figure 6-2, panel a1, b1, c1). This pattern was sustained when the 
proportions were adjusted for child sex and maternal characteristics (Figure 6-2, 
panel a2, b2, c2). These results suggested that, on average, preterm children had an 
earlier age of onset of childhood asthma and wheezing when compared with term 
children. 
6.4.2 Childhood Asthma Patterns Identified by TCRS Rules and by Longitudinal 
Latent Class Analysis 
Table 6-2 presents the distribution of asthma patterns defined by the original 
and modified TCRS rules. In addition to the original categories —“transient early 
asthma”, “persistent asthma”, late-onset asthma“, and “no asthma”, two new 
longitudinal patterns were identified and added to form the modified TCRS rules: 
“middle-onset asthma” (children had positive asthma in both ages 3-5 and age 6 but 
not during ages 0-2), and “transient middle asthma” (children only had asthma at 
ages 3-5 years). The original TCRS patterns assigned transient middle asthma by the 
modified rules (4.4% of the sample) to the no asthma pattern, and assigned middle-
onset asthma by the modified rules (3.8% of the sample) as late-onset asthma. These 
results suggested that the modified TCRS rules improve the classification by 
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differentiating distinct patterns which were grouped together by the original TCRS 
rules. 
The top section of Table 6-3 summarizes the model fitting statistics for LLCA 
with different numbers of classes for the total sample. Out of the 128 possible 
combinations of the 7 repeated measures for asthma, 63 combinations were 
observed. Overall, the goodness-of-fit statistics suggested that a 3-class model, a 4-
class model, and a 5-class model were the best fits to the data. The 4 class model 
was selected as the primary model for the following reasons: (1) the results from 
BLRT, the most recommended criterion38 for model fit, was not reliable for the 5-
class model and similar for the 3 and 4 classes models; (2) the 4-class model 
performed slightly better on predicting the observed combinations of asthma 
measures (smaller STD residual) than both the 3 and 5 class models, and was good 
enough for classification of the classes (higher entropy); (3) values of BIC favored the 
3 and 4 classes models, while AIC favored the 4 and 5 classes models; (4) the LMR 
likelihood ratio test suggested that the 4-class model fit the observed data slightly 
better than the 3-class model; (5) the 5-class model identified a class with small size 
(class 1 on Figure 6-3(b), 4%, n = 21), which made the model fitting for multiple-
group LCA and LCR hard; (6) the 4-class model identified an extra latent class of 
asthma compared with a 3-class model. However, the 5-class model identified an 
additional childhood asthma pattern --“transient early asthma”, which was often 
reported from studies focused on wheezing.10,11 Therefore, the 5-class model was 
also reported and used as a secondary model in following analyses. 
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Table 6-4 summarizes the estimated prevalence of the asthma patterns (classes) 
and the age-specific probabilities of asthma within each pattern (conditional 
probabilities, noted as “π”, SE is the Standard Error of π) from the four-class LLCA 
model. The four longitudinal patterns of childhood asthma were labelled according 
to the age-specific probabilities of having asthma. Class 1 was labelled “Middle-onset 
asthma”, as the probabilities of asthma were low in the first year but increased to a 
high level during age 1 to 2 years and remained high until age 6. Class 2 was labelled 
“Never asthma”, as the probabilities of asthma were close to 0 for all ages. Class 3 
was labelled “Persistent asthma”, as the probabilities of asthma were high and close 
to 1 for all ages. Class 4 was labelled “late-onset asthma”, as the probabilities of 
asthma were relatively low before age 5 and higher after age 5. Among all children, 
7% were middle-onset asthma, 5% persistent asthma, 14% late-onset asthma, and 
74% were never asthma. 
Figure 6-3 compares the prevalences of the asthma patterns and the age-
specific probabilities of asthma for each class for a 2-class (Figure 6-3a), a 3-class 
(Figure 6-3b), a 4-class (Figure 6-3c) and a 5-class model (Figure 6-3d). For the 5-class 
model, the additional identified class was labelled “Transient early asthma”, as the 
probabilities of asthma gradually decreased from moderate to 0. Sensitivity analysis 
on a sub-sample of children with annual pediatric visits (complete case analysis) 
confirmed the age trend (Figure 6-5) and longitudinal patterns of asthma (Table 6-12 
& Figure 6-6) in the first 7 years of life, with some slight variations in the age-specific 
probabilities of asthma. However, in the complete case analysis, the prevalences of 
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late-onset, middle-onset, and persistent asthma were inflated up to 2%, but the 
prevalence of transient early asthma decreased by 4%. This showed that, without 
imputation, the LLCA results might be biased towards asthma patterns with later 
onset and longer duration. 
Table 6-5 shows the cross-tabulations of the 4 and 5 class longitudinal patterns 
of childhood asthma identified by LLCA (assigned by most likely membership) and the 
TCRS asthma patterns. This table illustrates the differences between the asthma 
patterns defined by these two approaches. For example, many children of late-onset 
asthma defined by LLCA were assigned to other asthma patterns defined by the TCRS 
rules. 
6.4.3 Association between Preterm Birth and Longitudinal Patterns of Childhood 
Asthma Defined by TCRS Rules 
Table 6-6 presents the distributions of asthma patterns as defined by the two 
TCRS rules, for preterm and term born children, and results of Chi-square test of 
difference. When using the original TCRS rules (the top half of Table 6), preterm 
children had higher risks of transient early asthma (16.0% vs. 10.2%), late-onset 
asthma (7.1% > 6.1%), persistent asthma (22.4% > 6.9%), and a lower risk of never 
asthma (54.5% < 76.9%), Compared with term children as compared with term 
children (Chi-square = 35.46, df = 3, p < 0.001). Defined by the modified TCRS rules 
(the bottom half of Table 6), preterm children not only had a lower risk of never 
asthma (50.6% < 72.3%), but also lower risks of late-onset asthma (1.9% < 2.8%) and 
transient middle asthma (3.8% < 4.6%) compared with term children (Chi-square = 
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36.73, df = 5, p < 0.001). 
Table 6-7 presents multinomial regression analyses of the asthma patterns 
identified by the original TCRS rules (Model A) and the modified TCRS rules (Model 
B). Model A (the top half of Table 6-7) showed that preterm birth was associated 
with 4 times higher odds of having persistent asthma (p < 0.001), and 2 times higher 
odds of having transient early asthma (p < 0.05), and 1.5 times higher odds of having 
late-onset asthma (p = 0.311) than never asthma adjusting for covariates. Model B 
(the bottom half of Table 6-7) showed that the estimated Adjusted Odds Ratios (AOR) 
of having persistent and transient early asthma defined by the modified TCRS rules 
were similar to the results based on the original TCRS rules (Model A). In addition, 
when using the modified TCRS rules (Model B), preterm birth was associated with 2 
times higher odds of middle-onset asthma (p = 0.140), but not increased odds of 
transient middle and late-onset asthma (p = 0.789) or persistent asthma (p = 0.879). 
Results of global tests from broth models supported the overall effects of preterm 
birth, male sex, and maternal history of asthma on childhood asthma patterns other 
than never asthma. 
6.4.4 Association between Preterm Birth and Longitudinal Patterns of Childhood 
Asthma Defined by Longitudinal Latent Class Analysis 
The middle and bottom sections of Table 6-3 summarize the goodness-of-fit 
statistics for LLCA models with different numbers of classes, separately for preterm 
and term children. The AIC and BLRT statistics consistently suggested that the 4-class 
model of childhood asthma was best supported for both preterm and term children. 
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Thus, 4-class model was chosen as the primary model to compare over preterm birth 
status, while 5-class models were included as secondary model, to be paralleling the 
secondary model for all children mentioned above. 
Figure 6-4 presents the prevalences of the asthma patterns and the age-specific 
probabilities of asthma within each class for the 4-class model (Figure 6-4a&b) and 
the 5-class model (Figure 6-4c&d) for term and preterm children. For the 4-class 
models, the class of transient early asthma showed up only among term children 
(Figure 6-4a), while the class of middle-onset asthma showed up only among 
preterm children (Figure 6-4b). For the 5-class models, all five asthma patterns 
identified were identified in both term children (Figure 6-4c) and preterm children 
(Figure 6-4d), but with many variations in the age-specific probabilities of asthma. 
These exploratory analyses suggested that the structure of the latent classes might 
be not identical across preterm birth status. 
Table 6-8 and 6-9 summarize the multiple-group LCA models that tested 
whether the 4-class models were the same across preterm birth status. As shown in 
Table 6-8, the likelihood ratio tests for nested Model D vs. Model C favored Model D 
and supported the assumption of measurement invariance, meaning that the age-
specific probabilities of asthma could be identical across preterm birth status. As 
shown in Table 6-9, likelihood ratio tests for nested Model E vs. Model D also favored 
Model D and failed to support equivalent latent class prevalences, meaning that the 
prevalences of asthma patterns (classes) were significantly different across preterm 
birth status. Under the 5-class hypothesis, the two-group LCA for Models D and E did 
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not converged appropriately, so the relevant confirmatory analyses were not 
conducted. However, lack of convergence suggests that the 5-class model was not 
the best fitting model. In sum, the results of these confirmatory analyses supported 
using a four-class model (four longitudinal asthma patterns) in the LCR for 
investigating the relationship between preterm birth and longitudinal patterns of 
asthma. 
Table 6-10 presents the estimated prevalences of the asthma patterns from 
Model D, which assumes the age-specific probabilities of asthma are the same within 
classes across preterm birth status. It showed that preterm children had higher risks 
of overall childhood asthma (44% > 21%) and longitudinal asthma patterns (late-
onset asthma, 19% > 13%; persistent asthma, 10% > 2%; middle-onset asthma, 15% > 
6%), compared with term children. 
Table 6-11 presents the LCR analyses. The LCR for four asthma patterns (the top 
half of Table 6-11, Model F) showed that preterm birth was associated with an 8.5 
times higher odds of persistent asthma (p < 0.001), and about 3.6 times higher odds 
of middle-onset asthma (p < 0.001), and about 1.7 times higher odds of late-onset 
asthma (p = 0.198). The LCR for five asthma patterns (the bottom half of Table 6-11, 
Model G) found similar AOR for preterm birth as the LCR for four asthma patterns, 
and showed that preterm birth was associated with 3 times higher odds of transient 
early asthma (p = 0.007). Results of global tests from models supported the overall 
significant effects of preterm birth, male sex, and maternal history of asthma on 
having any pattern of asthma other than never asthma. 
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Sensitivity analyses for associations using LCR are summarized in Table 6-13, 6-
14, and 6-15. Complete case analysis (Table 6-13) confirmed the significance of the 
preterm birth-asthma patterns associations in the above analysis of a 4-class LCR 
model, but reported higher effect sizes and wider confidence intervals, particularly 
for persistent asthma. However, the results of the analysis of a 5-class LCR model 
were not well replicated in complete case analysis. Of note, the overall goodness-of-
fit for both the 4- and 5-class LCR models were inadequate (Pearson chi-squares tests 
of both suggested rejecting the null hypotheses), thus should not be relied on. 
Sensitivity analyses using five imputed datasets by MICE (Table 6-14) all 
consistently confirmed the found preterm birth-asthma patterns associations with 
desirable goodness-of-fit using 4-class LCR models, with some variations on effect 
sizes and inferences. The significant AORs estimated for the preterm birth effects 
from the primary analysis were slightly higher than the AORs from multiple 
imputation dataset 1, but lower than the AORs from the other four imputed datasets. 
The confidence intervals for these AORs estimated from the primary analysis were 
slightly wider than the confidence intervals estimated from multiple imputation 
dataset 1, but narrower than those estimated from the other four imputed datasets. 
The significant effects of male child sex and maternal history of asthma on childhood 
asthma patterns were mostly replicated using the five imputed datasets, except for 
some inconsistency over the effect of male sex on late-onset asthma and the effect 
of maternal asthma history on middle-onset asthma. Results from the 5-class LCR 
analysis reported above were not consistently confirmed using the five datasets with 
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multiple imputations (Table 6-15). In sum, sensitivity analyses based on multiple 
imputations replicated the major findings of the associations between preterm birth 
and asthma patterns from the primary analysis of the 4-class LCR analysis, and 
suggested that the primary analysis tended to underestimate the effects size of 
preterm birth with narrower confidence intervals. 
6.5 Discussion 
6.5.1 Longitudinal Patterns of Childhood Asthma 
This manuscript used both the TCRS rules and LLCA to study childhood asthma 
patterns. Similar to the results from the TCRS,9 this manuscript showed that half of 
the children with early asthma or wheezing diagnoses during ages 0-2 years persisted 
to at least age 6 years. Results of the modified TCRS rules suggested at least two 
more distinguishable patterns: middle-onset asthma and the transient middle 
asthma. Both patterns novel additions to the original TCRS findings and were 
supported by LLCA in recent literature.10 More than half of the children assigned to 
late-onset asthma by the original TCRS rules had their first diagnoses of asthma or 
wheezing between ages 3-5 years. In addition, about 5% children assigned to never 
asthma had a positive diagnoses during first 7 years of life. These facts suggest that 
including asthma diagnoses during ages 3-5 years will more accurately classify 
longitudinal patterns and better describe the natural history of childhood asthma. 
This manuscript is the first to use repeated measures of asthma diagnoses 
documented in EMR to study the longitudinal patterns of childhood asthma by LLCA. 
Among the latent classes identified in this manuscript, never, persistent, late-onset, 
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and transient early asthma patterns were also reported by other cohort studies 
focused on wheezing patterns with some variations of class prevalences and 
probabilities of age-specific outcome,10-12,44 while middle/intermediate-onset10,44 and 
transient middle phenotype10,12 was only identified by a couple studies. The 
consistency of childhood asthma patterns in this manuscript and wheezing patterns 
in other studies supported current understanding on the natural history of 
pulmonary conditions in childhood. 
The uniqueness of childhood asthma patterns found in this manuscript could be 
due to sample size, sample characteristics, and repeated measures of the outcome. 
Previous studies are larger than the size of the BBC sample included in this 
manuscript, which allows fitting LLCA with large numbers of classes and identifying 
classes with sparse sample size. Furthermore, the majority of these studies were 
conducted in Europe, where children may face different level and types of exposures 
which influence the manifestation of childhood asthma. The last and most important 
difference is that the age trend of wheezing is different from that of asthma. The 
PIAMA study has reported that parental reported wheezing decreased monotonically 
from 21% in the first year to about 6% in the seventh year of life.45 In contrast, 
childhood asthma (asthma and wheezing diagnoses) increased from 11% in the first 
year to 18% in the seventh year in this analysis (Table 6-1). The different age 
prevalence suggest that it is less likely to identify transient early or middle asthma 
than middle- or late-onset asthma based on EMR in a poor urban minority cohort. 
More studies need to be done using other cohorts or datasets to confirm the 
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difference between asthma patterns and wheezing patterns. 
In this analysis, the six patterns identified using the modified TCRS rules 
matched the overall patterns of asthma found by the LLCA, but differed in terms of 
the actual age-specific probabilities of asthma diagnoses. This is because the TCRS 
rules classified the children based on pre-specified ages groups (first three years and 
age 6) and clinically meaningful rules, while the LLCA was based on diagnoses of 
asthma and wheezing across all ages and grouped the children based on statistical 
similarity (data-driven approach). In addition, the TCRS rules grouped children based 
on simplified (2 or 3 time points) observed patterns of asthma, while the LLCA 
approach estimated the probability of belonging to different classes based on 
complex (7 time points) observed patterns of asthma and model assumptions. The 
LLCA approach is considered more comprehensive, objective, and robust to single 
time point data errors.1,10 In this analysis, LLCA models were less stable when 
predicting rare asthma patterns (e.g. transient early asthma) and less consistent with 
some clinical theories (e.g. late-onset asthma, which is close to but still somewhat 
different from that identified by TCRS rules). These challenges may come from the 
relative small sample size for a large number of observed data patterns, or the 
overall high and increasing prevalence of asthma by age in this cohort. 
Besides LLCA, other longitudinal latent analyses could also be used to classify 
childhood asthma patterns, such as growth mixture models (GMM)46 and its special 
case -- latent class growth analysis (LCGA)47. These methods can further describe the 
shape of latent class trajectories by estimating parameters using correlations and 
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covariances of the repeated outcome measures. LLCA were chosen rather than GMM 
and LCGA for three reasons. First, LLCA met the objective and stage of this 
manuscript, which was to study the longitudinal patterns of asthma by preterm birth 
status (a fixed exposure) using EMR data. A study found consistent wheezing patterns 
using both LLCA and LLGA analyses,11 which lent some support to this rationale. 
Second, LLCA models showed desirable goodness-of-fit for these data with a few 
violations of conditional independence assumptions. Third, LLCA seemed more stable 
than GMM and LCGM in this small dataset with many sparse data patterns. Further 
studies with larger datasets could be done using LCGA and GMM to quantify the 
shape of asthma diagnosis trajectories, and their associations with other time-variant 
variables. 
6.5.2 Association of Preterm Birth with Various Patterns of Childhood Asthma 
This manuscript is the first study in the field to examine the relationships 
between preterm birth and various longitudinal patterns of childhood asthma. It is 
also the first to apply multiple-group LCA to compare longitudinal patterns of 
childhood asthma across subpopulations, and demonstrated the utility of this 
approach for validating latent classes identified in clinical data. 
In the PIAMA cohort13, preterm birth was found to be associated with a 
significantly higher risk of transient early wheezing. In the BBC cohort, preterm birth 
increased the risk of most patterns of childhood asthma identified by the TCRS and 
the LLCA approaches, except for late-onset asthma and the middle transient asthma 
defined by the modified TCRS rule. The different results between the PIAMA and the 
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BBC may be explained by study design, sample characteristics, and measure of 
childhood asthma. 
First, by design, the BBC contained more children born preterm (28%) than the 
BMC patient population and thus the general population. In this period, the preterm 
birth rate was about 15% among the BMC patients,19 about 12% in the U.S.,48 and 8% 
in the Netherlands.49 Although the preterm birth rate was not reported for the 
PIAMA study, this difference was also reflected by mean gestational age: mean 
gestational age = 37 weeks in the BBC vs. 40 weeks in the PIAMA study.13 
Second, this cohort is drawn from a poor, urban, multiethnic population in 
Boston, while PIAMA is a multi-centered study of general patient population in the 
Netherlands. Risk profiles of these population are different in terms of race, maternal 
smoking rate, and poverty rate, and other variables. 
Third, childhood asthma was measured by physician diagnoses of asthma or 
wheezing from EMR in this manuscript, while the PIAMA study relied on parental 
reported wheezing from the ISAAC survey.50 Compared to parental reported 
wheezing, diagnoses of asthma or wheezing in the EMR were based on similar clinical 
evaluation, and are generally more accurate and not subject to recall errors or bias. A 
strength of this manuscript is the availability of physician diagnosis of asthma (a 
clinical diagnosis) and wheezing (a clinical symptom of asthma, but may be due to 
other reasons). As such, it allows me to combine both diagnoses of asthma and 
wheezing to generate an indicator of childhood asthma with more clinical relevance, 
and examine the role of preterm birth in the development of various longitudinal 
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patterns of childhood asthma. 
The differential association between preterm birth and various patterns of 
childhood asthma or wheezing is observed by previous studies and this manuscript. 
The underlying mechanisms require further investigation. According to literature, 
transient early wheezing is more likely to be associated with lower lung function in 
the first year of life and maternal smoking8,51 and male infant sex,13 and more 
exposure to lower respiratory tract infection (LRTI) and childcare,44 but less likely for 
early sensitization to alleges in very early life.10,51 Late-onset asthma is more likely to 
be related to sensitization to allergens and bronchial responsiveness,8,10 but not 
related to LRTI or childcare.44 Persistent wheezing is significantly associated with all 
the risk factors mentioned for transient early and late-onset longitudinal 
patterns.8,10,12,44 Limited studies on middle-onset phenotype suggest that it is related 
to sensitization to allergens and bronchial responsiveness,8,10 which is similar to late-
onset phenotype. Transient middle/intermediate wheezing is not associated with 
atopic sensitization but fraction of exhaled Nitric Oxide (FeNO) -- a proxy biomarker 
of the degree of eosinophilic airway inflammation12, which is somewhat similar but 
not as atopic as late-onset wheezing. On the other hand, preterm birth often leads to 
immature pulmonary development and lung injuries at birth,52,53 which increased the 
risk of wheezing immediately after birth. 
These findings from previous studies are consistent with the results in the 
present study: preterm birth dis clearly and strongly associated with transient and 
persistent asthma longitudinal patterns, but not associated with of late and middle-
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onset longitudinal patterns by the TCRS rules. However, these findings were not true 
for transient and middle-onset asthma defined by LLCA. This may be because the 
transient early and middle-onset asthma identified by LLCA are not capturing the 
same children as transient early and middle-onset asthma by TCRS rules. 
6.5.3 Strengths and Limitations 
Analyses in this manuscript have several strengths, including the relatively long 
time of follow-up (from birth to 6 years) by design, outcome measures based on 
physician diagnoses documented in EMR (less influenced by recall bias or 
inconsistent judgment standards), using both the TCRS rules and LLCA for pattern 
classification, and applying multi-group LLCA and LCR to examine group differences. 
Analyses in this manuscript also have some limitations. Despite the unique 
sampling and possible errors in EMR data, EMR data were recorded at different time 
points. To solve the problem, I recoded the outcome measures by year of age. This 
approach sacrifices detailed time information of diagnoses, but controls the scope of 
missing values and satisfies the hypothesis for LLCA. Existence of missing values at 
different ages would further decrease the sample size and bias the results. To solve 
this problem, I imputed the missing measures as negative diagnoses. This method 
may underestimate the prevalences of childhood for most ages. But, sensitivity 
analyses showed that results based on this method are similar to results based on 
multiple imputed datasets. In addition, 128 possible combinations of asthma 
patterns and 550 total sample in this dataset lead to sparse observed data sparse in 
this dataset, which makes it hard to identify the rare longitudinal patterns. More 
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discussion of the limitations can be found in Chapter 7. 
6.6 Conclusions 
Longitudinal patterns of childhood asthma can be identified by the TCRS rules 
(both original and modified), and by the LLCA approach using physician diagnoses of 
asthma and wheezing documented in the EMR. Preterm birth is significantly 
associated with persistent childhood asthma defined by both methods, with 
transient early asthma by the TCRS rules, and with middle-onset asthma by the LLCA 
approach only. Preterm birth is not significantly associated with asthma between 
ages 3-5 years and asthma occurring at age 6 years. More studies can be done to 
apply multi-group LCA and LCR to study natural history of asthma and its associated 
factors. More studies using LLCA approach are needed to confirm findings from the 
present study, and characterize the relationships and underlying mechanisms 
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Figure 6-1. Age Specific Proportions of Children Asthma by Preterm Birth Status 
Note: (a) childhood asthma = had asthma or a wheezing diagnoses for the specified age; (b) had 
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Figure 6-2. Unadjusted and Adjusted Kaplan-Meier Survival Estimates for Childhood 
Asthma by Preterm Birth Status 
Note: Y-axes of (a1) (b1) (c1) are unadjusted survival proportions of having the first relevant 
diagnosis; Y-axes of (a2) (b2) (c2) are survival proportions adjusted for child sex, maternal age, race, 
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Figure 6-3. Childhood Asthma Patterns Identified by Longitudinal Latent Class Analysis in 
the First 7 Years of Life 
Note: (a) longitudinal patterns of childhood asthma identified by a 2-class longitudinal latent class 
analysis (LLCA); (b) longitudinal patterns identified by a 3-class LLCA; (c) longitudinal patterns 
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Figure 6-4. Childhood Asthma Patterns Identified by Longitudinal Latent Class Analysis in 
the First 7 Years of Life for Preterm and Term Children 
Note: (a) (b) identified by a 4-class Longitudinal Latent Class Analysis (LLCA); (c) (d) identified by a 5-
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(b) 4-Class Model, Preterm
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(d) 5-class, Preterm
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Figure 6-5. Age Specific Prevalence of Childhood Asthma by Preterm Birth Status among 
Children with Yearly Visits to Boston Medical Center 
Note: (a) childhood asthma = had asthma or a wheezing diagnoses for the specified age; (b) had 
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Figure 6-6. Patterns of Asthma Identified by Longitudinal Latent Class Analysis among 
Children with Yearly Visits to Boston Medical Center 
Note: (a) longitudinal patterns of childhood asthma identified by a 2-class Longitudinal Latent Class 
Analysis (LLCA); (b) longitudinal patterns identified by a 3-class LLCA; (b) longitudinal patterns 
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Table 6-1. Characteristics of the Analytic Sample from the Boston Birth Cohort 
    
Total  
(n = 550) 
  
Preterm birth status 
 
Term  
(n = 394) 
Preterm  
(n = 156) 
P-value of 
Chi-square 
test Characteristics n col % n col % n col % 
Male sex 278 50.5  197 50.0 81 51.9 0.684 
Maternal black/African 
American race/ethnicity 
358 65.1  255 64.7 103 66.0 0.772 
Maternal history of asthma 87 15.8  50 12.7 37 23.7 0.001 
Maternal history of allergies 188 34.2  124 31.5 64 41.0 0.033 
Maternal continuous smoking 
during pregnancy 
56 10.2  35 8.9 21 13.5 0.110 
Childhood asthma:          
Age 0 62 11.3  27 6.9 35 22.4 <0.001 
Age 1 73 13.3  38 9.6 35 22.4 <0.001 
Age 2 70 12.7  31 7.9 39 25.0 <0.001 
Age 3 88 16.0  42 10.7 46 29.5 <0.001 
Age 4 79 14.4  39 9.9 40 25.6 <0.001 
Age 5 97 17.6  50 12.7 47 30.1 <0.001 
Age 6 97 17.6   51 12.9 46 29.5 <0.001 
Abbreviation: Col = column 
 
Table 6-2. Frequencies of Longitudinal Patterns of Childhood Asthma by TCRS Rules (n = 
550) 
TCRS longitudinal patterns applied to childhood asthma  
  
Classification criterion 
  n col % Age 0-2 Age 3-5 Age 6 
Original TCRS rule       
No asthma 388 70.5  No Yes/No No 
Transient early asthma 65 11.8  Yes Yes/No No 
Late-onset asthma 35 6.4  No Yes/No Yes 
Persistent asthma 62 11.3  Yes Yes/No Yes 
Modified TCRS rule         
No asthma 364 66.2  No No No 
Transient early asthma 65 11.8  Yes Yes/No No 
Late-onset asthma 14 2.5  No No Yes 
Persistent asthma 62 11.3  Yes Yes/No Yes 
Middle-onset asthma 21 3.8  No Yes Yes 
Transient middle asthma 24 4.4   No Yes No 
Abbreviations: Col= column, TCRS = Tucson Children’s Respiratory Study, col = column 
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Total (n = 550)           
2 15 232.00  <0.001 0.94  14  -1133.42  2296.84  2361.48  931.67  <0.001 <0.001 
3 23 175.84  <0.001 0.91  11  -1108.53  2263.05  2362.18  49.79  0.158  <0.001 
4 31 108.63  0.178  0.89  5  -1090.25  2242.51  2376.11  36.54  0.033  <0.001 
5 39 84.22  0.594  0.85  7  -1079.47  2236.93  2405.02  21.57  0.224  <0.001* 
6 47 69.83  0.785  0.91  5  -1073.52  2241.04  2443.61  11.90  0.080  0.375 * 
Preterm (n = 156)           
2 15 189.48  <0.001 0.95  12  -433.80  897.61  943.36  387.01  0.000  <0.001 
3 23 140.14  <0.001 0.96  9  -417.76  881.53  951.67  32.08  0.009  <0.001 
4 31 95.17  0.505  0.94  5  -404.58  871.16  965.71  26.37  0.010  <0.001 
5 39 69.19  0.931  0.97  5  -397.27  872.54  991.49  14.62  0.044  0.667 * 
6 47 56.19  0.980  0.97  5  -391.78  877.57  1020.91  10.97  0.057  1.000 *  
Term (n = 394)           
2 15 163.72  0.001  0.93  9  -673.62  1377.24  1436.88  441.94  0.000  <0.001 
3 23 119.72  0.139  0.83  6  -661.08  1368.15  1459.61  25.09  0.120  <0.001 
4 31 81.31  0.858  0.94  3  -651.23  1364.47  1487.73  19.69  0.461   0.050  
5 39 65.32  0.967  0.91  3  -645.43  1368.85  1523.93  11.61  0.156   1.000 
6 47 57.10  0.975  0.92  4  -640.71 1375.41  1562.30  9.41  0.038  1.000 * 
Abbreviations: STD residual = number of standardized residual (z-score) for each observed asthma pattern cell > 1.96; LL = the best Log-likelihood; AIC = the Akaike 
information criterion; BIC = Bayesian information criterion; LMP = Vuong-Lo-Mendell-Rubin likelihood ratio tests; BLRT = bootstrapped likelihood ratio tests 
Note: a value with * means that the best LL for some models was not replicated in more than half of random draws for at least 1000 random starts, so p-values may not be 




Table 6-4. Prevalences of Class Membership and Probabilities of Asthma at each Age given 
Class Membership for a 4-Class Latent Analysis Model (n = 550) 













 n Row %   n Row %   n Row %   n Row % 
Expected class 
prevalence 
39 0.07   407 0.74   25 0.05   79 0.14 
Probabilities of 
asthma 
π SE   π SE   π SE   π SE 
Age 0 0.00 0.00   0.04 0.02   1.00 0.00   0.24 0.07 
Age 1 0.50 0.11   0.04 0.01   0.91 0.07   0.20 0.06 
Age 2 0.68 0.10   0.01 0.01   1.00 0.00   0.18 0.07 
Age 3 0.93 0.10   0.00 0.01   0.97 0.06   0.34 0.09 
Age 4 1.00 0.00   0.01 0.01   0.70 0.10   0.26 0.14 
Age 5 0.83 0.07   0.01 0.01   0.73 0.10   0.55 0.16 
Age 6 0.92 0.08   0.03 0.01   0.69 0.10   0.42 0.13 
Abbreviations: π = probability of having asthma diagnosis at each age given their class membership; SE 






Table 6-5. Cross-Tabulations of Longitudinal Asthma Patterns Identified by the TCRS Rules and by Latent Class Analysis (n = 550) 
 Longitudinal asthma patterns identified by LLCA 
Longitudinal asthma patterns  
by the TCRS rules 
4-class model  5-class model 
Late-onset Middle-onset Persistent Never  Persistent Transient early Middle-onset Never Late-onset 
Original TCRS rules           
Never asthma 20 0 0 368  0 3 0 377 8 
Transient early asthma 19 2 8 36  8 35 3 12 7 
Late-onset asthma 14 7 0 14  0 0 7 14 14 
Persistent asthma 13 31 18 0  16 0 34 0 12 
Modified TCRS rules           
No asthma 0 0 0 364  0 0 0 364 0 
Transient early asthma 19 2 8 36  8 35 3 12 7 
Late-onset asthma 0 0 0 14  0 0 0 14 0 
Persistent asthma 13 31 18 0  16 0 34 0 12 
Middle-onset asthma 14 7 0 0  0 0 7 0 14 
Transient middle asthma 20 0 0 4  0 3 0 13 8 




Table 6-6. Longitudinal Asthma Patterns by the TCRS Rules across Preterm Birth Status 
Longitudinal asthma patterns  
by the TCRS rules 
Term  
(n = 394)  
Preterm  
(n = 156)   
Chi-square test n col %   n col %  
Original TCRS rules        
Never asthma 303 76.9  85 54.5  
35.46 (df = 3),  
p-value < 0.001 
Transient early asthma 40 10.2  25 16.0  
Late-onset asthma 24 6.1  11 7.1  
Persistent asthma 27 6.9   35 22.4   
Modified TCRS rules            
No asthma 285 72.3  79 50.6  
36.73 (df = 5),  
p-value < 0.001 
Transient early asthma 40 10.2  25 16.0  
Late-onset asthma 11 2.8  3 1.9  
Persistent asthma 27 6.9  35 22.4  
Middle-onset asthma 13 3.3  8 5.1  
Transient middle asthma 18 4.6   6 3.8   
Abbreviations: TCRS = Tucson Children’s Respiratory Study, df = degree of freedom
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(df = 3) 






    
Model A: Original TCRS rules 
Reference = Never asthma 
AOR [95%CI] AOR [95%CI] AOR [95%CI]     
Preterm birth 25.17*** 2.04* [1.16,3.61] 1.49 [0.69,3.21] 4.13*** [2.31,7.37]     
Male 10.83* 1.84* [1.06,3.18] 1.81 [0.88,3.70] 2.13* [1.18,3.83]     
Black 3.41 1.15 [0.65,2.04] 1.65 [0.74,3.67] 1.61 [0.85,3.04]     
Maternal history of asthma 23.01*** 2.97** [1.48,5.99] 3.22** [1.35,7.71] 4.35*** [2.16,8.73]     
Maternal history of allergies 0.75 1.09 [0.60,1.97] 1.38 [0.65,2.96] 1.11 [0.59,2.07]     
Maternal pregnancy smoking 2.91 1.78 [0.81,3.94] 1.31 [0.43,4.02] 1.77 [0.77,4.08]     






(df = 5) 










Model B: Modified TCRS rules 
Reference = Never asthma 
AOR [95%CI] AOR [95%CI] AOR [95%CI] AOR [95%CI] AOR [95%CI] 
Preterm birth 26.35*** 2.07* [1.17,3.68] 0.90 [0.24,3.35] 4.20*** [2.34,7.53] 2.03 [0.79,5.19] 1.14 [0.43,3.01] 
Male 15.55** 1.92* [1.11,3.34] 0.92 [0.31,2.72] 2.24** [1.24,4.04] 3.20* [1.19,8.57] 1.73 [0.74,4.03] 
Black 4.50 1.12 [0.63,1.98] 1.40 [0.43,4.59] 1.56 [0.82,2.96] 1.79 [0.63,5.11] 0.65 [0.28,1.51] 
Maternal history of asthma 24.00*** 2.98** [1.47,6.06] 1.88 [0.46,7.69] 4.38*** [2.16,8.88] 4.48** [1.54,13.1] 0.98 [0.26,3.60] 
Maternal history of allergies 5.32 1.16 [0.64,2.10] 2.12 [0.68,6.62] 1.17 [0.62,2.20] 1.14 [0.43,3.07] 2.40* [1.01,5.68] 
Maternal pregnancy smoking 3.66 1.85 [0.83,4.14] 0.81 [0.10,6.53] 1.85 [0.79,4.30] 1.76 [0.47,6.55] 1.46 [0.40,5.26] 
Constant  0.07*** [0.04,0.13] 0.02*** [0.01,0.08] 0.03*** [0.01,0.07] 0.01*** [0.00,0.04] 0.04*** [0.02,0.10] 
Abbreviations: TCRS = Tucson Children’s Respiratory Study. AOR = Adjusted Odds Ratio. CI = Confidence Interval. P-values: *, p < 0.01, **, p < 0.01, ***, p < 0.001. 
Note: Overall Likelihood ratio test (LRT) for Model A Chi-square = 79.36, degree of freedom [df] = 18, p < 0.001; Overall LRT for Model B: Chi-square = 92.40, df = 30, p < 




Table 6-8. Fit Statistics for Test of Measurement Invariance of Latent Asthma Classes of 




LL AIC BIC 
Model C: Age-specific probabilities of 
asthma vary across preterm birth status 
63 -1383.81  2893.62  3165.14  
Model D: Age-specific probabilities of 
asthma equal across preterm birth status 
35 -1399.93  2869.86  3020.71  
Likelihood Ratio Test for nested models: 2 times LL difference = 32.24, 
 df = 28, p-value = 0.265 
Abbreviations: LL = the best Log-likelihood; AIC = the Akaike information criterion; BIC = Bayesian 
information criterion. df = degree of freedom 
 
 
Table 6-9. Fit Statistics for Test of Latent Asthma Class Prevalences across Preterm Birth 




LL AIC BIC 
Model D: Prevalences of latent classes 
(longitudinal age patterns of childhood 




2869.86  3020.71  
Model E: Prevalences of latent class 
prevalences (longitudinal age patterns of 





2900.50  3038.42  
Likelihood Ratio Test for nested models: 2 times LL difference = 18.32,  
df = 3, p-value < 0.001 
Notes: age-specific probabilities constrained equal across preterm birth status; LL = the best Log-
likelihood; AIC = the Akaike information criterion; BIC = Bayesian information criterion. 
 
 
Table 6-10. Prevalences of Latent Asthma Classes across Preterm Birth Status (n = 550) 
 Longitudinal Latent Classes of Asthma 
 Late-onset asthma Persistent asthma Middle-onset asthma Never asthma 
Term 0.13 0.02 0.06 0.80 





Table 6-11. Adjusted Odds Ratios from Latent Class Regression Analysis of Childhood Asthma Patterns on Preterm Birth (n = 550) 
Model F: Four asthma patterns 
Global test for 
each explanatory 
variable 
(df = 3) 
Late-onset asthma  Middle-onset asthma  Persistent asthma         
Reference = Never asthma AOR [95%CI]   AOR [95%CI]   AOR [95%CI]         
Preterm birth 29.00*** 1.69   [0.76 ,3.74 ]  3.64  ** [1.90 ,6.97 ]  8.52  ** [2.62 ,27.7 ]         
Male 13.65** 2.68  * [1.19 ,6.06 ]  2.31  * [1.15 ,4.64 ]  1.23  [0.42 ,3.64 ]         
Black 1.91 1.06   [0.53 ,2.13 ]  1.60  [0.78 ,3.28 ]  1.40  [0.36 ,5.50 ]         
Maternal history of asthma 26.70*** 3.52  * [1.34 ,9.23 ]  2.56  * [1.02 ,6.46 ]  12.8  ** [3.64 ,44.9 ]         
Maternal history of allergies 3.35 1.44   [0.68 ,3.03 ]  1.09  [0.52 ,2.29 ]  2.56  [0.74 ,8.83 ]         
Maternal pregnancy smoking 2.61 1.83   [0.69 ,4.87 ]  1.88  [0.76 ,4.67 ]  1.65  [0.38 ,7.23 ]         
Constant   0.07  ** [0.03 ,0.19 ]   0.03  ** [0.01 ,0.08 ]   0.00  ** [0.00 ,0.04 ]               
Model G: Five asthma patterns Global test for 
each explanatory 
variable 
(df = 4) 
Late-onset asthma  Middle-onset asthma  Persistent asthma  Transient early asthma 
Reference = Never asthma AOR [95%CI]   AOR [95%CI]   AOR [95%CI]   AOR [95%CI] 
Preterm birth 28.70*** 1.95  [0.85,4.46]  3.75 *** [1.82,7.74]  8.69 *** [2.61,28.9]  1.60  [0.32,7.90] 
Male 14.17** 2.34  [0.96,5.69]  2.56 * [1.14,5.75]  1.06  [0.37,3.05]  2.83  [0.91,8.84] 
Black 4.18 1.52  [0.61,3.78]  1.48  [0.67,3.28]  1.58  [0.47,5.38]  0.61  [0.17,2.13] 
Maternal history of asthma 31.34*** 2.09  [0.61,7.13]  2.73  [0.88,8.51]  14.7 *** [4.26,50.9]  6.82 *** [2.11,22.1] 
Maternal history of allergies 4.74 1.71  [0.81,3.60]  0.92  [0.39,2.17]  2.83  [0.76,10.6]  0.97  [0.28,3.33] 
Maternal pregnancy smoking 4.82 0.78  [0.15,4.17]  2.24  [0.84,5.98]  1.83  [0.42,8.02]  2.97  [0.87,10.1] 
Constant   0.04 *** [0.01,0.09]   0.03 *** [0.01,0.07]   0.00 *** [0.00,0.02]   0.03 ** [0.00,0.27] 
Abbreviations: AOR = Adjusted Odds Ratio. CI = Confidence Interval. P-values: *, p < 0.01, **, p < 0.01, ***, p < 0.001. 
Notes: Model F: loglikelihood = -1042.45, number of parameters = 49; Pearson Chi-Square = 101.23, degree of freedom [df] = 96, p = 0.338. Model G: loglikelihood = -
1024.56, number of parameters = 63, Pearson Chi-Square = 84.03, df= 88, p = 0.600. Global test for each explanatory variable was a likelihood ratio test of nested models: 














LL AIC BIC 
2 times 





2 15 193.99  <0.001 0.94  13  -884.69  1799.38  1859.17  819.59 <0.001 <0.001 
3 23 131.45  0.036  0.88  10  -861.10  1768.20  1859.89  47.17  0.037  <0.001 
4 31 93.56  0.552  0.92  8  -845.69  1753.37  1876.95  30.83  <0.001 <0.001 
5 39 69.55  0.927  0.90  5  -838.61  1755.23  1910.70  14.15 0.424  0.500* 
Abbreviations: STD residual = number of standardized residual (z-score) for each observed asthma pattern cell > 1.96; LL = the best Log-likelihood; AIC= the Akaike 
information criterion; BIC = Bayesian information criterion; LMP = Vuong-Lo-Mendell-Rubin likelihood ratio tests; BLRT = bootstrapped likelihood ratio tests. 
Notes: a value with * means that the best LL for some models was not replicated in more than half of random draws for at least 1000 random starts, so p-values may not be 






Table 6-13. Adjusted Odds Ratios from Latent Class Regression Analysis of Childhood Asthma Patterns on Preterm Birth, Complete Data (n = 398) 
Model F: Four asthma 
patterns 
Late-onset asthma  Middle-onset asthma  Persistent asthma         
Reference = Never asthma AOR [95%CI]   AOR [95%CI] AOR [95%CI]         
Preterm birth 2.09  [ 0.84 , 5.18 ]  4.66  ** [ 1.69 , 12.8 ]  21.6  *** [ 3.58 , 130 ]         
Male 1.85  [ 0.70 , 4.86 ]  3.05   [ 0.98 , 9.53 ]  0.30   [ 0.05 , 1.85 ]         
Black 0.94  [ 0.38 , 2.31 ]  1.33   [ 0.51 , 3.45 ]  7.02   [ 0.30 , 167 ]         
Maternal history of asthma 6.98  *** [ 2.35 , 20.8 ]  0.46   [ 0.00 , 102 ]  ### *** [ 66.0 , ### ]         
Maternal history of allergies 1.34  [ 0.57 , 3.15 ]  1.26   [ 0.51 , 3.13 ]  8.41  * [ 1.29 , 54.9 ]         
Maternal pregnancy 
smoking 
2.60  [ 0.68 , 9.95 ]  0.26   [ 0.03 , 2.63 ]  ### ** [ 4.17 , ### ]         
Constant 0.07  *** [ 0.02 , 0.21 ]   0.04  *** [ 0.01 , 0.19 ]   0.00  *** [ 0.00 , 0.01 ]              
Model G: Five asthma 
patterns 
Late-onset asthma 1  Middle-onset asthma  Persistent asthma  Late-onset asthma 2 
Reference = Never asthma AOR [95%CI]   AOR [95%CI]   AOR [95%CI]   AOR [95%CI] 
Preterm birth 2.13  [ 0.78 , 5.78 ]  5.71  *** [ 2.55 , 12.8 ]  48.6  ** [ 4.09 , ### ]  0.58  [ 0.05 , 6.79 ] 
Male 0.76  [ 0.31 , 1.82 ]  3.22  * [ 1.25 , 8.27 ]  0.28   [ 0.02 , 3.39 ]  ### *** [ ### , ### ] 
Black ### *** [ ### , ### ]  1.16   [ 0.47 , 2.86 ]  1.50   [ 0.19 , 12.0 ]  0.00  [ 0.00 , 0.00 ] 
Maternal history of asthma 4.24 * [ 1.23 , 14.6 ]  0.00  *** [ 0.00 , 0.00 ]  ### *** [ ### , ### ]  ### *** [ 41.2 , ### ] 
Maternal history of allergies 1.37  [ 0.48 , 3.86 ]  1.16   [ 0.49 , 2.73 ]  44.8  *** [ 4.76 , ### ]  0.20  [ 0.01 , 2.65 ] 
Maternal pregnancy 
smoking 
0.87  [ 0.16 , 4.85 ]  0.26   [ 0.03 , 2.03 ]  ### *** [ ### , ### ]  ### *** [ 46.9 , ### ] 
Constant 0.00 *** [ 0.00 , 0.00 ]   0.03  *** [ 0.01 , 0.10 ]   0.00  *** [ 0.00 , 0.00 ]   0.00 *** [ 0.00 , 0.00 ] 
Abbreviations: AOR = Adjusted Odds Ratio. CI = Confidence Interval. ### = AOR > 99.99. P-values: *, p < 0.01, **, p < 0.01, ***, p < 0.001. 
Notes: Model F: loglikelihood = -796.95, number of parameters = 49; Pearson Chi-Square = 136.25, df = 96, p = 0.004. Model G: loglikelihood = -777.89, number of 
parameters = 63, Pearson Chi-Square = 128.66, df = 88, p = 0.003; best log-likelihood was not replicated under 1500 random starts, the solution for Model G may be not 




Table 6-14. Adjusted Odds Ratios from Latent Class Regression Analysis of Four Childhood Asthma Patterns on Preterm Birth, Multiple Imputations (n = 
550)  
Model F: Four asthma patterns Late-onset asthma  Middle-onset asthma  Persistent asthma 
Reference = Never asthma AOR [95%CI]   AOR [95%CI]   AOR [95%CI] 
Multiple imputation 1                        
Preterm birth 1.59  [ 0.73 , 3.47 ] 3.31 *** [ 1.66 , 6.61 ] 8.53 *** [ 2.64 , 27.6 ] 
Male 2.17  [ 0.93 , 5.08 ] 2.30 * [ 1.16 , 4.56 ] 1.17  [ 0.42 , 3.27 ] 
Black 1.00  [ 0.50 , 2.00 ] 1.41  [ 0.66 , 2.99 ] 1.29  [ 0.39 , 4.30 ] 
Maternal history of asthma 3.17 * [ 1.20 , 8.38 ] 2.29  [ 0.88 , 5.94 ] 11.3 *** [ 3.71 , 34.7 ] 
Maternal history of allergies 1.09  [ 0.52 , 2.25 ] 1.25  [ 0.56 , 2.82 ] 2.37  [ 0.75 , 7.50 ] 
Maternal pregnancy smoking 2.12  [ 0.76 , 5.97 ] 2.05  [ 0.70 , 6.01 ] 1.69  [ 0.41 , 6.91 ] 
Constant 0.08 *** [ 0.03 , 0.24 ] 0.03 *** [ 0.01 , 0.09 ] 0.00 *** [ 0.00 , 0.03 ] 
Multiple imputation 2                        
Preterm birth 1.94  [ 0.72 , 5.23 ] 3.78 *** [ 1.85 , 7.73 ] 9.37 *** [ 2.73 , 32.2 ] 
Male 3.66  [ 0.52 , 25.9 ] 2.30 * [ 1.15 , 4.59 ] 1.19  [ 0.38 , 3.71 ] 
Black 0.65  [ 0.24 , 1.77 ] 1.60  [ 0.78 , 3.25 ] 1.42  [ 0.32 , 6.27 ] 
Maternal history of asthma 4.25 * [ 1.30 , 13.9 ] 2.48  [ 0.97 , 6.33 ] 14.3 *** [ 3.63 , 56.4 ] 
Maternal history of allergies 1.04  [ 0.33 , 3.26 ] 1.08  [ 0.54 , 2.15 ] 2.60  [ 0.65 , 10.4 ] 
Maternal pregnancy smoking 1.92  [ 0.45 , 8.23 ] 1.68  [ 0.63 , 4.47 ] 1.81  [ 0.36 , 9.05 ] 
Constant 0.07 * [ 0.01 , 0.63 ] 0.03 *** [ 0.01 , 0.13 ] 0.00 *** [ 0.00 , 0.04 ] 
Multiple imputation 3                        
Preterm birth 2.07  [ 0.92 , 4.67 ] 3.69 *** [ 1.92 , 7.08 ] 9.07 *** [ 2.78 , 29.6 ] 
Male 2.77 * [ 1.06 , 7.22 ] 2.20 * [ 1.12 , 4.33 ] 1.25  [ 0.44 , 3.57 ] 
Black 1.13  [ 0.52 , 2.43 ] 1.64  [ 0.73 , 3.65 ] 1.37  [ 0.39 , 4.76 ] 
Maternal history of asthma 4.31 ** [ 1.43 , 13.0 ] 2.40  [ 0.86 , 6.75 ] 12.5 *** [ 3.90 , 39.9 ] 




Model F: Four asthma patterns Late-onset asthma  Middle-onset asthma  Persistent asthma 
Reference = Never asthma AOR [95%CI]   AOR [95%CI]   AOR [95%CI] 
Maternal pregnancy smoking 2.18  [ 0.72 , 6.56 ] 1.79  [ 0.57 , 5.56 ] 1.70  [ 0.41 , 6.95 ] 
Constant 0.06 *** [ 0.01 , 0.23 ] 0.03 *** [ 0.01 , 0.09 ] 0.00 *** [ 0.00 , 0.03 ] 
Multiple imputation 4                        
Preterm birth 2.14  [ 0.95 , 4.82 ] 3.72 *** [ 1.96 , 7.06 ] 9.68 *** [ 2.88 , 32.6 ] 
Male 2.94 * [ 1.00 , 8.64 ] 2.33 * [ 1.20 , 4.51 ] 1.31  [ 0.44 , 3.94 ] 
Black 0.70  [ 0.34 , 1.43 ] 1.75  [ 0.86 , 3.56 ] 1.26  [ 0.30 , 5.21 ] 
Maternal history of asthma 5.08 *** [ 1.89 , 13.7 ] 3.12 * [ 1.19 , 8.21 ] 15.6 *** [ 4.31 , 56.6 ] 
Maternal history of allergies 1.14  [ 0.48 , 2.71 ] 1.10  [ 0.55 , 2.20 ] 2.44  [ 0.69 , 8.70 ] 
Maternal pregnancy smoking 1.78  [ 0.62 , 5.13 ] 1.73  [ 0.71 , 4.21 ] 1.71  [ 0.38 , 7.78 ] 
Constant 0.09 *** [ 0.02 , 0.32 ] 0.03 *** [ 0.01 , 0.08 ] 0.00 *** [ 0.00 , 0.05 ] 
Multiple imputation 5                        
Preterm birth 1.56  [ 0.70 , 3.44 ] 3.92 *** [ 1.88 , 8.19 ] 8.84 *** [ 2.66 , 29.3 ] 
Male 2.67 * [ 1.11 , 6.40 ] 2.44 ** [ 1.21 , 4.94 ] 1.27  [ 0.44 , 3.65 ] 
Black 0.99  [ 0.47 , 2.06 ] 1.49  [ 0.64 , 3.47 ] 1.31  [ 0.38 , 4.45 ] 
Maternal history of asthma 3.98 ** [ 1.55 , 10.2 ] 2.59 * [ 1.02 , 6.62 ] 13.1 *** [ 4.08 , 42.3 ] 
Maternal history of allergies 1.28  [ 0.61 , 2.68 ] 1.17  [ 0.53 , 2.57 ] 2.47  [ 0.76 , 8.06 ] 
Maternal pregnancy smoking 2.57  [ 0.88 , 7.50 ] 1.91  [ 0.65 , 5.62 ] 1.86  [ 0.44 , 7.75 ] 
Constant 0.07 *** [ 0.02 , 0.23 ] 0.03 *** [ 0.01 , 0.11 ] 0.00 *** [ 0.00 , 0.03 ] 
Abbreviations: AOR = Adjusted Odds Ratio. CI = Confidence Interval. P-values: *, p < 0.01, **, p < 0.01, ***, p < 0.001 
Notes: For imputation 1: Pearson Chi-Square = 90.27, df = 96, p = 0.646. For imputation 2: Pearson Chi-Square = 95.86, df = 96, p = 0.485. For imputation 3: Pearson Chi-






Table 6-15. Adjusted Odds Ratios from Latent Class Regression Analysis of Five Childhood Asthma Patterns on Preterm Birth, Multiple Imputations (n = 
550)  
Model G: Five asthma patterns Late onset asthma  Middle-onset asthma  Persistent asthma  Transient early asthma 
Reference = Never asthma AOR [95%CI]   AOR [95%CI]   AOR [95%CI]   AOR [95%CI] 
Multiple imputation 1                                
Preterm birth 1.53  [ 0.77 , 3.06 ] 5.48 *** [ 2.29 , 13.1 ] 9.20 *** [ 3.08 , 27.5 ] 0.47  [ 0.02  , 9.07 ] 
Male 1.44  [ 0.69 , 3.00 ] 2.91 * [ 1.14 , 7.43 ] 1.41  [ 0.51 , 3.90 ] 672 ** [ ### , ### ] 
Black 2.68  [ 0.99 , 7.25 ] 0.90  [ 0.34 , 2.36 ] 1.00  [ 0.33 , 3.00 ] 0.00 *** [ 0.00  , 0.00 ] 
Maternal history of asthma 1.88  [ 0.76 , 4.62 ] 3.69 *** [ 1.28 , 10.6 ] 11.9 *** [ 4.01 , 35.6 ] 5.10  [ 0.20  , ### ] 
Maternal history of allergies 1.30  [ 0.65 , 2.60 ] 0.99  [ 0.40 , 2.45 ] 2.44  [ 0.82 , 7.26 ] 0.12  [ 0.01  , 1.55 ] 
Maternal pregnancy smoking 0.24  [ 0.02 , 2.88 ] 4.63  [ 1.66 , 13.0 ] 2.36  [ 0.60 , 9.30 ] 193 *** [ 9.55  , ### ] 
Constant 0.05 *** [ 0.02 , 0.13 ] 0.01 *** [ 0.00 , 0.04 ] 0.00 *** [ 0.00 , 0.02 ] 0.00 *** [ 0.00  , 0.04 ] 
Multiple imputation 2                                
Preterm birth 2.39  [ 0.89 , 6.42 ] 3.64 *** [ 1.85 , 7.16 ] 2.45  [ 0.50 , 11.9 ] 0.00 *** [ 0.00  , 0.00 ] 
Male 15.1  [ 0.57 , 397 ] 2.34 * [ 1.22 , 4.51 ] 0.17  [ 0.03 , 1.18 ] 0.00 *** [ 0.00  , 0.00 ] 
Black 0.33  [ 0.06 , 1.75 ] 1.47  [ 0.74 , 2.92 ] 5.51  [ 0.71 , 43.1 ] 2.55  [ 0.33  , 19.6 ] 
Maternal history of asthma 4.31 * [ 1.09 , 17.0 ] 0.67  [ 0.14 , 3.21 ] ### *** [ 47.5 , ### ] 118 ** [ 4.04  , ### ] 
Maternal history of allergies 0.65  [ 0.22 , 1.92 ] 1.17  [ 0.61 , 2.25 ] 8.17  [ 0.96 , 69.6 ] 19.6  [ 0.27  , ### ] 
Maternal pregnancy smoking 4.43  [ 0.88 , 22.4 ] 0.52  [ 0.13 , 2.03 ] 76.6 ** [ 4.64 , ### ] 9.69  [ 0.32  , 290 ] 
Constant 0.02 * [ 0.00 , 0.44 ] 0.05 *** [ 0.02 , 0.13 ] 0.00 *** [ 0.0 , 0.01 ] 0.00 * [ 0.00  , 0.49 ] 
Multiple imputation 3                                
Preterm birth 2.44 * [ 1.14 , 5.21 ] 3.25 *** [ 1.76 , 6.02 ] 6.27 ** [ 1.93 , 20.3 ] 0.00  [ 0.00  , 0.00 ] 
Male 4.28 ** [ 1.61 , 11.3 ] 1.97  [ 1.06 , 3.65 ] 1.08  [ 0.37 , 3.16 ] 0.00 *** [ 0.00  , 0.00 ] 
Black 1.14  [ 0.51 , 2.53 ] 1.37  [ 0.72 , 2.63 ] 1.18  [ 0.33 , 4.26 ] 0.00  [ 0.00  , 0.00 ] 




Model G: Five asthma patterns Late onset asthma  Middle-onset asthma  Persistent asthma  Transient early asthma 
Reference = Never asthma AOR [95%CI]   AOR [95%CI]   AOR [95%CI]   AOR [95%CI] 
Maternal history of allergies 0.89  [ 0.40 , 1.96 ] 1.17  [ 0.61 , 2.24 ] 2.15  [ 0.70 , 6.60 ] 0.00  [ 0.00  , 0.00 ] 
Maternal pregnancy smoking 2.83 * [ 1.11 , 7.18 ] 1.43  [ 0.61 , 3.35 ] 1.53  [ 0.38 , 6.13 ] 0.00 *** [ 0.00  , 0.00 ] 
Constant 0.03 *** [ 0.01 , 0.08 ] 0.04 *** [ 0.02 , 0.09 ] 0.01 *** [ 0.00 , 0.04 ] 0.00 *** [ 0.00  , 0.00 ] 
Multiple imputation 4                                
Preterm birth 1.86  [ 0.89 , 3.90 ] 4.21 *** [ 2.01 , 8.83 ] 10.1 *** [ 2.92 , 34.9 ] 5.42 * [ 1.23  , 24.0 ] 
Male 1.74  [ 0.81 , 3.74 ] 2.71 * [ 1.21 , 6.08 ] 1.20  [ 0.41 , 3.55 ] ###  [ ### , ### ] 
Black 1.15  [ 0.49 , 2.74 ] 1.53  [ 0.65 , 3.59 ] 1.44  [ 0.41 , 5.08 ] 0.16 * [ 0.03  , 0.76 ] 
Maternal history of asthma 2.70  [ 0.98 , 7.40 ] 3.48 ** [ 1.34 , 9.03 ] 16.1 *** [ 4.59 , 56.5 ] 11.2 ** [ 1.96  , 64.5 ] 
Maternal history of allergies 1.22  [ 0.59 , 2.53 ] 1.02  [ 0.46 , 2.29 ] 2.96  [ 0.76 , 11.6 ] 0.76  [ 0.15  , 3.98 ] 
Maternal pregnancy smoking 1.22  [ 0.36 , 4.16 ] 2.19  [ 0.84 , 5.68 ] 1.90  [ 0.43 , 8.43 ] 1.70  [ 0.25  , 11.8 ] 
Constant 0.08 *** [ 0.03 , 0.17 ] 0.02 *** [ 0.01 , 0.06 ] 0.00 *** [ 0.00 , 0.02 ] 0.00 *** [ 0.00  , 0.00 ] 
Multiple imputation 5                                
Preterm birth 1.68  [ 0.77 , 3.67 ] 3.82 *** [ 1.91 , 7.64 ] 9.32 *** [ 2.90 , 30.0 ] 1.68  [ 0.77  , 3.67 ] 
Male 2.81 * [ 1.19 , 6.65 ] 2.61 * [ 1.23 , 5.53 ] 1.28  [ 0.45 , 3.64 ] 2.81 * [ 1.19  , 6.65 ] 
Black 1.09  [ 0.54 , 2.18 ] 1.41  [ 0.68 , 2.92 ] 1.40  [ 0.43 , 4.54 ] 1.09  [ 0.54  , 2.18 ] 
Maternal history of asthma 4.25 ** [ 1.56 , 11.6 ] 2.66 * [ 1.02 , 6.95 ] 14.3 *** [ 4.50 , 45.5 ] 4.25 ** [ 1.56  , 11.6 ] 
Maternal history of allergies 1.25  [ 0.58 , 2.69 ] 1.16  [ 0.55 , 2.45 ] 2.54  [ 0.80 , 8.08 ] 1.25  [ 0.58  , 2.69 ] 
Maternal pregnancy smoking 2.32  [ 0.84 , 6.37 ] 1.86  [ 0.69 , 4.99 ] 1.81  [ 0.43 , 7.61 ] 2.32  [ 0.84  , 6.37 ] 
Constant 0.04 *** [ 0.01 , 0.12 ] 0.03 *** [ 0.01 , 0.09 ] 0.00 *** [ 0.00 , 0.02 ] 0.03 *** [ 0.01  , 0.09 ] 
Abbreviations: AOR = Adjusted Odds Ratio. CI = Confidence Interval. ### = AOR > 99.99. P-values: *, p < 0.01, **, p < 0.01, ***, p < 0.001.  
Notes: a) Model G based on multiple imputations 1 and 3 failed to replicate the best log-likelihood under 1500 random starts, the solutions may be not trusted. 
For imputation 1: Pearson Chi-Square = 92.34, df = 88, p = 0.355. For imputation 2: Pearson Chi-Square = 149.43, df = 88, p < 0.001. For imputation 3: Pearson Chi-Square = 



















This chapter provides a summary of the key research findings, reviews the 
strengths and limitations of the dissertation’s design, and discusses the research, 
clinical, and public health implications of the findings. 
7.1 Summary of Findings 
This dissertation investigated the relationship between preterm birth and the 
development of childhood asthma in a life-course framework, focusing on the pre- 
and peri-natal periods. The analysis was organized around three specific aims: 
1) To examine the consistency of various childhood asthma measures, and to 
determine whether the association between preterm birth and childhood 
asthma varies by measurement of asthma, degree of prematurity, and age at 
asthma assessment. 
2) To systematically examine the role of preterm birth and other pre- and peri-
natal risk factors in the development of childhood asthma. 
3) To characterize longitudinal patterns of childhood asthma using both the 
TCRS classification and statistical modeling, and to determine whether these 
longitudinal patterns vary between children born preterm and children born 
term. 
To address these aims, I used longitudinal data from the BBC, a large, well-
established, prospective birth cohort drawn from the urban, multiethnic, 
predominantly low income, population seeking obstetric and pediatric health care at 
the Boston Medical Center. The BBC contains higher percentage of preterm birth and 




oversampling of these high-risk newborns. The overall results from the association 
analyses are directly relevant to high risk, low income populations in Boston, and 
may be generalizable to other urban low income settings with similar characteristics. 
7.1.1 Key Findings 
The analyses for Specific Aim 1 explored the consistency of asthma measures 
based on electronic medical record (EMR) data and defined differently by type of 
EMR data (physician diagnosis vs. prescribed medication), clinical phenotype 
(wheezing vs. asthma vs. Asthma exacerbation), and number of episodes (single vs. 
multiple), and found that the measures varied in their agreements with each other 
(Kappa: 0.16 ~ 0.76) and in their estimates of asthma prevalence. However, the 
estimates of the association between preterm birth and childhood asthma are highly 
robust: for ages 0-5 years (AORs] range: 1.8 [95%CI, 1.5-2.3] to 2.9 [95%CI, 1.8-4.4]) 
and ages 6-9 years (AORs: 2.0 [95%CI, 1.3-3.0] to 2.9 [95%CI, 2.1-4.1]), compared 
with term born children. In addition, a dose-response association was observed 
between the degree of prematurity and asthma, with the highest risk of asthma 
among early preterm births (< 32 weeks of gestational age, followed by late preterm 
births (33-36 weeks); the lowest risk was among early term (37-38 weeks) and full 
term births (39-41 weeks). 
The analyses for Specific Aim 2 found that preterm birth was one of the 
strongest independent risk factors for asthma among the broad array of pre- and 
peri-natal risk factors examined. Preterm birth also was a significant mediator for 




to half of the chorioamnionitis effect, and a smaller proportion of the maternal 
race/ethnicity and maternal history of asthma effects. Preterm birth also significantly 
modified the effects of several pre- and peri-natal risk factors on asthma. Specifically, 
preterm birth enhanced the adverse effects of maternal persistent smoking during 
pregnancy, maternal history of atopy, and delivery by C-section. Similar patterns 
were seen when the analyses was stratified by child age (under age 6 years vs. 6-9 
years), though some of the prenatal effects attenuated or faded at older ages. These 
findings lent support to the fetal origins of asthma hypothesis, where preterm birth is 
an independent risk factor, mediator, and modifier in the pathways linking pre- and 
peri-natal variables to childhood asthma. 
The analyses for Specific Aim 3 found six longitudinal patterns using the 
modified TCRS classification approach (transient early, transient middle, middle-
onset, late-onset, persistent, and no asthma) and four patterns using the longitudinal 
latent class analysis approach (middle-onset, late-onset, persistent, and none 
asthma). Furthermore, these distinct childhood asthma patterns showed varied 
relationships with preterm birth. Preterm birth greatly increased the risk of 
persistent childhood asthma defined by both the TCRS and latent class analysis 
approaches, moderately increased the risk of transient early asthma by the TCRS 
classification approach and the risk of middle-onset asthma by the latent class 
analysis approach, but did not significantly increase the risk of transient middle 
asthma occurring between ages 3-5 years or late-onset asthma occurring at age 6 




7.1.2 Major Contributions 
This dissertation research contributes new knowledge to fill the four knowledge 
gaps (study population, measurement heterogeneity, life-course pathways, and 
longitudinal patterns) described in section 2.6. 
First, the dissertation used data from the BBC, which is drawn from a U.S. 
population with a high risk of asthma: the urban, predominantly low-income, 
multiethnic patient population at the Boston Medical Center. In the BMC obstetric 
patient population, the rate of preterm birth is about 16%, which has a 
corresponding population attributable fraction of 12% for ever diagnosed asthma 
and 18% for recurrent school age asthma. Preterm birth is a major risk factor for 
childhood asthma, particularly in the urban low-income population in the United 
States. 
Second, this dissertation research has extensively examined the measurement 
issues surrounding the preterm birth-asthma association, specifically, measures of 
asthma, degree of preterm birth, and age of assessment, and the impact of these 
measurement issues on the preterm birth-asthma link. This is the first original study, 
rather than a review or meta-analysis, to investigate these three measurement issues 
simultaneously. The results provide comprehensive comparisons for understanding 
the differences among asthma measures in childhood and strong support for the 
adverse effect of preterm birth on asthma. The results showed a dose-response 





Third, this dissertation research has pushed the field forward from the bivariate 
relationship between preterm birth and childhood asthma to an analysis of the 
pathways by which preterm birth shapes the development of asthma. By testing the 
mediating and moderating effects of preterm birth on the relationships between pre- 
and peri-natal risk factors and childhood asthma, this research adds to our 
understanding of the early origins of childhood asthma. The use of multiple 
approaches for analyzing mediation adds to the strength of the conclusions. 
Fourth, the longitudinal patterns of childhood asthma and their relationship 
with preterm birth were systematically investigated using both standard clinical 
categories and sophisticated statistical methods. These contributions include: 1) 
updating the original TCRS classification rules; 2) investigating the longitudinal 
pattern of physician diagnosed asthma rather than wheezing; 3) using EMR records 
rather than parental reports; 4) evaluating measurement invariance between 
children born preterm and children born term; 5) for the first time, examining the 
relationship between preterm birth and longitudinal patterns of asthma . This 
exploration of the heterogeneity of longitudinal patterns of asthma extends our 
understanding of the natural history of asthma in a high risk population, and moves 
research on the preterm birth-asthma relationship from the overall risk of childhood 
asthma to the risks of more refined longitudinal phenotypes of childhood asthma. 
7.2 Strengths 
The study design, sampling strategy, and data collection strategies of the BBC 




Study Design. The prospective birth cohort design with long-term follow-up 
(from birth up to age 10 years) of 2,701 mother-pair pairs provided a clear 
temporality between exposure and outcome, a good length of time to observe the 
outcome, and a large sample for assessing complex relationships and analyzing 
subgroups, all of which assured the internal validity of the analyses. 
Sampling Strategy. The BBC study recruited a unique sample with a high 
proportion of preterm births, and a high risk of asthma. Although this recruitment 
limited the generalizability of results to some extent, it increased the internal validity 
by increasing the exposure level of preterm birth, and allowed an in-depth analysis of 
childhood asthma in a high risk population. 
Data Collection Mode. The multi-pronged (maternal interviews, medical record 
abstraction, and electronic medical records) and longitudinal data collection of the 
BBC study provided the opportunity validate the quality of asthma measures, to 
examine the effects of an array of explanatory factors, and to examine the 
longitudinal patterns of childhood asthma. Moreover, the EMR recorded diagnoses 
were less likely to suffer from recall or reporting biases compared with parental 
reports. 
This dissertation is innovative because it integrated several conceptual 
frameworks, examined measurement dependence, tested life-course pathways, 
identified phenotypic heterogeneity of longitudinal patterns, and applying advanced 
analytical methods to address each study aim. 




developed and framed by integrating three conceptual approaches (causal pathways, 
life course and ecological), biological knowledge, and previous empirical findings 
about the early origins of asthma, with an emphasis on the role of preterm birth. The 
effort to bridge disciplines -- psychosocial, environmental and clinical -- to 
understand the pathways linking preterm birth and asthma expands the scope of 
traditional epidemiological studies in this field. 
Measurement Dependence. This dissertation explicitly acknowledged and 
analyzed the inconsistency and heterogeneity in the previously reported preterm 
birth-asthma association. Analyses for Specific Aim 1 were devoted to investigating 
the extent to which the preterm birth-asthma association depended on three aspects 
of measurement: measure of asthma, degree of preterm birth, and age of 
assessment. 
Advanced Analytical Methods. This dissertation applied four novel advanced 
statistical methods in the analyses for Specific Aim 2 and 3. These provided new 
types of evidence to understand the relationship between preterm birth and 
childhood asthma, with stronger causal and clinical inferences. The use of these 
methods shows how they can be used to improve MCH research. 
1) For the mediation analysis in Specific Aim 2, in addition to the classic 
approach to meditation analysis outlined by Baron and Kenny,1 with 
statistical tests for indirect effects using the Sobel test with 
bootstrapped confidence intervals, the new causal mediation analysis 




Both these approaches provided quantitative evaluation with 
statistical inference, but the latter was stronger in providing causal 
inference, establishing meaningful quantitative results, and handling 
binary mediators and outcomes. 
2) For the moderation analysis in Specific Aim 2, additive interaction 
analyses were conducted in addition to the multiplicative interaction 
analyses. Multiplicative interactions have been considered the 
standard for testing moderating effects in multiple logistic regression. 
However, compared with the multiplicative interactions, additive 
interactions provide more causal inference about changes in risk of 
asthma and stable results not influenced by the other main effects 
and interaction terms included in the model. 
3) The Longitudinal Latent Class Analysis used for Specific Aim 3 
allowed, for the first time, systematic tests for measurement 
invariance of the identified longitudinal patterns of asthma in relation 
to preterm birth status. This model checking procedure showed that 
longitudinal patterns of asthma were similar for preterm and term 
born children, though the distributions of patterns were different by 
preterm birth status. 
4) For the association analyses in Specific Aim 3, Latent Class Regression 




relationship between pre- and peri-natal variables and longitudinal 
patterns of asthma. This method tests the measurement model and 
association model simultaneously, so is more accurate and efficient 
than unweighted and weighed multinomial regression analysis. 
7.3 Limitations 
This dissertation is also subject to following limitations, including 
generalizability, selection bias, differential loss to follow-up, missing data, 
measurement bias, unmeasured variables, and scope of causal inference. 
Generalizability. The sample used by this dissertation was not selected using 
probability sampling and is composed mostly of poor, minority, residents of Boston 
largely covered by public welfare programs. Due to the unique demographic, 
environmental, urban planning, and health service of this location, cautions are 
needed in generalizing the study findings to other regions and countries with 
different characteristics. 
Selection Bias and Differential Loss to Follow-Up. While the participation rate 
in the baseline study was very high (over 90%), the follow-up study was a subset of 
the baseline study, in which only those children who continued to have pediatric 
primary care at BMC were followed. Comparisons of sample characteristics showed 
that the analytic sample in the follow-up study was not statically different from the 
whole cohort at baseline and all eligible pediatric patients.2 Compared with the 
analytic sample regardless of age, children retained to age 6 years are similar in 




allergies, and pregnancy smoking), but more likely to have mothers of African 
American ethnicity (66.2% > 59.3%, p < 0.001) or lower education attainment (some 
college and above, 28.9% < 35.1%, p < 0.001), and slightly more postnatal family 
member smoking (34.1% > 31.6%, p = 0.024). This selection bias could be due to 
demographic differences by birth cohorts or differential loss to follow-up -- children 
dropped out earlier than expected were likely to be the healthiest. Therefore, the 
results based on the analytic sample are less likely to biased due to selection of 
recruitment, but may be slightly biased to African American and low education 
population. 
Missing Data. The data from electronic medical records, medical record 
abstractions, and maternal interviews all contained missing values. This issue was 
approached systematically, and extensive sensitivity analyses were applied to assess 
the potential impact of the most problematic missing data. Missing values in the 
EMR data, as reviewed in Chapter 3, were likely to depend on missed clinic visits due 
to mild or no health problems. To address this informative missing pattern (i.e. not 
missing at random), the most frequent imputation used for EMR data was applied – 
assigning 0 (no asthma) for the asthma measure of the year of no clinic visits. 
Sensitivity analyses showed that this method slightly underestimated the risk of 
asthma compared with multiple imputation and complete cases methods, but 
generated robust results on the key hypotheses tests of the relationship between 
preterm birth and childhood asthma incidence or patterns. The missing values of 




interviews were handled according to the importance of the variable to the analysis 
and the amount of missing data. For those with high importance and low missing 
rate, deleting the case with missing values were applied; for those with less 
importance and relatively higher missing rate, multiple imputation based on 
variables with compile data were applied. Sensitivity analyses for results likely to be 
influenced by missing explanatory variables (see Chapter 5) showed that the main 
findings were similar when using complete data, all data, and imputed data using 
multiple chained equations. In sum, in this dissertation, the estimation of the risk of 
asthma might be slightly influenced by missing values, but the results of hypotheses 
testing were largely robust. 
Measurement Bias. Given the observational nature of this dissertation, 
theoretically both the maternal interviews and medical records are influenced by 
different types of errors and biases. First, maternal report of family context, 
psychosocial stress, health history might be subjected to recall bias, socioeconomic 
bias, social disability or self-serving bias. Second, physician diagnosis in medical 
records might be influenced by severity of patents symptoms and physician’s training 
or experience, and misclassification due to the difficulty of distinguishing other 
respiratory conditions which also cause asthma-like symptoms. This dissertation 
research was carefully conducted to control measurement biases on the major 
explanatory variable and outcome variables. For the major explanatory variable, 
preterm birth and gestational age, were measured by an algorithm of two sources 




certificates or maternal report that are often used by studies of the preterm birth-
asthma association. For asthma, analysis of measurement consistency was done for 
Specific Aim 1 to facilitate the selection of a measure to use in Specific Aim 2, and 
exploration of longitudinal patterns of asthma in Specific Aim 3 increased the 
construct validity and reliability of the asthma measures. 
Unmeasured Variables. The BBC study collected very comprehensive 
information about the clinical aspects of maternal and child health, but had limited 
information on the psychosocial aspects (including family processes, maternal mental 
health, and parenting styles) and limited years of data collection on household 
environment (including allergens and dust). Since these systems might contribute to 
the onset and progression of asthma, failing to include indicators for them might 
confound some of the associations between risk and preterm birth and childhood 
asthma, and compromise the completeness of the life course pathways. But as one of 
the first studies to test the life course pathways linking preterm birth and childhood 
asthma, this dissertation included the most important prenatal explanatory variables 
and selected the data collection period with the most complete data for these 
variables, to ensure the analytic results were not seriously confounded by variables 
not included for analysis. 
Causal Inference. In this dissertation, I was not able to manipulate the 
treatment, or to assign subjects randomly to the treatment of preterm birth, or find 
an instrumental variable to fully represent the risk of preterm birth. Observational 




inherent limitations for drawing causal conclusions. Therefore, all findings about the 
links between variables should be viewed as associations, instead of causal relations. 
However, for the observational studies, the causal inference associations can be 
evaluated by a set of causal criteria, including strength, consistency, specify, 
temporality, biological gradient, plausibility, coherence, experimental evidence, and 
analogy3,4. Among these criteria, temporality is of vital importance in observational 
studies. In this dissertation, the temporality criterion was largely satisfied by the 
prospective cohort study design, except for some variables measured or occurring at 
the same time, such as C-section delivery and preterm birth. The strength, 
consistency, and biological gradient criteria were partially addressed by analyses for 
Specific Aim 1. Specificity and plausibility were partially addressed by the mediation 
and moderation analyses in Specific Aim 2, and the literature review in Chapter 2. 
The remaining criteria, coherence, experimental evidence, and analogy were not 
covered by the specific aims of this dissertation research, and must be addressed by 
future studies. 
7.4 Implications 
This dissertation confirms the robust association between preterm birth and 
childhood asthma. More importantly, it provides new insight on the fetal origins of 
asthma, where preterm birth is not only an independent risk factor, but also a 
mediator and modifier for other pre- and peri-natal factors. This dissertation also 
contributes new knowledge on the natural history of asthma by delineating 




dissertation have important implications for future research directions and inform 
clinical and public health practice as highlighted below. 
7.4.1 Research 
Preterm birth and asthma are two major clinical and public health challenges 
worldwide. Yet few studies have examined the robustness of their relationship, 
common roots, and modifiable risk factors (common or unique) using a prospective 
birth cohort design. To further establish and understand the causal relationship 
between preterm birth and childhood asthma, more physiological and epigenetic 
studies are needed to understand the biological pathways, and even longer-term 
studies are needed to study asthma development from prenatal, to neonatal, to 
childhood, to adolescence. 
Findings from this dissertation also suggest several future directions of research 
on the relationship between preterm birth and childhood asthma, including asthma 
measurement, life course pathways, phenotypic heterogeneity, and the ”Preterm 
Birth Origins” hypothesis of the asthma epidemic. 
Asthma Measurement. This dissertation has shown that various measures of 
asthma defined by type of EMR data, clinical phenotype, and number of episodes 
were not always highly consistent; in particular, diagnoses of asthma and wheezing 
were just fairly consistent. These measures have generated significant differences 
when estimating prevalence in the same birth cohort, which implies that estimates of 
asthma prevalence are highly dependent on which measure is used. This dissertation 




significant, dependence on measures of asthma, and have high dependence on 
degree of prematurity. This implies that future original studies should clearly report 
their working definition of asthma and distribution of degree of prematurity, so the 
results can be carefully evaluated and compared with other studies. However, this 
dissertation has only discussed the consistency of asthma measures based on EMR 
data. More studies are needed to examine the impact of various asthma measures, 
such as parent report measures of asthma. 
Life Course Pathways. This dissertation provides a conceptual framework and 
analytical demonstration for testing the life course pathways in the early life origins 
of childhood asthma using mediation and moderation analyses. This dissertation 
expands the discussion from testing the simple binary associations or the joint 
effects of early life factors, to pathways with multiple determinants and sequential 
events. More studies are needed to study the infant origins hypothesis of asthma, i.e. 
effects of variables in the early postnatal period, which were not empirically tested in 
this dissertation. 
Phenotypic Heterogeneity. The finding that preterm birth was associated 
differently with distinct childhood asthma patterns not only confirms that childhood 
asthma is a disease with variant manifestations, but also indicates variant pathways 
or etiologies in the development of asthma. Since this dissertation is the first to study 
the longitudinal pattern of physician diagnosed asthma, more studies are needed to 
verify the findings. Following this direction, more studies could be done to examine if 





“Preterm Birth Origins” Hypothesis of the Asthma Epidemic. Findings from this 
dissertation support the adverse effect of preterm birth on the overall risk of 
childhood asthma, which also implies a “Preterm Birth Origins” hypothesis of asthma 
epidemic. This could be an additional way other than the “Hygiene Hypothesis”5 to 
understand the population-wide rising trend of asthma. This hypothesis is also 
consistent with some observations on race disparities and historical trends. The 
association between preterm birth and childhood asthma helps to explain the 
disparity of asthma among African American children. A U.S, based study has found 
that the disparity of the prevalence of childhood asthma between Black and White 
can be explained by their preterm birth status.6 Also, another study has found that 
preterm birth is positively associated with the risk of asthma, and negatively 
associated with allergic diseases, which suggests that the effect of preterm birth was 
not due to increased atopy. Globally, the prevalence rate of preterm birth7 parallels 
the childhood asthma prevalence rate.8,9 And the survival rate of preterm births, 
especially early preterm births, has increased since 1970s,5 which also parallels the 
increase of childhood asthma. These observations suggest that other than the 
exposure to infections that introduced Th2-biased responses (“Hygiene Hypothesis”), 
the growing population burden of preterm birth (especially early preterm) might be 
an important contributor to the rising rate of asthma.  
7.4.2 Clinical and Public Health Practice 




prevention of asthma from birth to school age, and the high burden of preterm birth 
and childhood asthma in a low-income multiethnic populations in the United States. 
Thus there are two reasons that actions need to be taken to reduce the burden of 
preterm birth and asthma. Findings from this dissertation have several implications 
for clinical and public health practice. 
For clinical practices, there are two types of implications: 1) for physician 
education, and 2) for prediction, diagnosis and management of asthma. 
Implications for physician education: 
 Asthma treatment and education guidelines should include the PTB-asthma 
relationship in order to inform physicians of related areas, including general 
pediatrics, pulmonologists, immunologists, neonatologists, obstetricians 
and gynecologists, about the increased risk of asthma among children born 
preterm, both early preterm or late term. 
 Asthma treatment and education guidelines should recommend that 
physicians inform patients or caregivers of the potential risk and trajectory 
of childhood asthma given the prenatal, perinatal, and early life 
characteristics of a child, and inform them about the known effective 
actions to alleviate the risk of developing asthma. The effective actions are 
listed below in the section for implications for interventions. 
Implications for prediction, diagnosis, and management of asthma: 
 Preterm birth, or degree of prematurity, should be considered as a major 




predictive indexes which are mostly developed based on European 
data10-12. According to findings in this dissertation based on a poor, 
urban, minority population, preterm birth is an equal or even more 
important determinant of higher Population Attributable Fraction (PAF) 
for asthma than maternal history of asthma, a well-established risk 
factor of asthma13,14. Updating a predictive tool for high risk population 
by including preterm birth or degree of prematurity might improve the 
predictive power of such tools for asthma in high risk populations in the 
United States. 
 EMR data, particularly diagnoses of asthma and wheezing, should be 
used to inform new diagnosis, track the diagnosing process, ensure the 
accuracy of diagnosis, and provide more data to understand influences 
on the diagnosing behaviors of physicians. 
 The EMR system should incorporate functions not only to record 
histories of diagnoses and prescriptions, but also useful tools based on 
clinical or statistical methods, such as those used in this dissertation, to 
inform physicians about the progression of asthmatic symptoms in a 
timely manner, to improve management and control of asthma. 
For public health practice, there are also two types of implications: 1) for 
prevention programs, and 2) for prediction, diagnosis and management of asthma, 
and policy development and evaluation. 




 The life-course perspective should be applied to develop effective 
preventions for asthma, as suggested by evidence of early life origins of 
asthma. Rather than focusing only on disease management and control 
when the symptoms of asthma already established (secondary and 
tertiary preventions) like the status quo (e.g. home visiting programs), 
future programs should also focus on primary interventions at early life 
stages, including prenatal, perinatal, and early childhood. 
 Programs focused on the pre- and peri-natal periods could target 
reducing preterm birth to prevent childhood asthma, in effect “hitting 
two birds with one stone”, i.e. addressing the problems of preterm birth 
and childhood asthma by one program. The strategies that are proven 
effective to reduce the preterm birth rate at population level, and those 
at clinical level that could be included in public health interventions, are 
smoking cessation, reducing multiple embryo transfers during assisted 
fertilities, cervical cerclage, progesterone treatment, and reducing non-
medically indicated labor induction or caesarean delivery.15 Some 
evidence suggest that maternal dietary intakes of some nutritional 
supplements (protein, zinc, magnesium)16 may reduce the risk of 
preterm birth, and high dietary intakes of vitamin D and E during 
pregnancy may reduce the risk of wheezing disorders.17 In line with 
findings from this dissertation, better management of pregnancy 




and pregnancy infections (urogenital infections and chorioamnionitis) 
may also reduce preterm birth rate.16 
 Postnatal intervention programs focused on early childhood should 
provide anticipatory guidance to families of infants born preterm 
regarding heightened risk of asthma and respiratory conditions, and 
education on potential preventive measures, as education and self-
management interventions18 are proven effective for asthma control. 
The potential preventive measures including influenza19,20 and 
pneumococcal21 vaccinations, respiratory syncytial virus (RSV) 
prophylaxis,22,23 good hand washing,24 avoiding secondhand smoke 
exposure,25 adherence to inhaled steroids if prescribed,26 multifaceted 
allergen avoidance,27 and feeding of hydrolyzed formula if breastfeeding 
is not possible.25 
Implications for policy development and evaluation: 
 Findings from this dissertation imply that primary prevention of PTB is 
not only important in itself but may simultaneously reduce the burden of 
childhood asthma, which may be a cost-efficient strategy for reducing 
the medical and societal costs of to both PTB and asthma, and improving 
population health across the lifespan. 
 Current estimation of the costs of preterm births and benefits of 
preterm birth interventions are likely to be underestimated, because the 




and independently linked to preterm birth, instead of indirect, and long-
term effects of preterm birth. Findings on mediating and moderating 
effects, and long-term respiratory effect of preterm birth from this 
dissertation are helpful to quantify the full spectrum of the costs caused 
by preterm birth, and the benefits of interventions targeting preterm 
birth. Findings from this dissertation underscore the importance to set 
MCH priorities and policies based on a life course paradigm. 
This dissertation also raised the possibility of pre-conception and prenatal 
prevention of childhood asthma. By updating the clinical guidelines based on new 
research evidence on preterm birth and childhood asthma, using preterm birth and 
EMR information to facilitate asthma diagnosis and management, enhancing primary 
prevention programs for preterm birth and childhood asthma, and advocating a life-
course strategy of policy making with better cost-effective evolutions, the challenge 
of the high burdens of preterm birth and childhood asthma will be effectively 
controlled, and the achievement of “Triple Aim”28 of health care -- “improving the 
experience of care”, ”improving the health of populations”, and “reducing per capita 
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 Bernard & Jane Guyer Scholarship Endowed Award, Bloomberg School of Public Heath, 
2013 
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Association of America Annual Conference. 
 He, H., Yasutake, S., Decker, M. R., Sonenstein, F. L., Blum, R., & Astone, N. (2013). The 
Trend of Undernutrition Status for Female Youth in Low Income and Middle Income 
Countries from 1999 to 2009. Paper presented at the Population Association of America 
Annual Conference. 
 Yasutake, S., He, H., Decker, M. R., Sonenstein, F. L., Blum, R., & Astone, N. M. (2013). 
Examination of Anemia among Young Women in 34 DHS Countries: Prevalence by Age, 
Residence, Education and Household Wealth. Paper presented at the Population 
Association of America Annual Conference. 
 He, H., Qu, Z., Wang, X., & Zhang, X. (2012). Poverty, Perceived Economic Stress and Self-
Esteem among Children from Impoverished Areas in China. Paper presented at the 
Population Association of America Annual Conference. 
 Coordinator of the Early Childhood Education and Welfare Policy Workshop, Beijing, 
2009.10. 
 Discussant of the Social Protection in Asia Programme Annual Conference (SPA), IDRC & 





Research Assistant, Johns Hopkins Bloomberg School of Public Health, Baltimore, 
2012.01 - 
Center on Early Origins of Diseases, 2013.12 - 
 Molecular Epidemiology of Preterm Birth: Environmental and Genetic Interactions 
Repository, NIH & March and Dime, 2013.07 - 
 BMC Children's Health Study, NIH & other foundations, 2013.07 - 
International Injury Research Unit, 2012.06 - 
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